App D: Misuse of Presc. Rx: Data from 2k2, 2k3, & 2k4 NSDUH, SAMHSA, Office of Applied Studies

51020

**Table 2.1AB Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older: Numbers in Thousands and Percentages, 2002-2004**
Drug	TIME PERIOD
	Lifetime			Past Year			Past Month
	2002	2003	2004	2002	2003	2004	2002	2003	2004
	Numbers in Thousands
*Low precision; no estimate reported. -- Not available. ^a Difference between estimate and 2004 estimate is statistically significant at the .05 level. ^b Difference between estimate and 2004 estimate is statistically significant at the .01 level. ¹ Nonmedical use of prescription-type pain relievers, tranquilizers, stimulants, or sedatives; does not include over-the-counter drugs. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
Nonmedical Use of Psychotherapeutics¹	46,558	47,882	48,013	14,680	14,986	14,643	6,210	6,336	6,007
Pain Relievers	29,611^a	31,207	31,768	10,992	11,671	11,256	4,377	4,693	4,404
OxyContin^®	1,924^b	2,832	3,072	--	--	1,213	--	--	325
Tranquilizers	19,267	20,220	19,852	4,849	5,051	5,068	1,804	1,830	1,616
Stimulants	21,072	20,798	19,982	3,181	2,751	2,918	1,218	1,191	1,189
Methamphetamine	12,383	12,303	11,726	1,541	1,315	1,440	597	607	583
Sedatives	9,960	9,510	9,891	981	831	737	436^a	294	265
Drug	Percentages
Nonmedical Use of Psychotherapeutics¹	19.8	20.1	20.0	6.2	6.3	6.1	2.6	2.7	2.5
Pain Relievers	12.6	13.1	13.2	4.7	4.9	4.7	1.9	2.0	1.8
OxyContin^®	0.8^b	1.2	1.3	--	--	0.5	--	--	0.1
Tranquilizers	8.2	8.5	8.3	2.1	2.1	2.1	0.8	0.8	0.7
Stimulants	9.0^a	8.8	8.3	1.4	1.2	1.2	0.5	0.5	0.5
Methamphetamine	5.3	5.2	4.9	0.7	0.6	0.6	0.3	0.3	0.2
Sedatives	4.2	4.0	4.1	0.4	0.3	0.3	0.2^a	0.1	0.1

51020

**Table 2.2AB Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17: Numbers in Thousands and Percentages, 2002-2004**
Drug	TIME PERIOD
	Lifetime			Past Year			Past Month
	2002	2003	2004	2002	2003	2004	2002	2003	2004
	Numbers in Thousands
*Low precision; no estimate reported. -- Not available. ^a Difference between estimate and 2004 estimate is statistically significant at the .05 level. ^b Difference between estimate and 2004 estimate is statistically significant at the .01 level. ¹ Nonmedical use of prescription-type pain relievers, tranquilizers, stimulants, or sedatives; does not include over-the-counter drugs. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
Nonmedical Use of Psychotherapeutics¹	3,389	3,351	3,394	2,283	2,289	2,225	979	997	914
Pain Relievers	2,775	2,798	2,879	1,870	1,917	1,865	794	801	751
OxyContin^®	224^b	254	305	--	--	194	--	--	66
Tranquilizers	834	874	816	568	586	532	188	226^a	161
Stimulants	1,074^b	1,007^a	867	650^b	568	496	200	221	178
Methamphetamine	366	328	299	226^a	174	163	63	69	57
Sedatives	238	249	251	138	131	133	47^a	47	26
Drug	Percentages
Nonmedical Use of Psychotherapeutics¹	13.7	13.4	13.5	9.2	9.2	8.8	4.0	4.0	3.6
Pain Relievers	11.2	11.2	11.4	7.6	7.7	7.4	3.2	3.2	3.0
OxyContin^®	0.9^a	1.0	1.2	--	--	0.8	--	--	0.3
Tranquilizers	3.4	3.5	3.2	2.3	2.3	2.1	0.8	0.9^a	0.6
Stimulants	4.3^b	4.0^b	3.4	2.6^b	2.3	2.0	0.8	0.9	0.7
Methamphetamine	1.5^a	1.3	1.2	0.9^a	0.7	0.6	0.3	0.3	0.2
Sedatives	1.0	1.0	1.0	0.6	0.5	0.5	0.2^a	0.2	0.1

51020

**Table 2.3AB Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25: Numbers in Thousands and Percentages, 2002-2004**
Drug	TIME PERIOD
	Lifetime			Past Year			Past Month
	2002	2003	2004	2002	2003	2004	2002	2003	2004
	Numbers in Thousands
*Low precision; no estimate reported. -- Not available. ^a Difference between estimate and 2004 estimate is statistically significant at the .05 level. ^b Difference between estimate and 2004 estimate is statistically significant at the .01 level. ¹ Nonmedical use of prescription-type pain relievers, tranquilizers, stimulants, or sedatives; does not include over-the-counter drugs. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
Nonmedical Use of Psychotherapeutics¹	8,587^b	9,211	9,392	4,411^a	4,598	4,751	1,683^b	1,913	1,959
Pain Relievers	6,854^b	7,513	7,813	3,540^a	3,803	3,834	1,262^b	1,486	1,504
OxyContin^®	820^b	1,145^b	1,376	--	--	562	--	--	142
Tranquilizers	3,473^b	3,898	3,919	1,509	1,682	1,658	487	525	566
Stimulants	3,340	3,420	3,426	1,144	1,114	1,181	386	400	446
Methamphetamine	1,756	1,650	1,688	525	506	516	160	185	186
Sedatives	648	565	627	162	156	163	49	58	49
Drug	Percentages
Nonmedical Use of Psychotherapeutics¹	27.7^a	29.0	29.2	14.2	14.5	14.8	5.4^a	6.0	6.1
Pain Relievers	22.1^b	23.7	24.3	11.4	12.0	11.9	4.1^a	4.7	4.7
OxyContin^®	2.6^b	3.6^b	4.3	--	--	1.7	--	--	0.4
Tranquilizers	11.2^a	12.3	12.2	4.9	5.3	5.2	1.6	1.7	1.8
Stimulants	10.8	10.8	10.6	3.7	3.5	3.7	1.2	1.3	1.4
Methamphetamine	5.7	5.2	5.2	1.7	1.6	1.6	0.5	0.6	0.6
Sedatives	2.1	1.8	1.9	0.5	0.5	0.5	0.2	0.2	0.2

51020

**Table 2.4AB Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older: Numbers in Thousands and Percentages, 2002-2004**
Drug	TIME PERIOD
	Lifetime			Past Year			Past Month
	2002	2003	2004	2002	2003	2004	2002	2003	2004
	Numbers in Thousands
*Low precision; no estimate reported. -- Not available. ^a Difference between estimate and 2004 estimate is statistically significant at the .05 level. ^b Difference between estimate and 2004 estimate is statistically significant at the .01 level. ¹ Nonmedical use of prescription-type pain relievers, tranquilizers, stimulants, or sedatives; does not include over-the-counter drugs. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
Nonmedical Use of Psychotherapeutics¹	34,582	35,320	35,227	7,986	8,099	7,667	3,549	3,426	3,134
Pain Relievers	19,983	20,896	21,076	5,582	5,950	5,556	2,321	2,406	2,149
OxyContin^®	881^b	1,433	1,392	--	--	457	--	--	118
Tranquilizers	14,959	15,447	15,117	2,772	2,783	2,878	1,129	1,078	889
Stimulants	16,658	16,371	15,689	1,387	1,068	1,241	631	570	565
Methamphetamine	10,261	10,325	9,739	790	636	761	375	353	340
Sedatives	9,075	8,696	9,012	681	544	441	340	189	190
Drug	Percentages
Nonmedical Use of Psychotherapeutics¹	19.3	19.5	19.2	4.5	4.5	4.2	2.0	1.9	1.7
Pain Relievers	11.1	11.5	11.5	3.1	3.3	3.0	1.3	1.3	1.2
OxyContin^®	0.5^b	0.8	0.8	--	--	0.2	--	--	0.1
Tranquilizers	8.3	8.5	8.3	1.5	1.5	1.6	0.6	0.6	0.5
Stimulants	9.3^a	9.0	8.6	0.8	0.6	0.7	0.4	0.3	0.3
Methamphetamine	5.7	5.7	5.3	0.4	0.4	0.4	0.2	0.2	0.2
Sedatives	5.1	4.8	4.9	0.4	0.3	0.2	0.2^a	0.1	0.1

51020

**Table 2.5AB Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Males Aged 12 or Older: Numbers in Thousands and Percentages, 2002-2004**
Drug	TIME PERIOD
	Lifetime			Past Year			Past Month
	2002	2003	2004	2002	2003	2004	2002	2003	2004
	Numbers in Thousands
*Low precision; no estimate reported. -- Not available. ^a Difference between estimate and 2004 estimate is statistically significant at the .05 level. ^b Difference between estimate and 2004 estimate is statistically significant at the .01 level. ¹ Nonmedical use of prescription-type pain relievers, tranquilizers, stimulants, or sedatives; does not include over-the-counter drugs. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
Nonmedical Use of Psychotherapeutics¹	24,371	24,844	25,503	7,472	7,559	7,460	3,086	3,123	3,019
Pain Relievers	16,237	16,824	17,273	5,917	6,121	5,903	2,303	2,416	2,187
OxyContin^®	1,161^b	1,804	1,938	--	--	741	--	--	177
Tranquilizers	10,051	10,159	10,551	2,390	2,498	2,399	829	818	810
Stimulants	11,703	11,273	11,211	1,659	1,399	1,563	652	633	604
Methamphetamine	7,401	7,363	6,985	859	778	889	343	398	300
Sedatives	5,653	5,590	5,499	490	323	317	196	99	103
Drug	Percentages
Nonmedical Use of Psychotherapeutics¹	21.5	21.6	21.9	6.6	6.6	6.4	2.7	2.7	2.6
Pain Relievers	14.3	14.6	14.8	5.2	5.3	5.1	2.0	2.1	1.9
OxyContin^®	1.0^b	1.6	1.7	--	--	0.6	--	--	0.2
Tranquilizers	8.8	8.8	9.1	2.1	2.2	2.1	0.7	0.7	0.7
Stimulants	10.3	9.8	9.6	1.5	1.2	1.3	0.6	0.6	0.5
Methamphetamine	6.5	6.4	6.0	0.8	0.7	0.8	0.3	0.3	0.3
Sedatives	5.0	4.9	4.7	0.4	0.3	0.3	0.2^a	0.1	0.1

51020

**Table 2.6AB Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Females Aged 12 or Older: Numbers in Thousands and Percentages, 2002-2004**
Drug	TIME PERIOD
	Lifetime			Past Year			Past Month
	2002	2003	2004	2002	2003	2004	2002	2003	2004
	Numbers in Thousands
*Low precision; no estimate reported. -- Not available. ^a Difference between estimate and 2004 estimate is statistically significant at the .05 level. ^b Difference between estimate and 2004 estimate is statistically significant at the .01 level. ¹ Nonmedical use of prescription-type pain relievers, tranquilizers, stimulants, or sedatives; does not include over-the-counter drugs. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
Nonmedical Use of Psychotherapeutics¹	22,187	23,038	22,510	7,208	7,427	7,183	3,125	3,213	2,988
Pain Relievers	13,374^a	14,383	14,496	5,075	5,549	5,353	2,075	2,277	2,217
OxyContin^®	763^b	1,029	1,134	--	--	472	--	--	148
Tranquilizers	9,216	10,061	9,302	2,458	2,553	2,669	975	1,012	806
Stimulants	9,369	9,525	8,770	1,522	1,352	1,355	566	558	585
Methamphetamine	4,982	4,941	4,741	682	537	551	254	210	282
Sedatives	4,308	3,921	4,392	490	509	420	241	195	162
Drug	Percentages
Nonmedical Use of Psychotherapeutics¹	18.3	18.8	18.1	5.9	6.1	5.8	2.6	2.6	2.4
Pain Relievers	11.0	11.7	11.7	4.2	4.5	4.3	1.7	1.9	1.8
OxyContin^®	0.6^b	0.8	0.9	--	--	0.4	--	--	0.1
Tranquilizers	7.6	8.2	7.5	2.0	2.1	2.2	0.8	0.8	0.6
Stimulants	7.7	7.8	7.1	1.3	1.1	1.1	0.5	0.5	0.5
Methamphetamine	4.1	4.0	3.8	0.6	0.4	0.4	0.2	0.2	0.2
Sedatives	3.5	3.2	3.5	0.4	0.4	0.3	0.2	0.2	0.1

51020

**Table 2.7A Nonmedical Use of Prescription-Type Psychotherapeutics in the Past Year, by Detailed Age Category: Numbers in Thousands, Annual Averages Based on 2002-2004**
Age Category	Any Prescription- Type Psycho- therapeutic Drug	PRESCRIPTION DRUG TYPE
		Pain Relievers	Tranquilizers	Stimulants		Sedatives
		Pain Relievers	Tranquilizers	Any Stimulant	Metham- phetamine	Sedatives
*Low precision; no estimate reported. NOTE: Nonmedical use of prescription-type pain relievers, tranquilizers, stimulants, or sedatives; does not include over-the-counter drugs. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
TOTAL	14,769	11,306	4,989	2,950	1,432	850
12	122	101	14	18	3	9
13	215	180	25	42	11	19
14	323	274	61	73	24	20
15	437	358	104	126	46	28
16	546	454	160	148	46	34
17	623	518	198	165	57	25
18	715	610	214	171	68	26
19	680	553	224	191	76	17
20	641	520	227	170	56	19
21	616	498	228	172	81	25
22	565	444	204	140	62	23
23	525	430	197	126	70	21
24	474	388	180	99	58	17
25	372	284	141	77	46	14
26-29	1,531	1,176	553	257	150	72
30-34	1,407	1,038	493	269	180	71
35-39	1,374	982	470	201	139	91
40-44	1,268	907	446	226	123	92
45-49	1,115	779	384	166	106	97
50-54	517	371	208	58	14	55
55-59	273	183	119	16	14	30
60-64	218	125	83	8	4	17
65+	214	134	55	30	*	31

51020

**Table 2.7B Nonmedical Use of Prescription-Type Psychotherapeutics in the Past Year, by Detailed Age Category: Percentages, Annual Averages Based on 2002-2004**
Age Category	Any Prescription- Type Psycho- therapeutic Drug	PRESCRIPTION DRUG TYPE
		Pain Relievers	Tranquilizers	Stimulants		Sedatives
		Pain Relievers	Tranquilizers	Any Stimulant	Metham- phetamine	Sedatives
*Low precision; no estimate reported. NOTE: Nonmedical use of prescription-type pain relievers, tranquilizers, stimulants, or sedatives; does not include over-the-counter drugs. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
TOTAL	6.2	4.8	2.1	1.2	0.6	0.4
12	3.0	2.5	0.4	0.4	0.1	0.2
13	5.0	4.2	0.6	1.0	0.3	0.4
14	7.5	6.4	1.4	1.7	0.5	0.5
15	10.5	8.6	2.5	3.0	1.1	0.7
16	13.3	11.0	3.9	3.6	1.1	0.8
17	15.4	12.8	4.9	4.1	1.4	0.6
18	15.8	13.5	4.7	3.8	1.5	0.6
19	17.1	13.9	5.7	4.8	1.9	0.4
20	16.0	13.0	5.7	4.2	1.4	0.5
21	15.3	12.4	5.7	4.3	2.0	0.6
22	14.2	11.2	5.1	3.5	1.6	0.6
23	13.4	11.0	5.0	3.2	1.8	0.5
24	12.7	10.4	4.8	2.7	1.5	0.5
25	10.6	8.1	4.0	2.2	1.3	0.4
26-29	10.1	7.8	3.7	1.7	1.0	0.5
30-34	7.1	5.2	2.5	1.4	0.9	0.4
35-39	6.5	4.6	2.2	0.9	0.7	0.4
40-44	5.7	4.0	2.0	1.0	0.5	0.4
45-49	5.2	3.6	1.8	0.8	0.5	0.5
50-54	2.7	1.9	1.1	0.3	0.1	0.3
55-59	1.8	1.2	0.8	0.1	0.1	0.2
60-64	1.8	1.0	0.7	0.1	0.0	0.1
65+	0.6	0.4	0.2	0.1	*	0.1

51020

Table 2.8A Nonmedical Use of Prescription-Type Psychotherapeutics in the Past Year among Persons Aged 12 or Older, by Demographic Characteristics: Numbers in Thousands, Annual Averages Based on 2002-2004
Demographic Characteristic	Any Prescription- Type Psycho- therapeutic Drug	PRESCRIPTION DRUG TYPE
		Pain Relievers	Tranquilizers	Stimulants		Sedatives
		Pain Relievers	Tranquilizers	Any Stimulant	Metham- phetamine	Sedatives
*Low precision; no estimate reported. NOTE: Nonmedical use of prescription-type pain relievers, tranquilizers, stimulants, or sedatives; does not include over-the-counter drugs. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
TOTAL	14,769	11,306	4,989	2,950	1,432	850
AGE
12-17	2,266	1,884	562	571	187	134
18-25	4,587	3,726	1,616	1,147	516	160
26 or Older	7,917	5,696	2,811	1,232	729	555
GENDER
Male	7,497	5,980	2,429	1,540	842	377
Female	7,272	5,326	2,560	1,410	590	473
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	12,883	9,807	4,547	2,693	1,280	790
White	11,151	8,395	4,167	2,424	1,141	711
Black or African American	1,079	931	168	107	33	48
American Indian or Alaska Native	109	75	44	32	22	6
Native Hawaiian or Other Pacific Islander	66	47	8	21	14	5
Asian	287	216	80	38	20	7
Two or More Races	192	143	80	71	49	14
Hispanic or Latino	1,886	1,499	443	257	151	59

51020

**Table 2.8B Nonmedical Use of Prescription-Type Psychotherapeutics in the Past Year among Persons Aged 12 or Older, by Demographic Characteristics: Percentages, Annual Averages Based on 2002-2004**
Demographic Characteristic	Any Prescription- Type Psycho- therapeutic Drug	PRESCRIPTION DRUG TYPE
		Pain Relievers	Tranquilizers	Stimulants		Sedatives
		Pain Relievers	Tranquilizers	Any Stimulant	Metham- phetamine	Sedatives
*Low precision; no estimate reported. NOTE: Nonmedical use of prescription-type pain relievers, tranquilizers, stimulants, or sedatives; does not include over-the-counter drugs. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
TOTAL	6.2	4.8	2.1	1.2	0.6	0.4
AGE
12-17	9.1	7.5	2.2	2.3	0.7	0.5
18-25	14.5	11.8	5.1	3.6	1.6	0.5
26 or Older	4.4	3.1	1.6	0.7	0.4	0.3
GENDER
Male	6.5	5.2	2.1	1.3	0.7	0.3
Female	5.9	4.3	2.1	1.1	0.5	0.4
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	6.2	4.7	2.2	1.3	0.6	0.4
White	6.7	5.1	2.5	1.5	0.7	0.4
Black or African American	3.9	3.4	0.6	0.4	0.1	0.2
American Indian or Alaska Native	8.1	5.6	3.3	2.4	1.7	0.4
Native Hawaiian or Other Pacific Islander	10.1	7.2	1.2	3.3	2.2	0.8
Asian	3.0	2.3	0.8	0.4	0.2	0.1
Two or More Races	7.5	5.6	3.1	2.8	1.9	0.5
Hispanic or Latino	6.3	5.0	1.5	0.9	0.5	0.2

51020

**Table 2.9A Nonmedical Use of Prescription-Type Psychotherapeutics in the Past Year among Persons Aged 12 to 17, by Demographic Characteristics: Numbers in Thousands, Annual Averages Based on 2002-2004**
Demographic Characteristic	Any Prescription- Type Psycho- therapeutic Drug	PRESCRIPTION DRUG TYPE
		Pain Relievers	Tranquilizers	Stimulants		Sedatives
		Pain Relievers	Tranquilizers	Any Stimulant	Metham- phetamine	Sedatives
*Low precision; no estimate reported. NOTE: Nonmedical use of prescription-type pain relievers, tranquilizers, stimulants, or sedatives; does not include over-the-counter drugs. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
TOTAL	2,266	1,884	562	571	187	134
GENDER
Male	1,051	893	244	249	78	57
Female	1,214	991	318	323	110	77
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	1,923	1,598	483	509	155	117
White	1,580	1,300	439	456	138	92
Black or African American	229	206	15	24	4	16
American Indian or Alaska Native	27	22	8	8	6	2
Native Hawaiian or Other Pacific Islander	7	6	*	4	1	*
Asian	40	32	9	7	3	2
Two or More Races	39	33	11	10	3	3
Hispanic or Latino	342	286	79	62	32	17

51020

**Table 2.9B Nonmedical Use of Prescription-Type Psychotherapeutics in the Past Year among Persons Aged 12 to 17, by Demographic Characteristics: Percentages, Annual Averages Based on 2002-2004**
Demographic Characteristic	Any Prescription- Type Psycho- therapeutic Drug	PRESCRIPTION DRUG TYPE
		Pain Relievers	Tranquilizers	Stimulants		Sedatives
		Pain Relievers	Tranquilizers	Any Stimulant	Metham- phetamine	Sedatives
*Low precision; no estimate reported. NOTE: Nonmedical use of prescription-type pain relievers, tranquilizers, stimulants, or sedatives; does not include over-the-counter drugs. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
TOTAL	9.1	7.5	2.2	2.3	0.7	0.5
GENDER
Male	8.2	7.0	1.9	1.9	0.6	0.4
Female	9.9	8.1	2.6	2.6	0.9	0.6
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	9.2	7.6	2.3	2.4	0.7	0.6
White	10.2	8.4	2.8	2.9	0.9	0.6
Black or African American	6.2	5.5	0.4	0.6	0.1	0.4
American Indian or Alaska Native	15.2	12.2	4.6	4.5	3.6	1.3
Native Hawaiian or Other Pacific Islander	9.9	7.9	*	5.2	0.8	*
Asian	4.1	3.3	0.9	0.7	0.3	0.2
Two or More Races	9.6	8.1	2.6	2.4	0.6	0.7
Hispanic or Latino	8.4	7.0	1.9	1.5	0.8	0.4

51020

Table 2.10A Nonmedical Use of Prescription-Type Psychotherapeutics in the Past Year among Persons Aged 18 to 25, by Demographic Characteristics: Numbers in Thousands, Annual Averages Based on 2002-2004
Demographic Characteristic	Any Prescription- Type Psycho- therapeutic Drug	PRESCRIPTION DRUG TYPE
		Pain Relievers	Tranquilizers	Stimulants		Sedatives
		Pain Relievers	Tranquilizers	Any Stimulant	Metham- phetamine	Sedatives
*Low precision; no estimate reported. NOTE: Nonmedical use of prescription-type pain relievers, tranquilizers, stimulants, or sedatives; does not include over-the-counter drugs. ¹ Retired persons, disabled persons, homemakers, students, or other persons not in the labor force are included in the Other Employment category. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
TOTAL	4,587	3,726	1,616	1,147	516	160
GENDER
Male	2,481	2,084	854	616	290	82
Female	2,106	1,641	762	530	225	78
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	4,004	3,263	1,456	1,029	447	139
White	3,500	2,839	1,344	933	403	127
Black or African American	292	262	53	34	8	5
American Indian or Alaska Native	36	25	13	16	12	1
Native Hawaiian or Other Pacific Islander	17	14	2	4	3	0
Asian	87	69	18	20	6	3
Two or More Races	72	54	26	23	15	3
Hispanic or Latino	583	463	160	117	69	22
EDUCATION
< High School	1,097	920	385	239	154	33
High School Graduate	1,526	1,248	520	368	206	56
Some College	1,533	1,221	552	432	132	53
College Graduate	430	337	159	107	23	19
CURRENT EMPLOYMENT
Full-Time	2,056	1,699	736	446	222	66
Part-Time	1,200	971	398	318	105	45
Unemployed	486	388	197	145	92	19
Other¹	845	668	285	237	97	31

51020

**Table 2.10B Nonmedical Use of Prescription-Type Psychotherapeutics in the Past Year among Persons Aged 18 to 25, by Demographic Characteristics: Percentages, Annual Averages Based on 2002-2004**
Demographic Characteristic	Any Prescription- Type Psycho- therapeutic Drug	PRESCRIPTION DRUG TYPE
		Pain Relievers	Tranquilizers	Stimulants		Sedatives
		Pain Relievers	Tranquilizers	Any Stimulant	Metham- phetamine	Sedatives
*Low precision; no estimate reported. NOTE: Nonmedical use of prescription-type pain relievers, tranquilizers, stimulants, or sedatives; does not include over-the-counter drugs. ¹ Retired persons, disabled persons, homemakers, students, or other persons not in the labor force are included in the Other Employment category. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
TOTAL	14.5	11.8	5.1	3.6	1.6	0.5
GENDER
Male	15.6	13.1	5.4	3.9	1.8	0.5
Female	13.3	10.4	4.8	3.4	1.4	0.5
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	15.4	12.5	5.6	4.0	1.7	0.5
White	17.8	14.5	6.8	4.8	2.1	0.6
Black or African American	6.9	6.2	1.2	0.8	0.2	0.1
American Indian or Alaska Native	18.9	13.1	7.0	8.7	6.5	0.6
Native Hawaiian or Other Pacific Islander	11.4	9.1	1.5	2.5	2.0	0.1
Asian	6.0	4.7	1.3	1.4	0.4	0.2
Two or More Races	19.3	14.5	7.0	6.1	3.9	0.8
Hispanic or Latino	10.4	8.2	2.8	2.1	1.2	0.4
EDUCATION
< High School	16.1	13.5	5.6	3.5	2.3	0.5
High School Graduate	14.0	11.5	4.8	3.4	1.9	0.5
Some College	15.3	12.2	5.5	4.3	1.3	0.5
College Graduate	10.8	8.5	4.0	2.7	0.6	0.5
CURRENT EMPLOYMENT
Full-Time	14.0	11.5	5.0	3.0	1.5	0.4
Part-Time	14.9	12.0	4.9	3.9	1.3	0.6
Unemployed	18.9	15.1	7.7	5.6	3.6	0.7
Other¹	13.5	10.6	4.5	3.8	1.5	0.5

51020

Table 2.11A Nonmedical Use of Prescription-Type Psychotherapeutics in the Past Year among Persons Aged 26 or Older, by Demographic Characteristics: Numbers in Thousands, Annual Averages Based on 2002-2004
Demographic Characteristic	Any Prescription- Type Psycho- therapeutic Drug	PRESCRIPTION DRUG TYPE
		Pain Relievers	Tranquilizers	Stimulants		Sedatives
		Pain Relievers	Tranquilizers	Any Stimulant	Metham- phetamine	Sedatives
*Low precision; no estimate reported. NOTE: Nonmedical use of prescription-type pain relievers, tranquilizers, stimulants, or sedatives; does not include over-the-counter drugs. ¹ Retired persons, disabled persons, homemakers, students, or other persons not in the labor force are included in the Other Employment category. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
TOTAL	7,917	5,696	2,811	1,232	729	555
GENDER
Male	3,965	3,003	1,331	675	474	237
Female	3,952	2,694	1,480	557	255	318
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	6,956	4,946	2,607	1,155	678	534
White	6,071	4,257	2,384	1,035	600	492
Black or African American	557	463	101	49	21	27
American Indian or Alaska Native	46	29	22	8	4	2
Native Hawaiian or Other Pacific Islander	41	27	4	14	*	*
Asian	160	115	53	11	11	2
Two or More Races	81	56	43	38	32	8
Hispanic or Latino	962	750	204	77	50	21
EDUCATION
< High School	1,356	1,067	436	221	152	77
High School Graduate	2,499	1,802	876	453	287	163
Some College	2,201	1,600	768	365	221	151
College Graduate	1,860	1,227	731	193	69	164
CURRENT EMPLOYMENT
Full-Time	5,061	3,714	1,711	712	425	316
Part-Time	982	627	362	183	103	56
Unemployed	478	378	209	123	79	72
Other¹	1,397	978	528	215	121	111

51020

**Table 2.11B Nonmedical Use of Prescription-Type Psychotherapeutics in the Past Year among Persons Aged 26 or Older, by Demographic Characteristics: Percentages, Annual Averages Based on 2002-2004**
Demographic Characteristic	Any Prescription- Type Psycho- therapeutic Drug	PRESCRIPTION DRUG TYPE
		Pain Relievers	Tranquilizers	Stimulants		Sedatives
		Pain Relievers	Tranquilizers	Any Stimulant	Metham- phetamine	Sedatives
*Low precision; no estimate reported. NOTE: Nonmedical use of prescription-type pain relievers, tranquilizers, stimulants, or sedatives; does not include over-the-counter drugs. ¹ Retired persons, disabled persons, homemakers, students, or other persons not in the labor force are included in the Other Employment category. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
TOTAL	4.4	3.1	1.6	0.7	0.4	0.3
GENDER
Male	4.6	3.5	1.5	0.8	0.5	0.3
Female	4.2	2.8	1.6	0.6	0.3	0.3
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	4.3	3.1	1.6	0.7	0.4	0.3
White	4.6	3.2	1.8	0.8	0.5	0.4
Black or African American	2.9	2.4	0.5	0.3	0.1	0.1
American Indian or Alaska Native	4.7	2.9	2.3	0.8	0.4	0.2
Native Hawaiian or Other Pacific Islander	9.8	6.4	1.0	3.3	*	*
Asian	2.2	1.6	0.7	0.1	0.1	0.0
Two or More Races	4.6	3.2	2.4	2.2	1.8	0.4
Hispanic or Latino	4.7	3.7	1.0	0.4	0.2	0.1
EDUCATION
< High School	4.5	3.5	1.4	0.7	0.5	0.3
High School Graduate	4.4	3.2	1.5	0.8	0.5	0.3
Some College	5.1	3.7	1.8	0.8	0.5	0.3
College Graduate	3.7	2.4	1.4	0.4	0.1	0.3
CURRENT EMPLOYMENT
Full-Time	4.9	3.6	1.7	0.7	0.4	0.3
Part-Time	5.0	3.2	1.8	0.9	0.5	0.3
Unemployed	9.4	7.4	4.1	2.4	1.6	1.4
Other¹	2.6	1.8	1.0	0.4	0.2	0.2

51128

Table 2.12A Nonmedical Use of Prescription-Type Psychotherapeutics in the Past Year among Persons Aged 18 or Older, by Demographic Characteristics: Numbers in Thousands, Annual Averages Based on 2002-2004
Demographic Characteristic	Any Prescription- Type Psycho- therapeutic Drug	PRESCRIPTION DRUG TYPE
		Pain Relievers	Tranquilizers	Stimulants		Sedatives
		Pain Relievers	Tranquilizers	Any Stimulant	Metham- phetamine	Sedatives
*Low precision; no estimate reported. NOTE: Nonmedical use of prescription-type pain relievers, tranquilizers, stimulants, or sedatives; does not include over-the-counter drugs. ¹ Retired persons, disabled persons, homemakers, students, or other persons not in the labor force are included in the Other Employment category. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
TOTAL	12,504	9,422	4,427	2,379	1,244	716
GENDER
Male	6,446	5,087	2,185	1,291	764	320
Female	6,058	4,335	2,243	1,087	480	396
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	10,960	8,209	4,064	2,184	1,125	673
White	9,571	7,096	3,728	1,968	1,003	619
Black or African American	849	726	153	83	29	31
American Indian or Alaska Native	82	54	36	24	16	3
Native Hawaiian or Other Pacific Islander	58	41	6	17	13	*
Asian	247	184	71	30	17	5
Two or More Races	152	110	69	61	46	11
Hispanic or Latino	1,544	1,213	364	194	119	43
EDUCATION
< High School	2,453	1,987	821	460	307	109
High School Graduate	4,026	3,050	1,396	821	492	219
Some College	3,735	2,821	1,320	797	354	204
College Graduate	2,290	1,564	890	300	92	184
CURRENT EMPLOYMENT
Full-Time	7,117	5,413	2,447	1,158	647	382
Part-Time	2,182	1,598	760	501	208	101
Unemployed	964	765	406	268	171	91
Other¹	2,242	1,646	814	451	218	142

51020

**Table 2.12B Nonmedical Use of Prescription-Type Psychotherapeutics in the Past Year among Persons Aged 18 or Older, by Demographic Characteristics: Percentages, Annual Averages Based on 2002-2004**
Demographic Characteristic	Any Prescription- Type Psycho- therapeutic Drug	PRESCRIPTION DRUG TYPE
		Pain Relievers	Tranquilizers	Stimulants		Sedatives
		Pain Relievers	Tranquilizers	Any Stimulant	Metham- phetamine	Sedatives
*Low precision; no estimate reported. NOTE: Nonmedical use of prescription-type pain relievers, tranquilizers, stimulants, or sedatives; does not include over-the-counter drugs. ¹ Retired persons, disabled persons, homemakers, students, or other persons not in the labor force are included in the Other Employment category. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
TOTAL	5.9	4.4	2.1	1.1	0.6	0.3
GENDER
Male	6.3	5.0	2.1	1.3	0.7	0.3
Female	5.5	3.9	2.0	1.0	0.4	0.4
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	5.9	4.4	2.2	1.2	0.6	0.4
White	6.4	4.7	2.5	1.3	0.7	0.4
Black or African American	3.6	3.1	0.6	0.4	0.1	0.1
American Indian or Alaska Native	7.0	4.6	3.0	2.1	1.4	0.3
Native Hawaiian or Other Pacific Islander	10.2	7.1	1.1	3.1	2.3	*
Asian	2.9	2.1	0.8	0.4	0.2	0.1
Two or More Races	7.1	5.1	3.2	2.8	2.2	0.5
Hispanic or Latino	6.0	4.7	1.4	0.8	0.5	0.2
EDUCATION
< High School	6.6	5.3	2.2	1.2	0.8	0.3
High School Graduate	5.9	4.5	2.1	1.2	0.7	0.3
Some College	7.0	5.3	2.5	1.5	0.7	0.4
College Graduate	4.2	2.9	1.6	0.6	0.2	0.3
CURRENT EMPLOYMENT
Full-Time	6.1	4.6	2.1	1.0	0.6	0.3
Part-Time	7.8	5.7	2.7	1.8	0.7	0.4
Unemployed	12.5	10.0	5.3	3.5	2.2	1.2
Other¹	3.8	2.8	1.4	0.8	0.4	0.2

51021

Table 2.13A Nonmedical Use of Prescription-Type Psychotherapeutics in the Past Year among Persons Aged 12 or Older, by Geographic Characteristics: Numbers in Thousands, Annual Averages Based on 2002-2004
Geographic Characteristic	Any Prescription- Type Psycho- therapeutic Drug	PRESCRIPTION DRUG TYPE
		Pain Relievers	Tranquilizers	Stimulants		Sedatives
		Pain Relievers	Tranquilizers	Any Stimulant	Metham- phetamine	Sedatives
*Low precision; no estimate reported. NOTE: Nonmedical use of prescription-type pain relievers, tranquilizers, stimulants, or sedatives; does not include over-the-counter drugs. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
TOTAL	14,769	11,306	4,989	2,950	1,432	850
GEOGRAPHIC DIVISION
Northeast	2,366	1,823	831	410	58	184
New England	789	557	275	172	16	89
Middle Atlantic	1,578	1,266	556	238	41	96
Midwest	3,123	2,416	956	676	300	168
East North Central	2,238	1,791	712	404	136	101
West North Central	886	624	244	272	165	67
South	5,363	4,100	2,178	962	426	300
South Atlantic	2,703	2,098	1,111	388	145	164
East South Central	967	737	464	192	94	58
West South Central	1,693	1,264	603	381	187	78
West	3,916	2,967	1,024	903	648	197
Mountain	1,193	927	343	273	207	56
Pacific	2,723	2,040	682	629	441	141
COUNTY TYPE
Large Metro	7,581	5,828	2,571	1,351	600	419
Small Metro	4,844	3,670	1,668	1,033	493	298
250K – 1 Mil. Pop.	3,130	2,356	1,042	630	308	161
< 250K Pop.	1,714	1,314	626	403	185	137
Nonmetro	2,345	1,808	751	566	338	133
Urbanized	1,060	848	333	247	144	42
Less Urbanized	1,092	818	349	266	167	82
Completely Rural	193	142	69	53	27	9

51021

**Table 2.13B Nonmedical Use of Prescription-Type Psychotherapeutics in the Past Year among Persons Aged 12 or Older, by Geographic Characteristics: Percentages, Annual Averages Based on 2002-2004**
Geographic Characteristic	Any Prescription- Type Psycho- therapeutic Drug	PRESCRIPTION DRUG TYPE
		Pain Relievers	Tranquilizers	Stimulants		Sedatives
		Pain Relievers	Tranquilizers	Any Stimulant	Metham- phetamine	Sedatives
*Low precision; no estimate reported. NOTE: Nonmedical use of prescription-type pain relievers, tranquilizers, stimulants, or sedatives; does not include over-the-counter drugs. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
TOTAL	6.2	4.8	2.1	1.2	0.6	0.4
GEOGRAPHIC DIVISION
Northeast	5.2	4.0	1.8	0.9	0.1	0.4
New England	6.6	4.7	2.3	1.4	0.1	0.7
Middle Atlantic	4.7	3.8	1.7	0.7	0.1	0.3
Midwest	5.8	4.5	1.8	1.3	0.6	0.3
East North Central	5.9	4.8	1.9	1.1	0.4	0.3
West North Central	5.5	3.9	1.5	1.7	1.0	0.4
South	6.3	4.8	2.6	1.1	0.5	0.4
South Atlantic	6.1	4.7	2.5	0.9	0.3	0.4
East South Central	6.8	5.2	3.3	1.3	0.7	0.4
West South Central	6.5	4.8	2.3	1.5	0.7	0.3
West	7.3	5.5	1.9	1.7	1.2	0.4
Mountain	7.6	5.9	2.2	1.7	1.3	0.4
Pacific	7.1	5.3	1.8	1.6	1.2	0.4
COUNTY TYPE
Large Metro	6.0	4.6	2.0	1.1	0.5	0.3
Small Metro	6.8	5.2	2.4	1.5	0.7	0.4
250K – 1 Mil. Pop.	6.7	5.1	2.2	1.4	0.7	0.3
< 250K Pop.	7.1	5.4	2.6	1.7	0.8	0.6
Nonmetro	5.8	4.5	1.9	1.4	0.8	0.3
Urbanized	6.3	5.0	2.0	1.5	0.9	0.2
Less Urbanized	5.6	4.2	1.8	1.4	0.9	0.4
Completely Rural	4.8	3.5	1.7	1.3	0.7	0.2

51021

**Table 2.14A Nonmedical Use of Prescription-Type Psychotherapeutics in the Past Year among Persons Aged 12 to 17, by Geographic Characteristics: Numbers in Thousands, Annual Averages Based on 2002-2004**
Geographic Characteristic	Any Prescription- Type Psycho- therapeutic Drug	PRESCRIPTION DRUG TYPE
		Pain Relievers	Tranquilizers	Stimulants		Sedatives
		Pain Relievers	Tranquilizers	Any Stimulant	Metham- phetamine	Sedatives
*Low precision; no estimate reported. NOTE: Nonmedical use of prescription-type pain relievers, tranquilizers, stimulants, or sedatives; does not include over-the-counter drugs. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
TOTAL	2,266	1,884	562	571	187	134
GEOGRAPHIC DIVISION
Northeast	350	294	74	89	13	23
New England	108	89	25	32	5	8
Middle Atlantic	241	205	48	57	8	15
Midwest	508	416	101	147	40	28
East North Central	364	309	71	99	23	20
West North Central	144	108	30	49	17	9
South	834	682	271	202	69	54
South Atlantic	408	332	129	94	33	26
East South Central	155	129	53	35	11	10
West South Central	271	222	90	74	26	18
West	574	491	116	132	64	28
Mountain	171	143	36	47	21	8
Pacific	404	348	80	86	43	20
COUNTY TYPE
Large Metro	1,102	920	260	272	78	67
Small Metro	728	600	198	180	67	46
250K – 1 Mil. Pop.	480	389	130	116	40	32
< 250K Pop.	248	211	68	65	27	13
Nonmetro	435	364	103	119	42	22
Urbanized	185	158	42	44	15	7
Less Urbanized	213	175	52	62	24	12
Completely Rural	37	31	9	13	3	2

51021

**Table 2.14B Nonmedical Use of Prescription-Type Psychotherapeutics in the Past Year among Persons Aged 12 to 17, by Geographic Characteristics: Percentages, Annual Averages Based on 2002-2004**
Geographic Characteristic	Any Prescription- Type Psycho- therapeutic Drug	PRESCRIPTION DRUG TYPE
		Pain Relievers	Tranquilizers	Stimulants		Sedatives
		Pain Relievers	Tranquilizers	Any Stimulant	Metham- phetamine	Sedatives
*Low precision; no estimate reported. NOTE: Nonmedical use of prescription-type pain relievers, tranquilizers, stimulants, or sedatives; does not include over-the-counter drugs. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
TOTAL	9.1	7.5	2.2	2.3	0.7	0.5
GEOGRAPHIC DIVISION
Northeast	7.8	6.5	1.6	2.0	0.3	0.5
New England	9.3	7.7	2.2	2.8	0.4	0.7
Middle Atlantic	7.3	6.2	1.4	1.7	0.2	0.5
Midwest	8.9	7.3	1.8	2.6	0.7	0.5
East North Central	9.1	7.7	1.8	2.5	0.6	0.5
West North Central	8.5	6.4	1.8	2.9	1.0	0.5
South	9.4	7.7	3.0	2.3	0.8	0.6
South Atlantic	9.1	7.4	2.9	2.1	0.7	0.6
East South Central	10.7	8.9	3.6	2.4	0.8	0.7
West South Central	9.1	7.5	3.0	2.5	0.9	0.6
West	9.7	8.3	2.0	2.2	1.1	0.5
Mountain	9.9	8.3	2.1	2.7	1.2	0.5
Pacific	9.7	8.3	1.9	2.1	1.0	0.5
COUNTY TYPE
Large Metro	8.3	6.9	2.0	2.0	0.6	0.5
Small Metro	9.8	8.1	2.7	2.4	0.9	0.6
250K – 1 Mil. Pop.	9.6	7.8	2.6	2.3	0.8	0.6
< 250K Pop.	10.2	8.7	2.8	2.7	1.1	0.6
Nonmetro	10.2	8.5	2.4	2.8	1.0	0.5
Urbanized	10.5	9.0	2.4	2.5	0.8	0.4
Less Urbanized	10.2	8.4	2.5	3.0	1.2	0.6
Completely Rural	8.7	7.1	2.0	3.1	0.8	0.5

51021

**Table 2.15A Nonmedical Use of Prescription-Type Psychotherapeutics in the Past Year among Persons Aged 18 to 25, by Geographic Characteristics: Numbers in Thousands, Annual Averages Based on 2002-2004**
Geographic Characteristic	Any Prescription- Type Psycho- therapeutic Drug	PRESCRIPTION DRUG TYPE
		Pain Relievers	Tranquilizers	Stimulants		Sedatives
		Pain Relievers	Tranquilizers	Any Stimulant	Metham- phetamine	Sedatives
*Low precision; no estimate reported. NOTE: Nonmedical use of prescription-type pain relievers, tranquilizers, stimulants, or sedatives; does not include over-the-counter drugs. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
TOTAL	4,587	3,726	1,616	1,147	516	160
GEOGRAPHIC DIVISION
Northeast	800	655	255	214	28	29
New England	262	214	83	89	10	8
Middle Atlantic	538	441	172	124	19	22
Midwest	1,035	851	324	264	118	33
East North Central	747	636	238	162	54	23
West North Central	288	215	86	103	64	10
South	1,703	1,369	749	391	166	63
South Atlantic	792	653	324	162	50	31
East South Central	314	255	169	69	34	11
West South Central	598	461	255	160	82	22
West	1,048	851	288	278	203	35
Mountain	357	287	113	90	65	17
Pacific	691	564	175	188	138	18
COUNTY TYPE
Large Metro	2,210	1,801	763	512	218	84
Small Metro	1,617	1,305	586	430	178	54
250K – 1 Mil. Pop.	1,009	808	352	254	104	33
< 250K Pop.	608	496	235	176	74	21
Nonmetro	759	620	267	205	119	23
Urbanized	367	306	130	92	46	11
Less Urbanized	339	274	119	99	65	11
Completely Rural	54	41	18	14	8	1

51021

**Table 2.15B Nonmedical Use of Prescription-Type Psychotherapeutics in the Past Year among Persons Aged 18 to 25, by Geographic Characteristics: Percentages, Annual Averages Based on 2002-2004**
Geographic Characteristic	Any Prescription- Type Psycho- therapeutic Drug	PRESCRIPTION DRUG TYPE
		Pain Relievers	Tranquilizers	Stimulants		Sedatives
		Pain Relievers	Tranquilizers	Any Stimulant	Metham- phetamine	Sedatives
*Low precision; no estimate reported. NOTE: Nonmedical use of prescription-type pain relievers, tranquilizers, stimulants, or sedatives; does not include over-the-counter drugs. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
TOTAL	14.5	11.8	5.1	3.6	1.6	0.5
GEOGRAPHIC DIVISION
Northeast	14.3	11.7	4.6	3.8	0.5	0.5
New England	17.9	14.6	5.7	6.1	0.7	0.5
Middle Atlantic	13.0	10.6	4.2	3.0	0.5	0.5
Midwest	14.1	11.6	4.4	3.6	1.6	0.5
East North Central	14.8	12.6	4.7	3.2	1.1	0.5
West North Central	12.7	9.5	3.8	4.5	2.8	0.4
South	15.1	12.1	6.6	3.5	1.5	0.6
South Atlantic	14.2	11.7	5.8	2.9	0.9	0.6
East South Central	16.3	13.2	8.8	3.6	1.8	0.5
West South Central	15.7	12.1	6.7	4.2	2.2	0.6
West	14.1	11.5	3.9	3.8	2.7	0.5
Mountain	16.0	12.9	5.1	4.0	2.9	0.7
Pacific	13.3	10.9	3.4	3.6	2.7	0.3
COUNTY TYPE
Large Metro	13.5	11.0	4.7	3.1	1.3	0.5
Small Metro	15.7	12.6	5.7	4.2	1.7	0.5
250K – 1 Mil. Pop.	15.2	12.1	5.3	3.8	1.6	0.5
< 250K Pop.	16.6	13.5	6.4	4.8	2.0	0.6
Nonmetro	15.4	12.5	5.4	4.1	2.4	0.5
Urbanized	15.9	13.3	5.6	4.0	2.0	0.5
Less Urbanized	15.0	12.1	5.3	4.4	2.9	0.5
Completely Rural	14.0	10.6	4.8	3.7	2.2	0.3

51021

Table 2.16A Nonmedical Use of Prescription-Type Psychotherapeutics in the Past Year among Persons Aged 26 or Older, by Geographic Characteristics: Numbers in Thousands, Annual Averages Based on 2002-2004
Geographic Characteristic	Any Prescription- Type Psycho- therapeutic Drug	PRESCRIPTION DRUG TYPE
		Pain Relievers	Tranquilizers	Stimulants		Sedatives
		Pain Relievers	Tranquilizers	Any Stimulant	Metham- phetamine	Sedatives
*Low precision; no estimate reported. NOTE: Nonmedical use of prescription-type pain relievers, tranquilizers, stimulants, or sedatives; does not include over-the-counter drugs. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
TOTAL	7,917	5,696	2,811	1,232	729	555
GEOGRAPHIC DIVISION
Northeast	1,217	874	502	107	16	132
New England	418	254	167	50	2	73
Middle Atlantic	798	620	335	57	14	59
Midwest	1,581	1,148	531	264	142	107
East North Central	1,127	847	404	143	59	58
West North Central	454	302	127	121	83	49
South	2,826	2,049	1,158	369	191	182
South Atlantic	1,503	1,114	658	133	63	107
East South Central	499	354	242	89	49	37
West South Central	824	581	258	147	79	38
West	2,294	1,625	620	492	380	134
Mountain	666	497	193	137	120	31
Pacific	1,628	1,128	427	355	260	103
COUNTY TYPE
Large Metro	4,268	3,107	1,548	567	304	268
Small Metro	2,498	1,765	883	423	248	198
250K – 1 Mil. Pop.	1,640	1,159	560	261	164	96
< 250K Pop.	858	606	323	162	84	102
Nonmetro	1,151	824	380	242	177	89
Urbanized	508	384	161	111	83	24
Less Urbanized	541	369	178	105	78	59
Completely Rural	102	71	42	26	15	6

51021

**Table 2.16B Nonmedical Use of Prescription-Type Psychotherapeutics in the Past Year among Persons Aged 26 or Older, by Geographic Characteristics: Percentages, Annual Averages Based on 2002-2004**
Geographic Characteristic	Any Prescription- Type Psycho- therapeutic Drug	PRESCRIPTION DRUG TYPE
		Pain Relievers	Tranquilizers	Stimulants		Sedatives
		Pain Relievers	Tranquilizers	Any Stimulant	Metham- phetamine	Sedatives
*Low precision; no estimate reported. NOTE: Nonmedical use of prescription-type pain relievers, tranquilizers, stimulants, or sedatives; does not include over-the-counter drugs. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
TOTAL	4.4	3.1	1.6	0.7	0.4	0.3
GEOGRAPHIC DIVISION
Northeast	3.5	2.5	1.4	0.3	0.0	0.4
New England	4.5	2.7	1.8	0.5	0.0	0.8
Middle Atlantic	3.1	2.4	1.3	0.2	0.1	0.2
Midwest	3.9	2.8	1.3	0.6	0.3	0.3
East North Central	3.9	3.0	1.4	0.5	0.2	0.2
West North Central	3.7	2.5	1.0	1.0	0.7	0.4
South	4.4	3.2	1.8	0.6	0.3	0.3
South Atlantic	4.4	3.2	1.9	0.4	0.2	0.3
East South Central	4.6	3.3	2.2	0.8	0.4	0.3
West South Central	4.2	3.0	1.3	0.8	0.4	0.2
West	5.7	4.0	1.5	1.2	0.9	0.3
Mountain	5.7	4.3	1.7	1.2	1.0	0.3
Pacific	5.7	3.9	1.5	1.2	0.9	0.4
COUNTY TYPE
Large Metro	4.4	3.2	1.6	0.6	0.3	0.3
Small Metro	4.7	3.3	1.7	0.8	0.5	0.4
250K – 1 Mil. Pop.	4.7	3.3	1.6	0.7	0.5	0.3
< 250K Pop.	4.7	3.3	1.8	0.9	0.5	0.6
Nonmetro	3.7	2.7	1.2	0.8	0.6	0.3
Urbanized	4.0	3.0	1.3	0.9	0.7	0.2
Less Urbanized	3.6	2.5	1.2	0.7	0.5	0.4
Completely Rural	3.2	2.2	1.3	0.8	0.5	0.2

51031

Table 2.17A Nonmedical Use of Prescription-Type Psychotherapeutics in the Past Year among Lifetime Users Aged 18 or Older, by Drug Type and Age at First Use: Numbers in Thousands, Annual Averages Based on 2002-2004
Age at First Use	Any Prescription- Type Psycho- therapeutic Drug	PRESCRIPTION DRUG TYPE
		Pain Relievers	Tranquilizers	Stimulants		Sedatives
		Pain Relievers	Tranquilizers	Any Stimulant	Metham- phetamine	Sedatives
	Past Year Use among Lifetime Users Aged 18 or Older
*Low precision; no estimate reported. NOTE: Nonmedical use of prescription-type pain relievers, tranquilizers, stimulants, or sedatives; does not include over-the-counter drugs. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
TOTAL	12,504	9,422	4,427	2,379	1,244	716
Under 16 Years	2,232	1,388	440	372	150	109
16 Years or Older	10,271	8,034	3,988	2,006	1,095	606
16 to 20 Years	5,423	3,882	1,697	1,148	574	235
21 to 25 Years	2,221	1,807	901	438	268	92
26 Years or Older	2,627	2,345	1,390	421	253	279
Age at First Use	Past Year Use among Lifetime Users Aged 18 to 25
TOTAL	4,587	3,726	1,616	1,147	516	160
Under 16 Years	1,028	683	232	206	86	36
16 Years or Older	3,558	3,042	1,385	941	430	125
16 to 20 Years	2,966	2,483	1,057	796	348	91
21 to 25 Years	592	559	328	145	82	34
Age at First Use	Past Year Use among Lifetime Users Aged 26 or Older
TOTAL	7,917	5,696	2,811	1,232	729	555
Under 16 Years	1,204	704	208	166	64	73
16 Years or Older	6,713	4,992	2,603	1,066	665	482
16 to 20 Years	2,457	1,398	640	353	226	144
21 to 25 Years	1,629	1,248	573	293	186	59
26 Years or Older	2,627	2,345	1,390	421	253	279

51031

Table 2.17B Nonmedical Use of Prescription-Type Psychotherapeutics in the Past Year among Lifetime Users Aged 18 or Older, by Drug Type and Age at First Use: Percentages, Annual Averages Based on 2002-2004
Age at First Use	Any Prescription- Type Psycho- therapeutic Drug	PRESCRIPTION DRUG TYPE
		Pain Relievers	Tranquilizers	Stimulants		Sedatives
		Pain Relievers	Tranquilizers	Any Stimulant	Metham- phetamine	Sedatives
	Past Year Use among Lifetime Users Aged 18 or Older
*Low precision; no estimate reported. NOTE: Nonmedical use of prescription-type pain relievers, tranquilizers, stimulants, or sedatives; does not include over-the-counter drugs. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
TOTAL	28.3	33.6	23.4	12.1	10.5	7.5
Under 16 Years	33.4	38.0	22.6	12.4	9.1	7.6
16 Years or Older	27.4	32.9	23.5	12.1	10.8	7.5
16 to 20 Years	27.8	34.9	23.6	11.4	9.2	4.9
21 to 25 Years	24.7	29.5	20.0	10.8	10.5	5.1
26 Years or Older	29.5	32.7	26.2	16.9	18.6	19.3
Age at First Use	Past Year Use among Lifetime Users Aged 18 to 25
TOTAL	50.6	50.4	43.0	33.8	30.4	26.2
Under 16 Years	51.3	49.8	39.8	26.0	23.0	26.2
16 Years or Older	50.4	50.5	43.5	36.1	32.4	26.2
16 to 20 Years	49.3	49.1	40.7	34.7	30.1	22.8
21 to 25 Years	56.8	57.7	55.8	47.0	48.9	43.7
Age at First Use	Past Year Use among Lifetime Users Aged 26 or Older
TOTAL	22.6	27.6	18.5	7.6	7.2	6.2
Under 16 Years	25.7	30.9	15.3	7.5	5.1	5.6
16 Years or Older	22.1	27.2	18.8	7.6	7.5	6.3
16 to 20 Years	18.2	23.1	13.9	4.5	4.4	3.2
21 to 25 Years	20.5	24.2	14.6	7.9	7.8	3.4
26 Years or Older	29.5	32.7	26.2	16.9	18.6	19.3

51024

Table 2.18A Number of Days of Nonmedical Use of Prescription-Type Psychotherapeutics in the Past Year among Past Year Users of the Drug Type, by Age Category: Numbers in Thousands, Annual Averages Based on 2002-2004
Number of Days Used in Past Year	PRESCRIPTION DRUG TYPE
	Pain Relievers	Tranquilizers	Stimulants		Sedatives
	Pain Relievers	Tranquilizers	Any Stimulant	Metham- phetamine	Sedatives
	Past Year Nonmedical Users Aged 12 or Older
*Low precision; no estimate reported. NOTE: Nonmedical use of prescription-type pain relievers, tranquilizers, stimulants, or sedatives; does not include over-the-counter drugs. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
1-11 Days	5,741	2,637	1,257	550	399
12-49 Days	2,744	1,201	657	306	239
50-99 Days	1,224	549	331	176	85
100-299 Days	1,404	550	597	336	114
300 or More Days	193	53	108	64	12
Number of Days Used in Past Year	Past Year Nonmedical Users Aged 12 to 17
1-11 Days	899	295	276	91	61
12-49 Days	489	139	134	46	34
50-99 Days	232	58	58	17	22
100-299 Days	235	67	90	29	14
300 or More Days	28	3	12	3	3
Number of Days Used in Past Year	Past Year Nonmedical Users Aged 18 to 25
1-11 Days	1,911	862	518	203	82
12-49 Days	951	393	281	121	38
50-99 Days	396	176	125	62	23
100-299 Days	420	172	200	118	16
300 or More Days	48	13	23	12	2
Number of Days Used in Past Year	Past Year Nonmedical Users Aged 26 or Older
1-11 Days	2,931	1,479	463	256	256
12-49 Days	1,304	669	242	138	168
50-99 Days	596	315	148	97	40
100-299 Days	749	311	306	190	84
300 or More Days	116	37	72	49	8

51024

Table 2.18B Number of Days of Nonmedical Use of Prescription-Type Psychotherapeutics in the Past Year among Past Year Users of the Drug Type, by Age Category: Percentage Distributions, Annual Averages Based on 2002-2004
Number of Days Used in Past Year	PRESCRIPTION DRUG TYPE
	Pain Relievers	Tranquilizers	Stimulants		Sedatives
	Pain Relievers	Tranquilizers	Any Stimulant	Metham- phetamine	Sedatives
	Past Year Nonmedical Users Aged 12 or Older
*Low precision; no estimate reported. NOTE: Nonmedical use of prescription-type pain relievers, tranquilizers, stimulants, or sedatives; does not include over-the-counter drugs. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
1-11 Days	50.8	52.8	42.6	38.4	46.9
12-49 Days	24.3	24.1	22.3	21.4	28.2
50-99 Days	10.8	11.0	11.2	12.3	10.0
100-299 Days	12.4	11.0	20.2	23.5	13.4
300 or More Days	1.7	1.1	3.7	4.5	1.5
Number of Days Used in Past Year	Past Year Nonmedical Users Aged 12 to 17
1-11 Days	47.7	52.5	48.3	48.8	45.4
12-49 Days	25.9	24.7	23.5	24.8	25.5
50-99 Days	12.3	10.3	10.1	9.3	16.6
100-299 Days	12.5	11.9	15.8	15.3	10.4
300 or More Days	1.5	0.5	2.2	1.8	2.1
Number of Days Used in Past Year	Past Year Nonmedical Users Aged 18 to 25
1-11 Days	51.3	53.3	45.2	39.3	50.8
12-49 Days	25.5	24.3	24.5	23.6	23.6
50-99 Days	10.6	10.9	10.9	12.0	14.4
100-299 Days	11.3	10.6	17.5	22.8	10.2
300 or More Days	1.3	0.8	2.0	2.3	1.0
Number of Days Used in Past Year	Past Year Nonmedical Users Aged 26 or Older
1-11 Days	51.5	52.6	37.6	35.2	46.1
12-49 Days	22.9	23.8	19.6	18.9	30.2
50-99 Days	10.5	11.2	12.0	13.3	7.2
100-299 Days	13.2	11.1	24.9	26.0	15.1
300 or More Days	2.0	1.3	5.9	6.7	1.4

51024

Table 2.19A Nonmedical Use of Prescription-Type Psychotherapeutics in the Past Year among Persons Aged 18 to 22, by Gender and College Enrollment Status: Numbers in Thousands, Annual Averages Based on 2002-2004
Gender and College Enrollment Status	Any Prescription- Type Psycho- therapeutic Drug	PRESCRIPTION DRUG TYPE
		Pain Relievers	Tranquilizers	Stimulants		Sedatives
		Pain Relievers	Tranquilizers	Any Stimulant	Metham- phetmaine	Sedatives
*Low precision; no estimate reported. NOTE: Nonmedical use of prescription-type pain relievers, tranquilizers, stimulants, or sedatives; does not include over-the-counter drugs. ¹ Estimates include those with unknown enrollment status. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
ALL PERSONS AGED 18 TO 22¹	3,216	2,625	1,097	844	343	109
Enrolled as Undergraduate	1,374	1,105	434	403	82	43
Full Time	1,154	918	355	356	62	37
Part Time	219	188	79	48	21	6
Not Enrolled as Undergraduate	1,552	1,268	583	378	237	59
MALES AGED 18 TO 22¹	1,744	1,475	580	435	186	57
Enrolled as Undergraduate	671	559	205	193	39	18
Full Time	568	470	168	171	33	16
Part Time	102	89	36	22	7	2
Not Enrolled as Undergraduate	891	756	326	204	134	34
FEMALES AGED 18 TO 22¹	1,472	1,150	517	409	157	52
Enrolled as Undergraduate	703	546	230	210	43	25
Full Time	586	447	187	184	29	21
Part Time	117	99	43	26	14	4
Not Enrolled as Undergraduate	661	512	257	174	103	24

51024

Table 2.19B Nonmedical Use of Prescription-Type Psychotherapeutics in the Past Year among Persons Aged 18 to 22, by Gender and College Enrollment Status: Percentages, Annual Averages Based on 2002-2004
Gender and College Enrollment Status	Any Prescription- Type Psycho- therapeutic Drug	PRESCRIPTION DRUG TYPE
		Pain Relievers	Tranquilizers	Stimulants		Sedatives
		Pain Relievers	Tranquilizers	Any Stimulant	Metham- phetmaine	Sedatives
*Low precision; no estimate reported. NOTE: Nonmedical use of prescription-type pain relievers, tranquilizers, stimulants, or sedatives; does not include over-the-counter drugs. ¹ Estimates include those with unknown enrollment status. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
ALL PERSONS AGED 18 TO 22¹	15.7	12.8	5.4	4.1	1.7	0.5
Enrolled as Undergraduate	14.8	11.9	4.7	4.3	0.9	0.5
Full Time	14.6	11.6	4.5	4.5	0.8	0.5
Part Time	15.7	13.4	5.7	3.4	1.5	0.4
Not Enrolled as Undergraduate	17.0	13.9	6.4	4.1	2.6	0.6
MALES AGED 18 TO 22¹	16.8	14.2	5.6	4.2	1.8	0.6
Enrolled as Undergraduate	15.6	13.0	4.7	4.5	0.9	0.4
Full Time	15.5	12.8	4.6	4.7	0.9	0.4
Part Time	15.8	13.8	5.6	3.4	1.0	0.3
Not Enrolled as Undergraduate	18.2	15.5	6.7	4.2	2.7	0.7
FEMALES AGED 18 TO 22¹	14.6	11.4	5.1	4.1	1.6	0.5
Enrolled as Undergraduate	14.2	11.0	4.6	4.2	0.9	0.5
Full Time	13.9	10.6	4.4	4.4	0.7	0.5
Part Time	15.6	13.1	5.8	3.4	1.9	0.5
Not Enrolled as Undergraduate	15.5	12.0	6.0	4.1	2.4	0.6

51024

Table 2.20A Nonmedical Use of Prescription-Type Psychotherapeutics in the Past Year among Females Aged 15 to 44, by Age Group and Pregnancy Status: Numbers in Thousands, Annual Averages Based on 2002-2004
Age and Pregnancy Status	Any Prescription- Type Psycho- therapeutic Drug	PRESCRIPTION DRUG TYPE
		Pain Relievers	Tranquilizers	Stimulants		Sedatives
		Pain Relievers	Tranquilizers	Any Stimulant	Metham- phetmaine	Sedatives
*Low precision; no estimate reported. NOTE: Nonmedical use of prescription-type pain relievers, tranquilizers, stimulants, or sedatives; does not include over-the-counter drugs. ¹ Estimates include those with unknown pregnancy status. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
ALL FEMALES AGED 15 TO 44¹	5,653	4,226	2,024	1,231	529	304
Pregnant	148	109	49	32	19	7
Not Pregnant	5,481	4,097	1,966	1,191	507	296
FEMALES AGED 15 TO 17¹	838	676	256	246	86	47
Pregnant	17	14	3	6	3	2
Not Pregnant	815	657	252	239	83	45
FEMALES AGED 18 TO 25¹	2,106	1,641	762	530	225	78
Pregnant	89	67	31	19	16	4
Not Pregnant	1,999	1,559	723	505	207	73
FEMALES AGED 26 TO 44¹	2,709	1,909	1,006	454	218	179
Pregnant	42	28	15	7	*	1
Not Pregnant	2,667	1,881	990	447	218	178

51024

**Table 2.20B Nonmedical Use of Prescription-Type Psychotherapeutics in the Past Year among Females Aged 15 to 44, by Age Group and Pregnancy Status: Percentages, Annual Averages Based on 2002-2004**
Age and Pregnancy Status	Any Prescription- Type Psycho- therapeutic Drug	PRESCRIPTION DRUG TYPE
		Pain Relievers	Tranquilizers	Stimulants		Sedatives
		Pain Relievers	Tranquilizers	Any Stimulant	Metham- phetmaine	Sedatives
*Low precision; no estimate reported. NOTE: Nonmedical use of prescription-type pain relievers, tranquilizers, stimulants, or sedatives; does not include over-the-counter drugs. ¹ Estimates include those with unknown pregnancy status. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
ALL FEMALES AGED 15 TO 44¹	9.1	6.8	3.3	2.0	0.9	0.5
Pregnant	6.0	4.4	2.0	1.3	0.8	0.3
Not Pregnant	9.3	6.9	3.3	2.0	0.9	0.5
FEMALES AGED 15 TO 17¹	13.9	11.2	4.2	4.1	1.4	0.8
Pregnant	18.2	15.0	3.3	6.4	3.2	1.7
Not Pregnant	13.8	11.1	4.3	4.0	1.4	0.8
FEMALES AGED 18 TO 25¹	13.3	10.4	4.8	3.4	1.4	0.5
Pregnant	9.6	7.3	3.3	2.1	1.7	0.5
Not Pregnant	13.5	10.6	4.9	3.4	1.4	0.5
FEMALES AGED 26 TO 44¹	6.8	4.8	2.5	1.1	0.5	0.4
Pregnant	2.9	1.9	1.0	0.5	*	0.1
Not Pregnant	7.0	4.9	2.6	1.2	0.6	0.5

51020

**Table 3.1A Nonmedical Use of Specific Pain Relievers in Lifetime, by Age Group: Numbers in Thousands, 2002-2004**
Pain Reliever	Total			AGE GROUP
	Total			12-17			18-25			26 or Older
	2002	2003	2004	2002	2003	2004	2002	2003	2004	2002	2003	2004
*Low precision; no estimate reported. ^a Difference between estimate and 2004 estimate is statistically significant at the .05 level. ^b Difference between estimate and 2004 estimate is statistically significant at the .01 level. ¹ Includes other-specify drug responses that are not asked about explicitly in the pain relievers module but fall into this category. ² Includes Darvocet^®, Darvon^® or Tylenol^® with Codeine, codeine, Phenaphen^® with Codeine, propoxyphene, and SK-65^®. ³ Includes Percocet^®, Percodan^® or Tylox^®, and OxyContin^®. ⁴ Includes Vicodin^®, Lortab^®, or Lorcet^®, and hydrocodone. ⁵ Includes tramadol and Ultram^®. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
Darvocet^®, Darvon^®, or Tylenol^® with Codeine	18,912	19,672	19,514	1,508	1,458	1,504	3,800^b	4,020	4,202	13,603	14,193	13,808
Percocet^®, Percodan^®, or Tylox^®	9,659^b	10,811	10,950	407^b	473	529	2,285^b	2,471^b	2,796	6,967	7,867	7,626
Vicodin^®, Lortab^®, or Lorcet^®	13,093^b	15,717	16,707	1,116^a	1,129^a	1,274	4,126^b	4,773^b	5,309	7,852^b	9,815	10,124
Codeine	6,897	6,985	6,693	513	526	523	1,878	2,074	2,062	4,506	4,385	4,108
Demerol^®	2,917^a	2,986^b	2,461	116	109	126	657	686	624	2,144^a	2,191^a	1,711
Dilaudid^®	1,116	914	859	7	13	17	101	80	97	1,008	821	745
Fioricet^®	445	466	454	13	17	20	64	49	65	368	401	369
Fiorinal^®	579	525	372	24	18	11	40	43	33	515	465	327
Hydrocodone	4,529^b	5,716	5,949	333^b	410	425	1,540^b	2,088	2,161	2,656^b	3,218	3,363
Methadone	928^b	1,159	1,306	116	109	123	306^b	396	456	506	655	727
Morphine	2,073	2,060	2,068	256	215	218	648^b	737	818	1,170	1,107	1,031
OxyContin^®	1,924^b	2,832	3,072	224^b	254	305	820^b	1,145^b	1,376	881^b	1,433	1,392
Phenaphen^® with Codeine	873^a	857^b	586	69	67^a	40	194	236	177	610^a	554	369
Propoxyphene	282	290	390	31	33	22	45^b	68	101	206	189	267
SK-65^®	42	48	37	13	16	9	10	14	15	19	18	13
Stadol^®	133	157	154	6	5	4	23^a	16^b	49	103	136	101
Talacen^®	55	43	116	14	7	10	13	13	25	28	23	81
Talwin^®	643^b	425	302	10	6	17	20	22	19	613^b	397	267
Talwin^® NX	105	53	100	10	8	8	9	12	15	86	33	77
Tramadol	52^b	186^a	328	11	14	20	20^b	68	99	21^b	103	209
Ultram^®	962	1,105	1,113	98^b	66	51	300	330	318	564	709	744
SELECTED GROUPS OF DRUGS
Propoxyphene or Codeine Products^1,2	20,653	21,428	21,066	1,696	1,693	1,702	4,337^a	4,611	4,692	14,620	15,124	14,672
Oxycodone Products^1,3	10,151^b	11,538	11,921	523^b	605	693	2,551^b	2,831^b	3,237	7,076^a	8,102	7,991
Hydrocodone Products^1,4	13,952^b	16,808	17,734	1,222^b	1,260^a	1,407	4,385^b	5,157^a	5,595	8,345^b	10,391	10,732
Tramadol Products^1,5	994^a	1,221	1,280	102	76	67	313	375	372	579^a	770	840

51020

**Table 3.1B Nonmedical Use of Specific Pain Relievers in Lifetime, by Age Group: Percentages, 2002-2004**
Pain Reliever	Total			AGE GROUP
	Total			12-17			18-25			26 or Older
	2002	2003	2004	2002	2003	2004	2002	2003	2004	2002	2003	2004
*Low precision; no estimate reported. ^a Difference between estimate and 2004 estimate is statistically significant at the .05 level. ^b Difference between estimate and 2004 estimate is statistically significant at the .01 level. ¹ Includes other-specify drug responses that are not asked about explicitly in the pain relievers module but fall into this category. ² Includes Darvocet^®, Darvon^® or Tylenol^® with Codeine, codeine, Phenaphen^® with Codeine, propoxyphene, and SK-65^®. ³ Includes Percocet^®, Percodan^® or Tylox^®, and OxyContin^®. ⁴ Includes Vicodin^®, Lortab^®, or Lorcet^®, and hydrocodone. ⁵ Includes tramadol and Ultram^®. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
Darvocet^®, Darvon^®, or Tylenol^® with Codeine	8.0	8.3	8.1	6.1	5.8	6.0	12.2	12.7	13.1	7.6	7.8	7.5
Percocet^®, Percodan^®, or Tylox^®	4.1^a	4.5	4.6	1.6^b	1.9	2.1	7.4^b	7.8^a	8.7	3.9	4.3	4.2
Vicodin^®, Lortab^®, or Lorcet^®	5.6^b	6.6	6.9	4.5^a	4.5^a	5.1	13.3^b	15.0^b	16.5	4.4^b	5.4	5.5
Codeine	2.9	2.9	2.8	2.1	2.1	2.1	6.1	6.5	6.4	2.5	2.4	2.2
Demerol^®	1.2^a	1.3^b	1.0	0.5	0.4	0.5	2.1	2.2	1.9	1.2^a	1.2^b	0.9
Dilaudid^®	0.5	0.4	0.4	0.0	0.1	0.1	0.3	0.3	0.3	0.6	0.5	0.4
Fioricet^®	0.2	0.2	0.2	0.1	0.1	0.1	0.2	0.2	0.2	0.2	0.2	0.2
Fiorinal^®	0.2	0.2	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.3	0.3	0.2
Hydrocodone	1.9^b	2.4	2.5	1.3^a	1.6	1.7	5.0^b	6.6	6.7	1.5^b	1.8	1.8
Methadone	0.4^b	0.5	0.5	0.5	0.4	0.5	1.0^b	1.2	1.4	0.3	0.4	0.4
Morphine	0.9	0.9	0.9	1.0	0.9	0.9	2.1^a	2.3	2.5	0.7	0.6	0.6
OxyContin^®	0.8^b	1.2	1.3	0.9^a	1.0	1.2	2.6^b	3.6^b	4.3	0.5^b	0.8	0.8
Phenaphen^® with Codeine	0.4^a	0.4^b	0.2	0.3^a	0.3^a	0.2	0.6	0.7	0.6	0.3^a	0.3^a	0.2
Propoxyphene	0.1	0.1	0.2	0.1	0.1	0.1	0.1^b	0.2	0.3	0.1	0.1	0.1
SK-65^®	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Stadol^®	0.1	0.1	0.1	0.0	0.0	0.0	0.1^a	0.1^b	0.2	0.1	0.1	0.1
Talacen^®	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
Talwin^®	0.3^b	0.2	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.3^b	0.2	0.1
Talwin^® NX	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Tramadol	0.0^b	0.1^a	0.1	0.0	0.1	0.1	0.1^b	0.2	0.3	0.0^b	0.1	0.1
Ultram^®	0.4	0.5	0.5	0.4^b	0.3	0.2	1.0	1.0	1.0	0.3	0.4	0.4
SELECTED GROUPS OF DRUGS
Propoxyphene or Codeine Products^1,2	8.8	9.0	8.8	6.9	6.8	6.7	14.0	14.5	14.6	8.2	8.4	8.0
Oxycodone Products^1,3	4.3^b	4.9	5.0	2.1^b	2.4	2.7	8.2^b	8.9^b	10.1	3.9	4.5	4.4
Hydrocodone Products^1,4	5.9^b	7.1	7.4	4.9^a	5.0	5.6	14.1^b	16.3^a	17.4	4.7^b	5.7	5.9
Tramadol Products^1,5	0.4^a	0.5	0.5	0.4^a	0.3	0.3	1.0	1.2	1.2	0.3^a	0.4	0.5

51020

**Table 3.2A Nonmedical Use of Specific Tranquilizers in Lifetime, by Age Group: Numbers in Thousands, 2002-2004**
Tranquilizer	Total			AGE GROUP
	Total			12-17			18-25			26 or Older
	2002	2003	2004	2002	2003	2004	2002	2003	2004	2002	2003	2004
*Low precision; no estimate reported. ^a Difference between estimate and 2004 estimate is statistically significant at the .05 level. ^b Difference between estimate and 2004 estimate is statistically significant at the .01 level. ¹ Includes other-specify drug responses that are not asked about explicitly in the tranquilizers module but fall into this category. ² Includes Klonopin^® or clonazepam, Xanax^®, alprazolam, Ativan^®, or lorazepam, Valium^® or diazepam, Librium^®, Limbitrol^®, Rohypnol^®, Serax^®, and Tranxene^®. ³ Includes Equanil^®, meprobamate, and Miltown^®. ⁴ Includes Flexeril^® and Soma^®. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
Klonopin^® or Clonazepam	2,374	2,851	2,746	180	160	164	724^b	964	1,048	1,470	1,727	1,533
Xanax^®, Alprazolam, Ativan^®, or Lorazepam	8,208^b	9,500	9,369	429	437	449	2,091^b	2,379	2,495	5,688	6,684	6,425
Valium^® or Diazepam	14,386	14,671	14,607	427	424	380	2,312	2,473	2,434	11,648	11,773	11,794
Atarax^®	371^a	292	186	26	17	22	45	42	42	301^a	233	122
BuSpar^®	693	587	702	51	53	42	220	205	260	421	329	401
Equanil^®	75	128	78	14	13	10	12	14	21	49	101	47
Flexeril^®	1,781	1,994	1,968	47	49	34	295^b	377	461	1,439	1,569	1,473
Librium^®	1,454^a	1,121	981	17	20	29	79	84	61	1,358^a	1,017	891
Limbitrol^®	115	41^a	96	9	7	14	32	11	24	73	23	58
Meprobamate	161	170	129	9	12	17	21	11	13	131	148	98
Miltown^®	169	98	73	12	8	14	6	8	6	151	82	52
Rohypnol^®	375	408	346	40	46	24	160	189	140	175	173	181
Serax^®	215	170	114	17	9	11	29	17	31	169	144	72
Soma^®	2,276	2,572	2,616	142	152	138	729^b	793^b	975	1,405	1,626	1,503
Tranxene^®	214	189	143	10	13	10	16	23	31	188	153	103
Vistaril^®	356	258	275	21	11	20	64	35	54	271	212	201
SELECTED GROUPS OF DRUGS
Benzodiazepines^1,2	18,132	18,930	18,643	729	732	704	3,223^b	3,645	3,602	14,180	14,553	14,337
Meprobamate Products^1,3	388	307	246	33	27	34	39	27	39	316	253	173
Muscle Relaxants^1,4	3,360^a	3,718	3,907	170	182	160	866^b	998^b	1,227	2,325	2,538	2,520

51020

**Table 3.2B Nonmedical Use of Specific Tranquilizers in Lifetime, by Age Group: Percentages, 2002-2004**
Tranquilizer	Total			AGE GROUP
	Total			12-17			18-25			26 or Older
	2002	2003	2004	2002	2003	2004	2002	2003	2004	2002	2003	2004
*Low precision; no estimate reported. ^a Difference between estimate and 2004 estimate is statistically significant at the .05 level. ^b Difference between estimate and 2004 estimate is statistically significant at the .01 level. ¹ Includes other-specify drug responses that are not asked about explicitly in the tranquilizers module but fall into this category. ² Includes Klonopin^® or clonazepam, Xanax^®, alprazolam, Ativan^®, or lorazepam, Valium^® or diazepam, Librium^®, Limbitrol^®, Rohypnol^®, Serax^®, and Tranxene^®. ³ Includes Equanil^®, meprobamate, and Miltown^®. ⁴ Includes Flexeril^® and Soma^®. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
Klonopin^® or Clonazepam	1.0	1.2	1.1	0.7	0.6	0.7	2.3^b	3.0	3.3	0.8	1.0	0.8
Xanax^®, Alprazolam, Ativan^®, or Lorazepam	3.5^a	4.0	3.9	1.7	1.7	1.8	6.7^b	7.5	7.7	3.2	3.7	3.5
Valium^® or Diazepam	6.1	6.2	6.1	1.7	1.7	1.5	7.5	7.8	7.6	6.5	6.5	6.4
Atarax^®	0.2^a	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2^a	0.1	0.1
BuSpar^®	0.3	0.2	0.3	0.2	0.2	0.2	0.7	0.6	0.8	0.2	0.2	0.2
Equanil^®	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0
Flexeril^®	0.8	0.8	0.8	0.2	0.2	0.1	0.9^b	1.2	1.4	0.8	0.9	0.8
Librium^®	0.6^a	0.5	0.4	0.1	0.1	0.1	0.3	0.3	0.2	0.8^a	0.6	0.5
Limbitrol^®	0.0	0.0^a	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0
Meprobamate	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.1
Miltown^®	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0
Rohypnol^®	0.2	0.2	0.1	0.2	0.2	0.1	0.5	0.6	0.4	0.1	0.1	0.1
Serax^®	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0
Soma^®	1.0	1.1	1.1	0.6	0.6	0.5	2.3^b	2.5^a	3.0	0.8	0.9	0.8
Tranxene^®	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1
Vistaril^®	0.2	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.2	0.2	0.1	0.1
SELECTED GROUPS OF DRUGS
Benzodiazepines^1,2	7.7	8.0	7.8	2.9	2.9	2.8	10.4	11.5	11.2	7.9	8.0	7.8
Meprobamate Products^1,3	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1
Muscle Relaxants^1,4	1.4	1.6	1.6	0.7	0.7	0.6	2.8^b	3.1^b	3.8	1.3	1.4	1.4

51020

**Table 3.3A Nonmedical Use of Specific Stimulants in Lifetime, by Age Group: Numbers in Thousands, 2002-2004**
Stimulant	Total			AGE GROUP
	Total			12-17			18-25			26 or Older
	2002	2003	2004	2002	2003	2004	2002	2003	2004	2002	2003	2004
*Low precision; no estimate reported. ^a Difference between estimate and 2004 estimate is statistically significant at the .05 level. ^b Difference between estimate and 2004 estimate is statistically significant at the .01 level. ¹ Also known as crank, crystal, ice, or speed. ² Respondents were asked about their use of prescription diet pills and were given the following as examples: amphetamines, Benzedrine^®, Biphetamine^®, Fastin^®, or phentermine. However, respondents were not given an exhaustive list of examples of prescription diet pills. ³ Includes other-specify drug responses that are not asked about explicitly in the stimulants module but fall into this category. ⁴ Includes prescription diet pills, Dexedrine^®, dextroamphetamine, and Ionamin^®. ⁵ Includes Mazanor^® and Sanorex^®. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
Methamphetamine,¹ Desoxyn^®, or Methedrine^®	12,383	12,303	11,726	366	328	299	1,756	1,650	1,688	10,261	10,325	9,739
Prescription Diet Pills²	8,980	8,671	8,104	267	251	236	692	743	689	8,021	7,677	7,179
Ritalin^® or Methylphenidate	4,528	4,168	4,182	587^b	547^a	445	1,662	1,806	1,729	2,280	1,816	2,008
Cylert^®	196	198	232	18	23	26	39	36	32	139	140	173
Dexedrine^®	3,274^b	2,553	2,580	70	69	62	318	291	318	2,887^b	2,193	2,200
Dextroamphetamine	553	498	675	22	31	29	78	80	83	453	387	563
Didrex^®	177	196	184	21	19	13	31	25	33	124	152	138
Eskatrol^®	302	89^a	289	10	4	15	15	4	13	276	81^a	261
Ionamin^®	491	583	459	19	26	12	28	23	13	445	535	433
Mazanor^®	65	30	65	16	10	13	3	8	8	45	13	44
Obedrin-LA^®	79	18	*	6	13	*	6	5	*	68	*	*
Plegine^®	68	45	25	12	5	13	8	2	3	48	37	9
Preludin^®	856^a	705	529	10	13	13	35	52^a	23	811^a	640	493
Sanorex^®	137	105	106	12	20	23	23	17	33	102	68	50
Tenuate^®	275	146	221	10	13	10	10	17	14	255	116	196
SELECTED GROUPS OF DRUGS
Amphetamine, Dextroamphetamine and Phentermine Products^3,4	10,589^a	10,080	9,509	367	385	357	1,069	1,117	1,177	9,153^a	8,578	7,974
Mazindol Products^3,5	187	127	156	24	26	32	25	21	34	138	80	90

51020

**Table 3.3B Nonmedical Use of Specific Stimulants in Lifetime, by Age Group: Percentages, 2002-2004**
Stimulant	Total			AGE GROUP
	Total			12-17			18-25			26 or Older
	2002	2003	2004	2002	2003	2004	2002	2003	2004	2002	2003	2004
*Low precision; no estimate reported. ^a Difference between estimate and 2004 estimate is statistically significant at the .05 level. ^b Difference between estimate and 2004 estimate is statistically significant at the .01 level. ¹ Also known as crank, crystal, ice, or speed. ² Respondents were asked about their use of prescription diet pills and were given the following as examples: amphetamines, Benzedrine^®, Biphetamine^®, Fastin^®, or phentermine. However, respondents were not given an exhaustive list of examples of prescription diet pills. ³ Includes other-specify drug responses that are not asked about explicitly in the stimulants module but fall into this category. ⁴ Includes prescription diet pills, Dexedrine^®, dextroamphetamine, and Ionamin^®. ⁵ Includes Mazanor^® and Sanorex^®. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
Methamphetamine,¹ Desoxyn^®, or Methedrine^®	5.3	5.2	4.9	1.5^a	1.3	1.2	5.7	5.2	5.2	5.7	5.7	5.3
Prescription Diet Pills²	3.8^a	3.6	3.4	1.1	1.0	0.9	2.2	2.3	2.1	4.5^a	4.2	3.9
Ritalin^® or Methylphenidate	1.9	1.8	1.7	2.4^b	2.2^b	1.8	5.4	5.7	5.4	1.3	1.0	1.1
Cylert^®	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
Dexedrine^®	1.4^b	1.1	1.1	0.3	0.3	0.2	1.0	0.9	1.0	1.6^b	1.2	1.2
Dextroamphetamine	0.2	0.2	0.3	0.1	0.1	0.1	0.3	0.3	0.3	0.3	0.2	0.3
Didrex^®	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
Eskatrol^®	0.1	0.0^a	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0^a	0.1
Ionamin^®	0.2	0.2	0.2	0.1	0.1	0.0	0.1	0.1	0.0	0.2	0.3	0.2
Mazanor^®	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
Obedrin-LA^®	0.0	0.0	*	0.0	0.1	*	0.0	0.0	*	0.0	*	*
Plegine^®	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
Preludin^®	0.4^a	0.3	0.2	0.0	0.1	0.1	0.1	0.2^a	0.1	0.5^a	0.4	0.3
Sanorex^®	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0
Tenuate^®	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.1
SELECTED GROUPS OF DRUGS
Amphetamine, Dextroamphetamine and Phentermine Products^3,4	4.5^b	4.2	4.0	1.5	1.5	1.4	3.4	3.5	3.7	5.1^b	4.7	4.4
Mazindol Products^3,5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0

51020

**Table 3.4A Nonmedical Use of Specific Sedatives in Lifetime, by Age Group: Numbers in Thousands, 2002-2004**
Sedative	Total			AGE GROUP
	Total			12-17			18-25			26 or Older
	2002	2003	2004	2002	2003	2004	2002	2003	2004	2002	2003	2004
*Low precision; no estimate reported. ^a Difference between estimate and 2004 estimate is statistically significant at the .05 level. ^b Difference between estimate and 2004 estimate is statistically significant at the .01 level. ¹ Respondents were asked about their use of barbiturates and were given the following as examples: Nembutal^®, pentobarbital, Seconal^®, secobarbital, or butalbital. However, respondents were not given an exhaustive list of examples of barbiturates. ² Includes other-specify drug responses that are not asked about explicitly in the sedatives module but fall into this category. ³ Includes Restoril^®, temazepam, Dalmane^®, or Halcion^®. ⁴ Includes barbiturates, Amytal^®, Butisol^®, phenobarbital, and Tuinal^®. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
Methaqualone, Sopor^®, or Quaalude^®	7,320	6,997	7,114	60	64	54	305	258	254	6,955	6,676	6,805
Barbiturates¹	3,375^b	3,301^b	2,603	29	44	37	121	101	118	3,226^b	3,156^b	2,447
Restoril^® or Temazepam	1,003	923	779	48	50	42	108	90	119	847	783	617
Amytal^®	274	209	249	4^a	26	21	21	19	23	249	164	204
Butisol^®	109	103	69	8	15	17	14	12	22	87	76	30
Chloral Hydrate	214	149	220	7	11	19	9	25	11	198	114	190
Dalmane^®	638	435	440	22	23	40	16	19	14	600	393	386
Halcion^®	939	668	674	17	23	34	64	53	55	857^a	592	585
Phenobarbital	1,568^a	1,300	1,132	37	29	25	105	91	82	1,426^a	1,180	1,025
Placidyl^®	1,045	783	885	12	12	4	34^a	14	13	998	758	868
Tuinal^®	1,393^a	1,077	1,021	8	14	8	17	10	11	1,368^a	1,053	1,002
SELECTED GROUPS OF DRUGS
Temazepam, Flurazepam, or Triazolam^2,3	2,101^b	1,662	1,492	82	75	95	175	143	173	1,844^b	1,443	1,224
Any Barbiturates^2,4	4,058^a	4,031^a	3,359	73	98	82	209	181	196	3,775^a	3,753^a	3,081

51020

**Table 3.4B Nonmedical Use of Specific Sedatives in Lifetime, by Age Group: Percentages, 2002-2004**
Sedative	Total			AGE GROUP
	Total			12-17			18-25			26 or Older
	2002	2003	2004	2002	2003	2004	2002	2003	2004	2002	2003	2004
*Low precision; no estimate reported. ^a Difference between estimate and 2004 estimate is statistically significant at the .05 level. ^b Difference between estimate and 2004 estimate is statistically significant at the .01 level. ¹ Respondents were asked about their use of barbiturates and were given the following as examples: Nembutal^®, pentobarbital, Seconal^®, secobarbital, or butalbital. However, respondents were not given an exhaustive list of examples of barbiturates. ² Includes other-specify drug responses that are not asked about explicitly in the sedatives module but fall into this category. ³ Includes Restoril^®, temazepam, Dalmane^®, or Halcion^®. ⁴ Includes barbiturates, Amytal^®, Butisol^®, phenobarbital, and Tuinal^®. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
Methaqualone, Sopor^®, or Quaalude^®	3.1	2.9	3.0	0.2	0.3	0.2	1.0	0.8	0.8	3.9	3.7	3.7
Barbiturates¹	1.4^b	1.4^b	1.1	0.1	0.2	0.1	0.4	0.3	0.4	1.8^b	1.7^b	1.3
Restoril^® or Temazepam	0.4^a	0.4	0.3	0.2	0.2	0.2	0.3	0.3	0.4	0.5^a	0.4	0.3
Amytal^®	0.1	0.1	0.1	0.0^a	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
Butisol^®	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0
Chloral Hydrate	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.1
Dalmane^®	0.3	0.2	0.2	0.1	0.1	0.2	0.1	0.1	0.0	0.3	0.2	0.2
Halcion^®	0.4^a	0.3	0.3	0.1	0.1	0.1	0.2	0.2	0.2	0.5^a	0.3	0.3
Phenobarbital	0.7^a	0.5	0.5	0.2	0.1	0.1	0.3	0.3	0.3	0.8^a	0.7	0.6
Placidyl^®	0.4	0.3	0.4	0.1	0.0	0.0	0.1^a	0.0	0.0	0.6	0.4	0.5
Tuinal^®	0.6^a	0.5	0.4	0.0	0.1	0.0	0.1	0.0	0.0	0.8^a	0.6	0.5
SELECTED GROUPS OF DRUGS
Temazepam, Flurazepam, or Triazolam^2,3	0.9^b	0.7	0.6	0.3	0.3	0.4	0.6	0.4	0.5	1.0^b	0.8	0.7
Any Barbiturates^2,4	1.7^a	1.7^a	1.4	0.3	0.4	0.3	0.7	0.6	0.6	2.1^a	2.1^a	1.7

51215

**Table 3.5A Nonmedical Use of Specific Pain Relievers in Lifetime, by Gender and Age Group: Numbers in Thousands, Annual Averages Based on 2002-2004**
Pain Reliever	Total	GENDER		AGE GROUP
Pain Reliever	Total	Male	Female	12 to 17	18 to 25	26 or Older
*Low precision; no estimate reported. ¹ Includes other-specify drug responses that are not asked about explicitly in the pain relievers module but fall into this category. ² Includes Darvocet^®, Darvon^® or Tylenol^® with Codeine, codeine, Phenaphen^® with Codeine, propoxyphene, and SK-65^®. ³ Includes Percocet^®, Percodan^® or Tylox^®, and OxyContin^®. ⁴ Includes Vicodin^®, Lortab^®, or Lorcet^®, and hydrocodone. ⁵ Includes tramadol and Ultram^®. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
Darvocet^®, Darvon^®, or Tylenol^® with Codeine	19,366	10,711	8,655	1,490	4,007	13,868
Percocet^®, Percodan^®, or Tylox^®	10,473	6,201	4,272	469	2,517	7,487
Vicodin^®, Lortab^®, or Lorcet^®	15,172	8,417	6,756	1,173	4,736	9,264
Codeine	6,859	4,219	2,640	521	2,005	4,333
Demerol^®	2,788	1,744	1,044	117	656	2,015
Dilaudid^®	963	667	296	12	93	858
Fioricet^®	455	216	239	17	59	379
Fiorinal^®	492	205	287	18	38	436
Hydrocodone	5,398	3,055	2,343	389	1,930	3,079
Methadone	1,131	712	419	116	386	629
Morphine	2,067	1,315	752	230	734	1,103
OxyContin^®	2,609	1,634	975	261	1,114	1,235
Phenaphen^® with Codeine	772	477	294	59	202	511
Propoxyphene	321	160	161	29	71	221
SK-65^®	42	27	15	12	13	16
Stadol^®	148	82	66	5	29	113
Talacen^®	71	45	26	10	17	44
Talwin^®	457	285	172	11	20	425
Talwin^® NX	86	44	42	9	12	65
Tramadol	188	124	64	15	62	111
Ultram^®	1,060	530	530	72	316	672
SELECTED GROUPS OF DRUGS
Propoxyphene or Codeine Products^1,2	21,049	11,725	9,325	1,697	4,547	14,805
Oxycodone Products^1,3	11,203	6,637	4,566	607	2,873	7,723
Hydrocodone Products^1,4	16,165	8,932	7,233	1,296	5,046	9,823
Tramadol Products^1,5	1,165	594	571	82	353	730

51215

**Table 3.5B Nonmedical Use of Specific Pain Relievers in Lifetime, by Gender and Age Group: Percentages, Annual Averages Based on 2002-2004**
Pain Reliever	Total	GENDER		AGE GROUP
Pain Reliever	Total	Male	Female	12 to 17	18 to 25	26 or Older
*Low precision; no estimate reported. ¹ Includes other-specify drug responses that are not asked about explicitly in the pain relievers module but fall into this category. ² Includes Darvocet^®, Darvon^® or Tylenol^® with Codeine, codeine, Phenaphen^® with Codeine, propoxyphene, and SK-65^®. ³ Includes Percocet^®, Percodan^® or Tylox^®, and OxyContin^®. ⁴ Includes Vicodin^®, Lortab^®, or Lorcet^®, and hydrocodone. ⁵ Includes tramadol and Ultram^®. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
Darvocet^®, Darvon^®, or Tylenol^® with Codeine	8.1	9.3	7.1	6.0	12.7	7.7
Percocet^®, Percodan^®, or Tylox^®	4.4	5.4	3.5	1.9	8.0	4.1
Vicodin^®, Lortab^®, or Lorcet^®	6.4	7.3	5.5	4.7	15.0	5.1
Codeine	2.9	3.7	2.2	2.1	6.3	2.4
Demerol^®	1.2	1.5	0.9	0.5	2.1	1.1
Dilaudid^®	0.4	0.6	0.2	0.0	0.3	0.5
Fioricet^®	0.2	0.2	0.2	0.1	0.2	0.2
Fiorinal^®	0.2	0.2	0.2	0.1	0.1	0.2
Hydrocodone	2.3	2.7	1.9	1.6	6.1	1.7
Methadone	0.5	0.6	0.3	0.5	1.2	0.3
Morphine	0.9	1.1	0.6	0.9	2.3	0.6
OxyContin^®	1.1	1.4	0.8	1.0	3.5	0.7
Phenaphen^® with Codeine	0.3	0.4	0.2	0.2	0.6	0.3
Propoxyphene	0.1	0.1	0.1	0.1	0.2	0.1
SK-65^®	0.0	0.0	0.0	0.0	0.0	0.0
Stadol^®	0.1	0.1	0.1	0.0	0.1	0.1
Talacen^®	0.0	0.0	0.0	0.0	0.1	0.0
Talwin^®	0.2	0.2	0.1	0.0	0.1	0.2
Talwin^® NX	0.0	0.0	0.0	0.0	0.0	0.0
Tramadol	0.1	0.1	0.1	0.1	0.2	0.1
Ultram^®	0.4	0.5	0.4	0.3	1.0	0.4
SELECTED GROUPS OF DRUGS
Propoxyphene or Codeine Products^1,2	8.9	10.2	7.6	6.8	14.4	8.2
Oxycodone Products^1,3	4.7	5.8	3.7	2.4	9.1	4.3
Hydrocodone Products^1,4	6.8	7.8	5.9	5.2	15.9	5.4
Tramadol Products^1,5	0.5	0.5	0.5	0.3	1.1	0.4

51215

**Table 3.6A Nonmedical Use of Specific Tranquilizers in Lifetime, by Gender and Age Group: Numbers in Thousands, Annual Averages Based on 2002-2004**
Tranquilizer	Total	GENDER		AGE GROUP
Tranquilizer	Total	Male	Female	12 to 17	18 to 25	26 or Older
*Low precision; no estimate reported. ¹ Includes other-specify drug responses that are not asked about explicitly in the tranquilizers module but fall into this category. ² Includes Klonopin^® or clonazepam, Xanax^®, alprazolam, Ativan^®, or lorazepam, Valium^® or diazepam, Librium^®, Limbitrol^®, Rohypnol^®, Serax^®, and Tranxene^®. ³ Includes Equanil^®, meprobamate, and Miltown^®. ⁴ Includes Flexeril^® and Soma^®. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
Klonopin^® or Clonazepam	2,657	1,412	1,244	168	912	1,577
Xanax^®, Alprazolam, Ativan^®, or Lorazepam	9,025	4,417	4,608	438	2,321	6,266
Valium^® or Diazepam	14,555	8,046	6,509	410	2,406	11,738
Atarax^®	283	171	112	22	43	219
BuSpar^®	661	333	328	49	228	383
Equanil^®	94	45	49	12	16	66
Flexeril^®	1,914	913	1,002	43	377	1,494
Librium^®	1,185	643	543	22	75	1,089
Limbitrol^®	84	41	43	10	22	51
Meprobamate	153	98	55	13	15	126
Miltown^®	113	68	45	11	7	95
Rohypnol^®	376	243	134	37	163	176
Serax^®	167	91	75	12	26	129
Soma^®	2,488	1,332	1,156	144	832	1,512
Tranxene^®	182	99	83	11	23	148
Vistaril^®	296	130	166	17	51	228
SELECTED GROUPS OF DRUGS
Benzodiazepines^1,2	18,569	9,646	8,922	722	3,490	14,357
Meprobamate Products^1,3	314	183	131	31	35	247
Muscle Relaxants^1,4	3,662	1,876	1,786	171	1,030	2,461

51215

**Table 3.6B Nonmedical Use of Specific Tranquilizers in Lifetime, by Gender and Age Group: Percentages, Annual Averages Based on 2002-2004**
Tranquilizer	Total	GENDER		AGE GROUP
Tranquilizer	Total	Male	Female	12 to 17	18 to 25	26 or Older
*Low precision; no estimate reported. ¹ Includes other-specify drug responses that are not asked about explicitly in the tranquilizers module but fall into this category. ² Includes Klonopin^® or clonazepam, Xanax^®, alprazolam, Ativan^®, or lorazepam, Valium^® or diazepam, Librium^®, Limbitrol^®, Rohypnol^®, Serax^®, and Tranxene^®. ³ Includes Equanil^®, meprobamate, and Miltown^®. ⁴ Includes Flexeril^® and Soma^®. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
Klonopin^® or Clonazepam	1.1	1.2	1.0	0.7	2.9	0.9
Xanax^®, Alprazolam, Ativan^®, or Lorazepam	3.8	3.8	3.8	1.8	7.3	3.5
Valium^® or Diazepam	6.1	7.0	5.3	1.6	7.6	6.5
Atarax^®	0.1	0.1	0.1	0.1	0.1	0.1
BuSpar^®	0.3	0.3	0.3	0.2	0.7	0.2
Equanil^®	0.0	0.0	0.0	0.0	0.0	0.0
Flexeril^®	0.8	0.8	0.8	0.2	1.2	0.8
Librium^®	0.5	0.6	0.4	0.1	0.2	0.6
Limbitrol^®	0.0	0.0	0.0	0.0	0.1	0.0
Meprobamate	0.1	0.1	0.0	0.1	0.0	0.1
Miltown^®	0.0	0.1	0.0	0.0	0.0	0.1
Rohypnol^®	0.2	0.2	0.1	0.1	0.5	0.1
Serax^®	0.1	0.1	0.1	0.0	0.1	0.1
Soma^®	1.0	1.2	0.9	0.6	2.6	0.8
Tranxene^®	0.1	0.1	0.1	0.0	0.1	0.1
Vistaril^®	0.1	0.1	0.1	0.1	0.2	0.1
SELECTED GROUPS OF DRUGS
Benzodiazepines^1,2	7.8	8.4	7.3	2.9	11.0	7.9
Meprobamate Products^1,3	0.1	0.2	0.1	0.1	0.1	0.1
Muscle Relaxants^1,4	1.5	1.6	1.5	0.7	3.3	1.4

51215

**Table 3.7A Nonmedical Use of Specific Stimulants in Lifetime, by Gender and Age Group: Numbers in Thousands, Annual Averages Based on 2002-2004**
Stimulants	Total	GENDER		AGE GROUP
Stimulants	Total	Male	Female	12 to 17	18 to 25	26 or Older
*Low precision; no estimate reported. ¹ Also known as crank, crystal, ice, or speed. ² Respondents were asked about their use of prescription diet pills and were given the following as examples: amphetamines, Benzedrine^®, Biphetamine^®, Fastin^®, or phentermine. However, respondents were not given an exhaustive list of examples of prescription diet pills. ³ Includes other-specify drug responses that are not asked about explicitly in the stimulants module but fall into this category. ⁴ Includes prescription diet pills, Dexedrine^®, dextroamphetamine, and Ionamin^®. ⁵ Includes Mazanor^® and Sanorex^®. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
Methamphetamine,¹ Desoxyn^®, or Methedrine^®	12,138	7,250	4,888	331	1,698	10,109
Prescription Diet Pills²	8,585	4,505	4,080	251	708	7,626
Ritalin^® or Methylphenidate	4,293	2,577	1,716	526	1,732	2,035
Cylert^®	209	137	72	22	36	151
Dexedrine^®	2,803	1,587	1,216	67	309	2,427
Dextroamphetamine	575	334	241	28	80	467
Didrex^®	186	95	91	18	30	138
Eskatrol^®	227	138	89	10	11	206
Ionamin^®	511	291	220	19	21	471
Mazanor^®	54	20	34	13	6	34
Obedrin-LA^®	33	8	24	7	4	23
Plegine^®	46	31	15	10	4	31
Preludin^®	697	447	250	12	37	648
Sanorex^®	116	73	44	18	24	73
Tenuate^®	214	77	137	11	14	189
SELECTED GROUPS OF DRUGS
Amphetamine, Dextroamphetamine, and Phentermine Products^3,4	10,059	5,260	4,799	370	1,121	8,568
Mazindol Products^3,5	157	90	66	27	27	103

51215

**Table 3.7B Nonmedical Use of Specific Stimulants in Lifetime, by Gender and Age Group: Percentages, Annual Averages Based on 2002-2004**
Stimulants	Total	GENDER		AGE GROUP
Stimulants	Total	Male	Female	12 to 17	18 to 25	26 or Older
*Low precision; no estimate reported. ¹ Also known as crank, crystal, ice, or speed. ² Respondents were asked about their use of prescription diet pills and were given the following as examples: amphetamines, Benzedrine^®, Biphetamine^®, Fastin^®, or phentermine. However, respondents were not given an exhaustive list of examples of prescription diet pills. ³ Includes other-specify drug responses that are not asked about explicitly in the stimulants module but fall into this category. ⁴ Includes prescription diet pills, Dexedrine^®, dextroamphetamine, and Ionamin^®. ⁵ Includes Mazanor^® and Sanorex^®. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
Methamphetamine,¹ Desoxyn^®, or Methedrine^®	5.1	6.3	4.0	1.3	5.4	5.6
Prescription Diet Pills²	3.6	3.9	3.3	1.0	2.2	4.2
Ritalin^® or Methylphenidate	1.8	2.2	1.4	2.1	5.5	1.1
Cylert^®	0.1	0.1	0.1	0.1	0.1	0.1
Dexedrine^®	1.2	1.4	1.0	0.3	1.0	1.3
Dextroamphetamine	0.2	0.3	0.2	0.1	0.3	0.3
Didrex^®	0.1	0.1	0.1	0.1	0.1	0.1
Eskatrol^®	0.1	0.1	0.1	0.0	0.0	0.1
Ionamin^®	0.2	0.3	0.2	0.1	0.1	0.3
Mazanor^®	0.0	0.0	0.0	0.1	0.0	0.0
Obedrin-LA^®	0.0	0.0	0.0	0.0	0.0	0.0
Plegine^®	0.0	0.0	0.0	0.0	0.0	0.0
Preludin^®	0.3	0.4	0.2	0.0	0.1	0.4
Sanorex^®	0.0	0.1	0.0	0.1	0.1	0.0
Tenuate^®	0.1	0.1	0.1	0.0	0.0	0.1
SELECTED GROUPS OF DRUGS
Amphetamine, Dextroamphetamine, and Phentermine Products^3,4	4.2	4.6	3.9	1.5	3.5	4.7
Mazindol Products^3,5	0.1	0.1	0.1	0.1	0.1	0.1

51215

**Table 3.8A Nonmedical Use of Specific Sedatives in Lifetime, by Gender and Age Group: Numbers in Thousands, Annual Averages Based on 2002-2004**
Sedative	Total	GENDER		AGE GROUP
Sedative	Total	Male	Female	12 to 17	18 to 25	26 or Older
*Low precision; no estimate reported. ¹ Respondents were asked about their use of barbiturates and were given the following as examples: Nembutal^®, pentobarbital, Seconal^®, secobarbital, or butalbital. However, respondents were not given an exhaustive list of examples of barbiturates. ² Includes other-specify drug responses that are not asked about explicitly in the sedatives module but fall into this category. ³ Includes Restoril^®, temazepam, Dalmane^®, or Halcion^®. ⁴ Includes barbiturates, Amytal^®, Butisol^®, phenobarbital, and Tuinal^®. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003 and 2004.
Methaqualone, Sopor^®, or Quaalude^®	7,144	4,325	2,818	59	272	6,812
Barbiturates¹	3,093	1,985	1,108	37	113	2,943
Restoril^® or Temazepam	901	440	462	47	106	749
Amytal^®	244	185	59	17	21	206
Butisol^®	94	68	26	13	16	64
Chloral Hydrate	194	98	96	12	15	167
Dalmane^®	504	293	211	28	17	459
Halcion^®	760	370	390	25	57	678
Phenobarbital	1,333	776	557	30	93	1,210
Placidyl^®	905	611	293	9	20	875
Tuinal^®	1,164	721	443	10	13	1,141
SELECTED GROUPS OF DRUGS
Temazepam, Flurazepam, or Triazolam^2,3	1,751	898	853	84	164	1,504
Any Barbiturates^2,4	3,816	2,360	1,456	84	195	3,537

51215

**Table 3.8B Nonmedical Use of Specific Sedatives in Lifetime, by Gender and Age Group: Percentages, Annual Averages Based on 2002-2004**
Sedative	Total	GENDER		AGE GROUP
Sedative	Total	Male	Female	12 to 17	18 to 25	26 or Older
*Low precision; no estimate reported. ¹ Respondents were asked about their use of barbiturates and were given the following as examples: Nembutal^®, pentobarbital, Seconal^®, secobarbital, or butalbital. However, respondents were not given an exhaustive list of examples of barbiturates. ² Includes other-specify drug responses that are not asked about explicitly in the sedatives module but fall into this category. ³ Includes Restoril^®, temazepam, Dalmane^®, or Halcion^®. ⁴ Includes barbiturates, Amytal^®, Butisol^®, phenobarbital, and Tuinal^®. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003 and 2004.
Methaqualone, Sopor^®, or Quaalude^®	3.0	3.8	2.3	0.2	0.9	3.8
Barbiturates¹	1.3	1.7	0.9	0.1	0.4	1.6
Restoril^® or Temazepam	0.4	0.4	0.4	0.2	0.3	0.4
Amytal^®	0.1	0.2	0.0	0.1	0.1	0.1
Butisol^®	0.0	0.1	0.0	0.1	0.1	0.0
Chloral Hydrate	0.1	0.1	0.1	0.0	0.0	0.1
Dalmane^®	0.2	0.3	0.2	0.1	0.1	0.3
Halcion^®	0.3	0.3	0.3	0.1	0.2	0.4
Phenobarbital	0.6	0.7	0.5	0.1	0.3	0.7
Placidyl^®	0.4	0.5	0.2	0.0	0.1	0.5
Tuinal^®	0.5	0.6	0.4	0.0	0.0	0.6
SELECTED GROUPS OF DRUGS
Temazepam, Flurazepam, or Triazolam^2,3	0.7	0.8	0.7	0.3	0.5	0.8
Any Barbiturates^2,4	1.6	2.1	1.2	0.3	0.6	2.0

51117

**Table 3.9A Nonmedical Use of Specific Prescription Pain Relievers among Lifetime Users of Any Pain Reliever, by Age Group: Numbers in Thousands, Annual Averages Based on 2002-2004**
Pain Reliever	TOTAL	AGE GROUP
Pain Reliever	TOTAL	12-17	18-25	26 or Older
*Low precision; no estimate reported. ¹ Includes other-specify drug responses that are not asked about explicitly in the pain relievers module but fall into this category. ² Includes Darvocet^®, Darvon^® or Tylenol^® with Codeine, codeine, Phenaphen^® with Codeine, propoxyphene, and SK-65^®. ³ Includes Percocet^®, Percodan^® or Tylox^®, and OxyContin^®. ⁴ Includes Vicodin^®, Lortab^®, or Lorcet^®, and hydrocodone. ⁵ Includes tramadol and Ultram^®. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
ANY PAIN RELIEVER	30,862	2,817	7,393	20,652
Darvocet^®, Darvon^®, or Tylenol^® with Codeine	19,366	1,490	4,007	13,868
Percocet^®, Percodan^®, or Tylox^®	10,473	469	2,517	7,487
Vicodin^®, Lortab^®, or Lorcet^®	15,172	1,173	4,736	9,264
Codeine	6,859	521	2,005	4,333
Demerol^®	2,788	117	656	2,015
Dilaudid^®	963	12	93	858
Fioricet^®	455	17	59	379
Fiorinal^®	492	18	38	436
Hydrocodone	5,398	389	1,930	3,079
Methadone	1,131	116	386	629
Morphine	2,067	230	734	1,103
OxyContin^®	2,609	261	1,114	1,235
Phenaphen^® with Codeine	772	59	202	511
Propoxyphene	321	29	71	221
SK-65^®	42	12	13	16
Stadol^®	148	5	29	113
Talacen^®	71	10	17	44
Talwin^®	457	11	20	425
Talwin^® NX	86	9	12	65
Tramadol	188	15	62	111
Ultram^®	1,060	72	316	672
SELECTED GROUPS OF DRUGS
Propoxyphene or Codeine Products^1,2	21,049	1,697	4,547	14,805
Oxycodone Products^1,3	11,203	607	2,873	7,723
Hydrocodone Products^1,4	16,165	1,296	5,046	9,823
Tramadol Products^1,5	1,165	82	353	730

51117

**Table 3.9B Nonmedical Use of Specific Prescription Pain Relievers among Lifetime Users of Any Pain Reliever, by Age Group: Percentages, Annual Averages Based on 2002-2004**
Pain Reliever	TOTAL	AGE GROUP
Pain Reliever	TOTAL	12-17	18-25	26 or Older
*Low precision; no estimate reported. NOTE: The denominator for percentages is the total number of lifetime nonmedical users of any prescription pain reliever. ¹ Includes other-specify drug responses that are not asked about explicitly in the pain relievers module but fall into this category. ² Includes Darvocet^®, Darvon^® or Tylenol^® with Codeine, codeine, Phenaphen^® with Codeine, propoxyphene, and SK-65^®. ³ Includes Percocet^®, Percodan^® or Tylox^®, and OxyContin^®. ⁴ Includes Vicodin^®, Lortab^®, or Lorcet^®, and hydrocodone. ⁵ Includes tramadol and Ultram^®. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
ANY PAIN RELIEVER	100.0	100.0	100.0	100.0
Darvocet^®, Darvon^®, or Tylenol^® with Codeine	62.7	52.9	54.2	67.2
Percocet^®, Percodan^®, or Tylox^®	33.9	16.7	34.0	36.3
Vicodin^®, Lortab^®, or Lorcet^®	49.2	41.6	64.1	44.9
Codeine	22.2	18.5	27.1	21.0
Demerol^®	9.0	4.2	8.9	9.8
Dilaudid^®	3.1	0.4	1.3	4.2
Fioricet^®	1.5	0.6	0.8	1.8
Fiorinal^®	1.6	0.6	0.5	2.1
Hydrocodone	17.5	13.8	26.1	14.9
Methadone	3.7	4.1	5.2	3.0
Morphine	6.7	8.2	9.9	5.3
OxyContin^®	8.5	9.3	15.1	6.0
Phenaphen^® with Codeine	2.5	2.1	2.7	2.5
Propoxyphene	1.0	1.0	1.0	1.1
SK-65^®	0.1	0.4	0.2	0.1
Stadol^®	0.5	0.2	0.4	0.5
Talacen^®	0.2	0.4	0.2	0.2
Talwin^®	1.5	0.4	0.3	2.1
Talwin^® NX	0.3	0.3	0.2	0.3
Tramadol	0.6	0.5	0.8	0.5
Ultram^®	3.4	2.5	4.3	3.3
SELECTED GROUPS OF DRUGS
Propoxyphene or Codeine Products^1,2	68.2	60.2	61.5	71.7
Oxycodone Products^1,3	36.3	21.5	38.9	37.4
Hydrocodone Products^1,4	52.4	46.0	68.2	47.6
Tramadol Products^1,5	3.8	2.9	4.8	3.5

51117

**Table 3.10A Nonmedical Use of Specific Prescription Pain Relievers among Past Year Initiates of Any Pain Reliever, by Age Group: Numbers in Thousands, Annual Averages Based on 2002-2004**
Pain Reliever	TOTAL	AGE GROUP
Pain Reliever	TOTAL	12-17	18-25	26 or Older
*Low precision; no estimate reported. ¹ Includes other-specify drug responses that are not asked about explicitly in the pain relievers module but fall into this category. ² Includes Darvocet^®, Darvon^® or Tylenol^® with Codeine, codeine, Phenaphen^® with Codeine, propoxyphene, and SK-65^®. ³ Includes Percocet^®, Percodan^® or Tylox^®, and OxyContin^®. ⁴ Includes Vicodin^®, Lortab^®, or Lorcet^®, and hydrocodone. ⁵ Includes tramadol and Ultram^®. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
ANY PAIN RELIEVER	2,399	902	881	615
Darvocet^®, Darvon^®, or Tylenol^® with Codeine	822	362	255	205
Percocet^®, Percodan^®, or Tylox^®	426	143	190	93
Vicodin^®, Lortab^®, or Lorcet^®	1,207	433	499	274
Codeine	328	163	141	25
Demerol^®	69	21	35	13
Dilaudid^®	8	3	2	*
Fioricet^®	8	3	5	0
Fiorinal^®	10	6	1	3
Hydrocodone	369	134	146	89
Methadone	52	29	14	9
Morphine	109	63	34	12
OxyContin^®	170	78	78	14
Phenaphen^® with Codeine	23	15	8	1
Propoxyphene	10	5	2	3
SK-65^®	4	3	1	*
Stadol^®	1	*	0	1
Talacen^®	6	4	2	*
Talwin^®	2	1	1	*
Talwin^® NX	3	2	0	*
Tramadol	12	2	6	*
Ultram^®	55	18	18	*
SELECTED GROUPS OF DRUGS
Propoxyphene or Codeine Products^1,2	997	443	332	222
Oxycodone Products^1,3	528	188	239	101
Hydrocodone Products^1,4	1,368	486	556	326
Tramadol Products^1,5	67	21	23	23

51117

**Table 3.10B Nonmedical Use of Specific Prescription Pain Relievers among Past Year Initiates of Any Pain Reliever, by Age Group: Percentages, Annual Averages Based on 2002-2004**
Pain Reliever	TOTAL	AGE GROUP
Pain Reliever	TOTAL	12-17	18-25	26 or Older
*Low precision; no estimate reported. NOTE: The denominator for percentages is the total number of persons who initiated nonmedical use of any prescription pain reliever in the past 12 months. ¹ Includes other-specify drug responses that are not asked about explicitly in the pain relievers module but fall into this category. ² Includes Darvocet^®, Darvon^® or Tylenol^® with Codeine, codeine, Phenaphen^® with Codeine, propoxyphene, and SK-65^®. ³ Includes Percocet^®, Percodan^® or Tylox^®, and OxyContin^®. ⁴ Includes Vicodin^®, Lortab^®, or Lorcet^®, and hydrocodone. ⁵ Includes tramadol and Ultram^®. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
ANY PAIN RELIEVER	100.0	100.0	100.0	100.0
Darvocet^®, Darvon^®, or Tylenol^® with Codeine	34.3	40.1	28.9	33.3
Percocet^®, Percodan^®, or Tylox^®	17.8	15.9	21.5	15.2
Vicodin^®, Lortab^®, or Lorcet^®	50.3	48.0	56.6	44.6
Codeine	13.7	18.0	16.0	4.0
Demerol^®	2.9	2.3	4.0	2.1
Dilaudid^®	0.3	0.4	0.3	*
Fioricet^®	0.3	0.4	0.5	0.0
Fiorinal^®	0.4	0.7	0.1	0.5
Hydrocodone	15.4	14.9	16.5	14.5
Methadone	2.2	3.2	1.6	1.5
Morphine	4.5	6.9	3.9	2.0
OxyContin^®	7.1	8.7	8.8	2.3
Phenaphen^® with Codeine	1.0	1.6	0.9	0.1
Propoxyphene	0.4	0.6	0.3	0.5
SK-65^®	0.2	0.3	0.1	*
Stadol^®	0.0	*	0.0	0.1
Talacen^®	0.2	0.5	0.2	*
Talwin^®	0.1	0.1	0.1	*
Talwin^® NX	0.1	0.3	0.0	*
Tramadol	0.5	0.3	0.7	*
Ultram^®	2.3	2.0	2.1	*
SELECTED GROUPS OF DRUGS
Propoxyphene or Codeine Products^1,2	41.6	49.1	37.6	36.1
Oxycodone Products^1,3	22.0	20.8	27.1	16.4
Hydrocodone Products^1,4	57.0	53.9	63.1	53.0
Tramadol Products^1,5	2.8	2.3	2.7	3.8

51117

**Table 3.11A Nonmedical Use of Specific Prescription Tranquilizers among Lifetime Users of Any Tranquilizer, by Age Group: Numbers in Thousands, Annual Averages Based on 2002-2004**
Tranquilizer	TOTAL	AGE GROUP
Tranquilizer	TOTAL	12-17	18-25	26 or Older
*Low precision; no estimate reported. ¹ Includes other-specify drug responses that are not asked about explicitly in the tranquilizers module but fall into this category. ² Includes Klonopin^® or clonazepam, Xanax^®, alprazolam, Ativan^®, or lorazepam, Valium^® or diazepam, Librium^®, Limbitrol^®, Rohypnol^®, Serax^®, and Tranxene^®. ³ Includes Equanil^®, meprobamate, and Miltown^®. ⁴ Includes Flexeril^® and Soma^®. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
ANY TRANQUILIZER	19,780	842	3,763	15,175
Klonopin^® or Clonazepam	2,657	168	912	1,577
Xanax^®, Alprazolam, Ativan^®, or Lorazepam	9,025	438	2,321	6,266
Valium^® or Diazepam	14,555	410	2,406	11,738
Atarax^®	283	22	43	219
BuSpar^®	661	49	228	383
Equanil^®	94	12	16	66
Flexeril^®	1,914	43	377	1,494
Librium^®	1,185	22	75	1,089
Limbitrol^®	84	10	22	51
Meprobamate	153	13	15	126
Miltown^®	113	11	7	95
Rohypnol^®	376	37	163	176
Serax^®	167	12	26	129
Soma^®	2,488	144	832	1,512
Tranxene^®	182	11	23	148
Vistaril^®	296	17	51	228
SELECTED GROUPS OF DRUGS
Benzodiazepines^1,2	18,569	722	3,490	14,357
Meprobamate Products^1,3	314	31	35	247
Muscle Relaxants^1,4	3,662	171	1,030	2,461

51117

**Table 3.11B Nonmedical Use of Specific Prescription Tranquilizers among Lifetime Users of Any Tranquilizer, by Age Group: Percentages, Annual Averages Based on 2002-2004**
Tranquilizer	TOTAL	AGE GROUP
Tranquilizer	TOTAL	12-17	18-25	26 or Older
*Low precision; no estimate reported. NOTE: The denominator for percentages is the total number of lifetime nonmedical users of any prescription tranquilizer. ¹ Includes other-specify drug responses that are not asked about explicitly in the tranquilizers module but fall into this category. ² Includes Klonopin^® or clonazepam, Xanax^®, alprazolam, Ativan^®, or lorazepam, Valium^® or diazepam, Librium^®, Limbitrol^®, Rohypnol^®, Serax^®, and Tranxene^®. ³ Includes Equanil^®, meprobamate, and Miltown^®. ⁴ Includes Flexeril^® and Soma^®. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
ANY TRANQUILIZER	100.0	100.0	100.0	100.0
Klonopin^® or Clonazepam	13.4	19.9	24.2	10.4
Xanax^®, Alprazolam, Ativan^®, or Lorazepam	45.6	52.1	61.7	41.3
Valium^® or Diazepam	73.6	48.7	63.9	77.4
Atarax^®	1.4	2.6	1.1	1.4
BuSpar^®	3.3	5.8	6.1	2.5
Equanil^®	0.5	1.4	0.4	0.4
Flexeril^®	9.7	5.1	10.0	9.8
Librium^®	6.0	2.6	2.0	7.2
Limbitrol^®	0.4	1.2	0.6	0.3
Meprobamate	0.8	1.5	0.4	0.8
Miltown^®	0.6	1.3	0.2	0.6
Rohypnol^®	1.9	4.4	4.3	1.2
Serax^®	0.8	1.4	0.7	0.8
Soma^®	12.6	17.1	22.1	10.0
Tranxene^®	0.9	1.3	0.6	1.0
Vistaril^®	1.5	2.1	1.4	1.5
SELECTED GROUPS OF DRUGS
Benzodiazepines^1,2	93.9	85.8	92.7	94.6
Meprobamate Products^1,3	1.6	3.7	0.9	1.6
Muscle Relaxants^1,4	18.5	20.3	27.4	16.2

51117

**Table 3.12A Nonmedical Use of Specific Prescription Tranquilizers among Past Year Initiates of Any Tranquilizer, by Age Group: Numbers in Thousands, Annual Averages Based on 2002-2004**
Tranquilizer	TOTAL	AGE GROUP
Tranquilizer	TOTAL	12-17	18-25	26 or Older
*Low precision; no estimate reported. ¹ Includes other-specify drug responses that are not asked about explicitly in the tranquilizers module but fall into this category. ² Includes Klonopin^® or clonazepam, Xanax^®, alprazolam, Ativan^®, or lorazepam, Valium^® or diazepam, Librium^®, Limbitrol^®, Rohypnol^®, Serax^®, and Tranxene^®. ³ Includes Equanil^®, meprobamate, and Miltown^®. ⁴ Includes Flexeril^® and Soma^®. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
ANY TRANQUILIZER	1,145	315	431	400
Klonopin^® or Clonazepam	167	48	68	50
Xanax^®, Alprazolam, Ativan^®, or Lorazepam	583	155	230	198
Valium^® or Diazepam	481	134	194	154
Atarax^®	13	7	6	*
BuSpar^®	37	16	13	8
Equanil^®	7	5	1	*
Flexeril^®	80	14	20	45
Librium^®	15	10	4	*
Limbitrol^®	2	0	1	*
Meprobamate	6	4	0	*
Miltown^®	4	4	*	*
Rohypnol^®	14	11	3	*
Serax^®	4	4	*	*
Soma^®	147	45	66	36
Tranxene^®	7	2	3	*
Vistaril^®	13	7	4	*
SELECTED GROUPS OF DRUGS
Benzodiazepines^1,2	979	262	378	339
Meprobamate Products^1,3	15	12	2	*
Muscle Relaxants^1,4	211	59	78	75

51117

**Table 3.12B Nonmedical Use of Specific Prescription Tranquilizers among Past Year Initiates of Any Tranquilizer, by Age Group: Percentages, Annual Averages Based on 2002-2004**
Tranquilizer	TOTAL	AGE GROUP
Tranquilizer	TOTAL	12-17	18-25	26 or Older
*Low precision; no estimate reported. NOTE: The denominator for percentages is the total number of persons who initiated nonmedical use of any prescription tranquilizer in the past 12 months. ¹ Includes other-specify drug responses that are not asked about explicitly in the tranquilizers module but fall into this category. ² Includes Klonopin^® or clonazepam, Xanax^®, alprazolam, Ativan^®, or lorazepam, Valium^® or diazepam, Librium^®, Limbitrol^®, Rohypnol^®, Serax^®, and Tranxene^®. ³ Includes Equanil^®, meprobamate, and Miltown^®. ⁴ Includes Flexeril^® and Soma^®. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
ANY TRANQUILIZER	100.0	100.0	100.0	100.0
Klonopin^® or Clonazepam	14.5	15.3	15.9	12.5
Xanax^®, Alprazolam, Ativan^®, or Lorazepam	50.9	49.4	53.3	49.4
Valium^® or Diazepam	42.0	42.6	44.9	38.5
Atarax^®	1.1	2.1	1.4	*
BuSpar^®	3.2	5.0	3.1	2.0
Equanil^®	0.6	1.6	0.3	*
Flexeril^®	7.0	4.5	4.7	11.3
Librium^®	1.3	3.3	0.8	*
Limbitrol^®	0.1	0.1	0.3	*
Meprobamate	0.5	1.3	0.1	*
Miltown^®	0.4	1.4	*	*
Rohypnol^®	1.2	3.4	0.7	*
Serax^®	0.3	1.1	*	*
Soma^®	12.8	14.2	15.4	9.0
Tranxene^®	0.6	0.6	0.6	*
Vistaril^®	1.1	2.2	0.9	*
SELECTED GROUPS OF DRUGS
Benzodiazepines^1,2	85.5	83.3	87.7	84.8
Meprobamate Products^1,3	1.3	3.8	0.5	*
Muscle Relaxants^1,4	18.5	18.6	18.1	18.7

51117

**Table 3.13A Nonmedical Use of Specific Prescription Stimulants among Lifetime Users of Any Stimulant, by Age Group: Numbers in Thousands, Annual Averages Based on 2002-2004**
Stimulant	TOTAL	AGE GROUP
Stimulant	TOTAL	12-17	18-25	26 or Older
*Low precision; no estimate reported. ¹ Also known as crank, crystal, ice, or speed. ² Respondents were asked about their use of prescription diet pills and were given the following as examples: amphetamines, Benzedrine^®, Biphetamine^®, Fastin^®, or phentermine. However, respondents were not given an exhaustive list of examples of prescription diet pills. ³ Includes other-specify drug responses that are not asked about explicitly in the stimulants module but fall into this category. ⁴ Includes prescription diet pills, Dexedrine^®, dextroamphetamine, and Ionamin^®. ⁵ Includes Mazanor^® and Sanorex^®. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
ANY STIMULANT	20,617	983	3,395	16,239
Methamphetamine,¹ Desoxyn^®, or Methedrine^®	12,138	331	1,698	10,109
Prescription Diet Pills²	8,585	251	708	7,626
Ritalin^® or Methylphenidate	4,293	526	1,732	2,035
Cylert^®	209	22	36	151
Dexedrine^®	2,803	67	309	2,427
Dextroamphetamine	575	28	80	467
Didrex^®	186	18	30	138
Eskatrol^®	227	10	11	206
Ionamin^®	511	19	21	471
Mazanor^®	54	13	6	34
Obedrin-LA^®	33	7	4	23
Plegine^®	46	10	4	31
Preludin^®	697	12	37	648
Sanorex^®	116	18	24	73
Tenuate^®	214	11	14	189
SELECTED GROUPS OF DRUGS
Amphetamine, Dextroamphetamine, and Phentermine Products^3,4	10,059	370	1,121	8,568
Mazindol Products^3,5	157	27	27	103

51117

**Table 3.13B Nonmedical Use of Specific Prescription Stimulants among Lifetime Users of Any Stimulant, by Age Group: Percentages, Annual Averages Based on 2002-2004**
Stimulant	TOTAL	AGE GROUP
Stimulant	TOTAL	12-17	18-25	26 or Older
*Low precision; no estimate reported. NOTE: The denominator for percentages is the total number of lifetime nonmedical users of any prescription stimulant or methamphetamine. ¹ Also known as crank, crystal, ice, or speed. ² Respondents were asked about their use of prescription diet pills and were given the following as examples: amphetamines, Benzedrine^®, Biphetamine^®, Fastin^®, or phentermine. However, respondents were not given an exhaustive list of examples of prescription diet pills. ³ Includes other-specify drug responses that are not asked about explicitly in the stimulants module but fall into this category. ⁴ Includes prescription diet pills, Dexedrine^®, dextroamphetamine, and Ionamin^®. ⁵ Includes Mazanor^® and Sanorex^®. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
ANY STIMULANT	100.0	100.0	100.0	100.0
Methamphetamine,¹ Desoxyn^®, or Methedrine^®	58.9	33.7	50.0	62.2
Prescription Diet Pills²	41.6	25.6	20.9	47.0
Ritalin^® or Methylphenidate	20.8	53.6	51.0	12.5
Cylert^®	1.0	2.3	1.1	0.9
Dexedrine^®	13.6	6.8	9.1	14.9
Dextroamphetamine	2.8	2.8	2.4	2.9
Didrex^®	0.9	1.8	0.9	0.8
Eskatrol^®	1.1	1.0	0.3	1.3
Ionamin^®	2.5	1.9	0.6	2.9
Mazanor^®	0.3	1.4	0.2	0.2
Obedrin-LA^®	0.2	0.7	0.1	0.1
Plegine^®	0.2	1.0	0.1	0.2
Preludin^®	3.4	1.2	1.1	4.0
Sanorex^®	0.6	1.9	0.7	0.5
Tenuate^®	1.0	1.1	0.4	1.2
SELECTED GROUPS OF DRUGS
Amphetamine, Dextroamphetamine, and Phentermine Products^3,4	48.8	37.6	33.0	52.8
Mazindol Products^3,5	0.8	2.8	0.8	0.6

51117

**Table 3.14A Nonmedical Use of Specific Prescription Stimulants among Past Year Initiates of Any Stimulant, by Age Group: Numbers in Thousands, Annual Averages Based on 2002-2004**
Stimulant	TOTAL	AGE GROUP
Stimulant	TOTAL	12-17	18-25	26 or Older
*Low precision; no estimate reported. ¹ Also known as crank, crystal, ice, or speed. ² Respondents were asked about their use of prescription diet pills and were given the following as examples: amphetamines, Benzedrine^®, Biphetamine^®, Fastin^®, or phentermine. However, respondents were not given an exhaustive list of examples of prescription diet pills. ³ Includes other-specify drug responses that are not asked about explicitly in the stimulants module but fall into this category. ⁴ Includes prescription diet pills, Dexedrine^®, dextroamphetamine, and Ionamin^®. ⁵ Includes Mazanor^® and Sanorex^®. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
ANY STIMULANT	764	301	307	*
Methamphetamine,¹ Desoxyn^®, or Methedrine^®	240	94	97	*
Prescription Diet Pills²	157	70	53	*
Ritalin^® or Methylphenidate	323	143	125	*
Cylert^®	5	3	1	*
Dexedrine^®	38	16	18	*
Dextroamphetamine	10	4	3	*
Didrex^®	10	4	1	*
Eskatrol^®	6	3	1	*
Ionamin^®	6	4	3	*
Mazanor^®	2	2	*	*
Obedrin-LA^®	1	1	*	*
Plegine^®	3	3	0	*
Preludin^®	2	2	0	*
Sanorex^®	5	4	1	*
Tenuate^®	2	2	0	*
SELECTED GROUPS OF DRUGS
Amphetamine, Dextroamphetamine, and Phentermine Products^3,4	283	112	121	*
Mazindol Products^3,5	7	6	1	*

51117

**Table 3.14B Nonmedical Use of Specific Prescription Stimulants among Past Year Initiates of Any Stimulant, by Age Group: Percentages, Annual Averages Based on 2002-2004**
Stimulant	TOTAL	AGE GROUP
Stimulant	TOTAL	12-17	18-25	26 or Older
*Low precision; no estimate reported. NOTE: The denominator for percentages is the total number of persons who initiated nonmedical use of any prescription stimulant or methamphetamine reliever in the past 12 months. ¹ Also known as crank, crystal, ice, or speed. ² Respondents were asked about their use of prescription diet pills and were given the following as examples: amphetamines, Benzedrine^®, Biphetamine^®, Fastin^®, or phentermine. However, respondents were not given an exhaustive list of examples of prescription diet pills. ³ Includes other-specify drug responses that are not asked about explicitly in the stimulants module but fall into this category. ⁴ Includes prescription diet pills, Dexedrine^®, dextroamphetamine, and Ionamin^®. ⁵ Includes Mazanor^® and Sanorex^®. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
ANY STIMULANT	100.0	100.0	100.0	*
Methamphetamine,¹ Desoxyn^®, or Methedrine^®	31.5	31.3	31.5	*
Prescription Diet Pills²	20.6	23.2	17.2	*
Ritalin^® or Methylphenidate	42.3	47.5	40.8	*
Cylert^®	0.7	0.9	0.2	*
Dexedrine^®	4.9	5.4	6.0	*
Dextroamphetamine	1.3	1.3	1.0	*
Didrex^®	1.3	1.5	0.3	*
Eskatrol^®	0.7	0.8	0.3	*
Ionamin^®	0.8	1.2	0.9	*
Mazanor^®	0.3	0.8	*	*
Obedrin-LA^®	0.1	0.2	*	*
Plegine^®	0.4	0.9	0.1	*
Preludin^®	0.3	0.5	0.1	*
Sanorex^®	0.6	1.2	0.3	*
Tenuate^®	0.3	0.6	0.2	*
SELECTED GROUPS OF DRUGS
Amphetamine, Dextroamphetamine, and Phentermine Products^3,4	37.0	37.0	39.3	*
Mazindol Products^3,5	0.9	1.9	0.3	*

51117

**Table 3.15A Nonmedical Use of Specific Prescription Sedatives among Lifetime Users of Any Sedative, by Age Group: Numbers in Thousands, Annual Averages Based on 2002-2004**
Sedative	TOTAL	AGE GROUP
Sedative	TOTAL	12-17	18-25	26 or Older
*Low precision; no estimate reported. ¹ Respondents were asked about their use of barbiturates and were given the following as examples: Nembutal^®, pentobarbital, Seconal^®, secobarbital, or butalbital. However, respondents were not given an exhaustive list of examples of barbiturates. ² Includes other-specify drug responses that are not asked about explicitly in the sedatives module but fall into this category. ³ Includes Restoril^®, temazepam, Dalmane^®, or Halcion^®. ⁴ Includes barbiturates, Amytal^®, Butisol^®, phenobarbital, and Tuinal^®. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
ANY SEDATIVE	9,787	246	613	8,928
Methaqualone, Sopor^®, or Quaalude^®	7,144	59	272	6,812
Barbiturates¹	3,093	37	113	2,943
Restoril^® or Temazepam	901	47	106	749
Amytal^®	244	17	21	206
Butisol^®	94	13	16	64
Chloral Hydrate	194	12	15	167
Dalmane^®	504	28	17	459
Halcion^®	760	25	57	678
Phenobarbital	1,333	30	93	1,210
Placidyl^®	905	9	20	875
Tuinal^®	1,164	10	13	1,141
SELECTED GROUPS OF DRUGS
Temazepam, Flurazepam, or Triazolam^2,3	1,751	84	164	1,504
Any Barbiturates^2,4	3,816	84	195	3,537

51117

**Table 3.15B Nonmedical Use of Specific Prescription Sedatives among Lifetime Users of Any Sedative, by Age Group: Percentages, Annual Averages Based on 2002-2004**
Sedative	TOTAL	AGE GROUP
Sedative	TOTAL	12-17	18-25	26 or Older
*Low precision; no estimate reported. NOTE: The denominator for percentages is the total number of lifetime nonmedical users of any prescription sedative. ¹ Respondents were asked about their use of barbiturates and were given the following as examples: Nembutal^®, pentobarbital, Seconal^®, secobarbital, or butalbital. However, respondents were not given an exhaustive list of examples of barbiturates. ² Includes other-specify drug responses that are not asked about explicitly in the sedatives module but fall into this category. ³ Includes Restoril^®, temazepam, Dalmane^®, or Halcion^®. ⁴ Includes barbiturates, Amytal^®, Butisol^®, phenobarbital, and Tuinal^®. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
ANY SEDATIVE	100.0	100.0	100.0	100.0
Methaqualone, Sopor^®, or Quaalude^®	73.0	24.1	44.4	76.3
Barbiturates¹	31.6	14.9	18.5	33.0
Restoril^® or Temazepam	9.2	18.9	17.2	8.4
Amytal^®	2.5	6.9	3.4	2.3
Butisol^®	1.0	5.4	2.6	0.7
Chloral Hydrate	2.0	4.9	2.4	1.9
Dalmane^®	5.2	11.6	2.7	5.1
Halcion^®	7.8	10.0	9.4	7.6
Phenobarbital	13.6	12.3	15.1	13.6
Placidyl^®	9.2	3.8	3.3	9.8
Tuinal^®	11.9	4.0	2.1	12.8
SELECTED GROUPS OF DRUGS
Temazepam, Flurazepam, or Triazolam^2,3	17.9	34.1	26.7	16.8
Any Barbiturates^2,4	39.0	34.2	31.9	39.6

51117

**Table 3.16A Nonmedical Use of Specific Prescription Sedatives among Past Year Initiates of Any Sedative, by Age Group: Numbers in Thousands, Annual Averages Based on 2002-2004**
Sedative	TOTAL	AGE GROUP
Sedative	TOTAL	12-17	18-25	26 or Older
*Low precision; no estimate reported. ¹ Respondents were asked about their use of barbiturates and were given the following as examples: Nembutal^®, pentobarbital, Seconal^®, secobarbital, or butalbital. However, respondents were not given an exhaustive list of examples of barbiturates. ² Includes other-specify drug responses that are not asked about explicitly in the sedatives module but fall into this category. ³ Includes Restoril^®, temazepam, Dalmane^®, or Halcion^®. ⁴ Includes barbiturates, Amytal^®, Butisol^®, phenobarbital, and Tuinal^®. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
ANY SEDATIVE	214	65	49	*
Methaqualone, Sopor^®, or Quaalude^®	23	15	5	*
Barbiturates¹	23	7	4	*
Restoril^® or Temazepam	37	12	*	*
Amytal^®	2	2	*	*
Butisol^®	6	4	2	*
Chloral Hydrate	4	3	*	*
Dalmane^®	9	7	*	*
Halcion^®	16	4	4	*
Phenobarbital	17	8	4	*
Placidyl^®	1	1	*	*
Tuinal^®	0	*	*	*
SELECTED GROUPS OF DRUGS
Temazepam, Flurazepam, or Triazolam^2,3	58	20	13	*
Any Barbiturates^2,4	45	18	9	*

51117

**Table 3.16B Nonmedical Use of Specific Prescription Sedatives among Past Year Initiates of Any Sedative, by Age Group: Percentages, Annual Averages Based on 2002-2004**
Sedative	TOTAL	AGE GROUP
Sedative	TOTAL	12-17	18-25	26 or Older
*Low precision; no estimate reported. NOTE: The denominator for percentages is the total number of persons who initiated nonmedical use of any prescription sedative in the past 12 months. ¹ Respondents were asked about their use of barbiturates and were given the following as examples: Nembutal^®, pentobarbital, Seconal^®, secobarbital, or butalbital. However, respondents were not given an exhaustive list of examples of barbiturates. ² Includes other-specify drug responses that are not asked about explicitly in the sedatives module but fall into this category. ³ Includes Restoril^®, temazepam, Dalmane^®, or Halcion^®. ⁴ Includes barbiturates, Amytal^®, Butisol^®, phenobarbital, and Tuinal^®. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
ANY SEDATIVE	100.0	100.0	100.0	*
Methaqualone, Sopor^®, or Quaalude^®	11.0	23.4	10.3	*
Barbiturates¹	10.8	10.8	7.1	*
Restoril^® or Temazepam	17.4	18.2	*	*
Amytal^®	1.2	3.4	*	*
Butisol^®	2.6	5.7	3.7	*
Chloral Hydrate	1.6	4.4	*	*
Dalmane^®	4.1	10.9	*	*
Halcion^®	7.6	6.2	8.8	*
Phenobarbital	8.1	13.0	7.9	*
Placidyl^®	0.3	1.1	*	*
Tuinal^®	0.1	*	*	*
SELECTED GROUPS OF DRUGS
Temazepam, Flurazepam, or Triazolam^2,3	27.2	30.5	26.6	*
Any Barbiturates^2,4	21.2	28.4	19.0	*

51122

Table 4.1B Past Year Initiation of Nonmedical Use of Prescription-Type Psychotherapeutic Drugs among Persons Aged 12 or Older, Persons Aged 12 or Older at Risk for Initiation, and Past Year Users Aged 12 or Older, by Age Group: Numbers in Thousands and Percentages, Annual Averages Based on 2002-2004
Drug	NUMBER OF PAST YEAR INITIATES (1,000s)¹	PERCENTAGE OF PAST YEAR INITIATES AMONG TOTAL POPULATION¹	PERCENTAGE OF PAST YEAR INITIATES AMONG PERSONS AT RISK FOR INITIATION^1,2	PERCENTAGE OF PAST YEAR INITIATES AMONG PAST YEAR USERS¹
Drug	Aged 12 or Older
*Low precision; no estimate reported. ¹ Past Year Initiates are defined as persons who used the substance(s) for the first time in the 12 months prior to date of interview. ² At Risk for Initiation is defined as persons who did not use the substance(s) in their lifetime or used the substance(s) for the first time in the past year. ³ Nonmedical use of prescription-type pain relievers, tranquilizers, stimulants, or sedatives; does not include over-the-counter drugs. ⁴ Estimates for OxyContin^® are based on 2004 data only. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
Nonmedical Use of Any Psychotherapeutics³	2,657	1.1	1.4	18.0
Pain Relievers	2,399	1.0	1.1	21.2
OxyContin^®4	615	0.3	0.3	50.7
Tranquilizers	1,145	0.5	0.5	23.0
Stimulants	764	0.3	0.4	25.9
Methamphetamine	292	0.1	0.1	20.4
Sedatives	214	0.1	0.1	25.2
Drug	Aged 12 to 17
Nonmedical Use of Any Psychotherapeutics³	959	3.8	4.3	42.3
Pain Relievers	902	3.6	3.9	47.8
OxyContin^®4	141	0.6	0.6	72.8
Tranquilizers	315	1.3	1.3	56.0
Stimulants	301	1.2	1.2	52.8
Methamphetamine	112	0.4	0.5	60.0
Sedatives	65	0.3	0.3	48.4
Drug	Aged 18 to 25
Nonmedical Use of Any Psychotherapeutics³	948	3.0	4.0	20.6
Pain Relievers	881	2.8	3.5	23.6
OxyContin^®4	290	0.9	0.9	51.6
Tranquilizers	431	1.4	1.5	26.7
Stimulants	307	1.0	1.1	26.8
Methamphetamine	121	0.4	0.4	23.5
Sedatives	49	0.2	0.2	30.7
Drug	Aged 26 or Older
Nonmedical Use of Any Psychotherapeutics³	750	0.4	0.5	9.5
Pain Relievers	615	0.3	0.4	10.8
OxyContin^®4	183	0.1	0.1	*
Tranquilizers	400	0.2	0.2	14.2
Stimulants	155	0.1	0.1	12.6
Methamphetamine	59	0.0	0.0	8.1
Sedatives	100	0.1	0.1	18.0

51122

Table 4.2B Past Year Initiation of Nonmedical Use of Prescription-Type Psychotherapeutic Drugs among Persons Aged 12 or Older, Persons Aged 12 or Older at Risk for Initiation, and Past Year Users Aged 12 or Older, by Gender: Numbers in Thousands and Percentages, Annual Averages Based on 2002-2004
Drug	NUMBER OF PAST YEAR INITIATES (1,000s)¹	PERCENTAGE OF PAST YEAR INITIATES AMONG TOTAL POPULATION¹	PERCENTAGE OF PAST YEAR INITIATES AMONG PERSONS AT RISK FOR INITIATION^1,2	PERCENTAGE OF PAST YEAR INITIATES AMONG PAST YEAR USERS¹
Drug	Males
*Low precision; no estimate reported. ¹ Past Year Initiates are defined as persons who used the substance(s) for the first time in the 12 months prior to date of interview. ² At Risk for Initiation is defined as persons who did not use the substance(s) in their lifetime or used the substance(s) for the first time in the past year. ³ Nonmedical use of prescription-type pain relievers, tranquilizers, stimulants, or sedatives; does not include over-the-counter drugs. ⁴ Estimates for OxyContin^® are based on 2004 data only. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
Nonmedical Use of Any Psychotherapeutics³	1,111	1.0	1.2	14.8
Pain Relievers	1,063	0.9	1.1	17.8
OxyContin^®4	339	0.3	0.3	45.7
Tranquilizers	444	0.4	0.4	18.3
Stimulants	328	0.3	0.3	21.3
Methamphetamine	137	0.1	0.1	16.3
Sedatives	68	0.1	0.1	17.9
Drug	Females
Nonmedical Use of Any Psychotherapeutics³	1,546	1.3	1.5	21.2
Pain Relievers	1,336	1.1	1.2	25.0
OxyContin^®4	276	0.2	0.2	58.4
Tranquilizers	702	0.6	0.6	27.4
Stimulants	436	0.4	0.4	30.9
Methamphetamine	155	0.1	0.1	26.2
Sedatives	147	0.1	0.1	31.0

51122

Table 4.3B Past Year Initiation of Nonmedical Use of Prescription-Type Psychotherapeutic Drugs among Persons Aged 12 or Older, Persons Aged 12 or Older at Risk for Initiation, and Past Year Users Aged 12 or Older, by Geographic Region: Numbers in Thousands and Percentages, Annual Averages Based on 2002-2004
Drug	NUMBER OF PAST YEAR INITIATES (1,000s)¹	PERCENTAGE OF PAST YEAR INITIATES AMONG TOTAL POPULATION¹	PERCENTAGE OF PAST YEAR INITIATES AMONG PERSONS AT RISK FOR INITIATION^1,2	PERCENTAGE OF PAST YEAR INITIATES AMONG PAST YEAR USERS¹
Drug	Northeast
*Low precision; no estimate reported. ¹ Past Year Initiates are defined as persons who used the substance(s) for the first time in the 12 months prior to date of interview. ² At Risk for Initiation is defined as persons who did not use the substance(s) in their lifetime or used the substance(s) for the first time in the past year. ³ Nonmedical use of prescription-type pain relievers, tranquilizers, stimulants, or sedatives; does not include over-the-counter drugs. ⁴ Estimates for OxyContin^® are based on 2004 data only. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
Nonmedical Use of Any Psychotherapeutics³	463	1.0	1.2	19.4
Pain Relievers	396	0.9	1.0	21.5
OxyContin^®4	122	0.3	0.3	*
Tranquilizers	209	0.5	0.5	25.1
Stimulants	134	0.3	0.3	32.8
Methamphetamine	22	0.0	0.1	*
Sedatives	49	0.1	0.1	*
Drug	Midwest
Nonmedical Use of Any Psychotherapeutics³	616	1.1	1.4	19.7
Pain Relievers	568	1.1	1.2	23.5
OxyContin^®4	139	0.3	0.3	50.2
Tranquilizers	232	0.4	0.5	24.3
Stimulants	186	0.3	0.4	27.5
Methamphetamine	62	0.1	0.1	20.8
Sedatives	51	0.1	0.1	30.2
Drug	South
Nonmedical Use of Any Psychotherapeutics³	941	1.1	1.4	17.6
Pain Relievers	860	1.0	1.1	21.0
OxyContin^®4	202	0.2	0.2	50.8
Tranquilizers	473	0.6	0.6	21.7
Stimulants	262	0.3	0.3	27.3
Methamphetamine	108	0.1	0.1	25.5
Sedatives	69	0.1	0.1	22.8
Drug	West
Nonmedical Use of Any Psychotherapeutics³	637	1.2	1.5	16.3
Pain Relievers	575	1.1	1.2	19.4
OxyContin^®4	151	0.3	0.3	*
Tranquilizers	231	0.4	0.5	22.6
Stimulants	182	0.3	0.4	20.1
Methamphetamine	99	0.2	0.2	15.3
Sedatives	46	0.1	0.1	23.4

51122

Table 4.4B Mean Age at First Use among Past Year Initiates into Nonmedical Use of Prescription-Type Psychotherapeutic Drugs among the Total Population Aged 12 or Older, by Age at Initiation and Gender: Annual Averages Based on 2002-2004
Drug	PAST YEAR INITIATES AT ANY AGE¹	PAST YEAR INITIATES WHO FIRST USED PRIOR TO AGE 18¹	PAST YEAR INITIATES WHO FIRST USED PRIOR TO AGE 21¹
Drug	Mean Age among All Persons
*Low precision; no estimate reported. ¹ Past Year Initiates are defined as persons who used the substance(s) for the first time in the 12 months prior to date of interview. ² Nonmedical use of prescription-type pain relievers, tranquilizers, stimulants, or sedatives; does not include over-the-counter drugs. ³ Estimates for OxyContin^® are based on 2004 data only. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
Nonmedical Use of Any Psychotherapeutics²	23.4	15.1	16.3
Pain Relievers	22.8	15.1	16.3
OxyContin^®3	24.5	15.7	17.3
Tranquilizers	24.5	15.5	16.8
Stimulants	21.8	15.1	16.5
Methamphetamine	20.5	15.2	16.4
Sedatives	29.5	14.6	15.6
Drug	Mean Age among Males
Nonmedical Use of Any Psychotherapeutics²	21.6	15.3	16.5
Pain Relievers	21.2	15.4	16.5
OxyContin^®3	25.2	16.0	17.4
Tranquilizers	22.4	15.7	17.0
Stimulants	21.8	15.2	16.6
Methamphetamine	19.9	15.3	16.8
Sedatives	20.9	14.9	16.1
Drug	Mean Age among Females
Nonmedical Use of Any Psychotherapeutics²	24.7	14.9	16.2
Pain Relievers	24.1	14.9	16.1
OxyContin^®3	23.6	15.4	17.0
Tranquilizers	25.7	15.4	16.6
Stimulants	21.8	15.1	16.4
Methamphetamine	21.0	15.1	16.0
Sedatives	33.5	14.4	15.2

60315

**Table 5.1A Lifetime Use of Both Prescription-Type Psychotherapeutics and Other Substances among Persons Aged 12 or Older, by Drug Type: Numbers in Thousands, Annual Averages Based on 2002-2004**
Other Substance Use in Lifetime	Any Prescription- Type Psycho- therapeutic Drug¹	PRESCRIPTION DRUG TYPE
		Pain Relievers	Tranquilizers	Stimulants		Sedatives
		Pain Relievers	Tranquilizers	Any Stimulant	Metham- phetamine	Sedatives
*Low precision; no estimate reported. N/A: Not applicable. ¹ Nonmedical use of prescription-type pain relievers, tranquilizers, stimulants, or sedatives; does not include over-the-counter drugs. ² Nonmedical use of the prescription drug specified in the column, with or without other lifetime illicit or nonmedical use of other drugs. ³ Never used marijuana or hashish, cocaine, heroin, hallucinogens, or inhalants. Except for the "Any Prescription-Type Psychotherapeutic Drug" column, never used any prescription-type psychotherapeutic drug other than the drug category specified in a given column. ⁴ Nonmedical use of the prescription drug specified in the column and lifetime use of marijuana or hashish, cocaine, heroin, hallucinogens, or inhalants, or nonmedical use of any other prescription-type psychotherapeutic drug. ⁵ Lifetime use of both the prescription drug specified in the column and any of the following drugs: marijuana or hashish, cocaine, crack cocaine, heroin, hallucinogens, LSD, PCP, Ecstasy, or inhalants. ⁶ Lifetime use of prescription drug specified in column and any other prescription drug shown in the indented stub immediately below. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
TOTAL²	47,484	30,862	19,780	20,617	12,138	9,787
NO OTHER ILLICIT DRUG USE³	8,621	4,955	1,209	921	159	289
ANY OTHER ILLICIT DRUG USE⁴	38,863	25,907	18,571	19,697	11,979	9,498
ANY NONPSYCHOTHERAPEUTIC⁵	38,863	24,821	17,693	19,250	11,893	9,240
Marijuana or Hashish	37,458	23,763	17,283	18,909	11,764	9,081
Cocaine	21,736	13,727	11,832	13,302	9,466	7,272
Crack	5,993	4,444	3,901	3,998	3,261	2,205
Heroin	2,898	2,308	2,130	2,051	1,607	1,599
Hallucinogens	22,940	15,119	12,403	13,549	9,283	7,377
LSD	17,347	11,458	9,924	10,983	7,853	6,371
PCP	5,688	3,924	3,698	4,069	3,089	3,077
Ecstasy	7,723	6,089	4,831	4,189	2,796	1,649
Inhalants	14,830	10,438	8,262	8,660	5,694	4,868
ANY OTHER PSYCHOTHERAPEUTICS⁶	N/A	17,111	15,556	13,539	8,259	8,265
Pain Relievers	N/A	N/A	12,839	10,456	6,447	5,750
Tranquilizers	N/A	12,839	N/A	8,723	5,581	5,967
Any Stimulants	N/A	10,456	8,723	N/A	N/A	5,883
Methamphetamine	N/A	6,447	5,581	N/A	N/A	3,953
Sedatives	N/A	5,750	5,967	5,883	3,953	N/A
ALCOHOL	45,482	29,322	19,367	20,351	12,057	9,652
CIGARETTES	41,525	26,638	18,249	19,208	11,571	9,170

60315

**Table 5.1B Lifetime Use of Both Prescription-Type Psychotherapeutics and Other Substances among Persons Aged 12 or Older, by Drug Type: Percentages, Annual Averages Based on 2002-2004**
Other Substance Use in Lifetime	Any Prescription- Type Psycho- therapeutic Drug¹	PRESCRIPTION DRUG TYPE
		Pain Relievers	Tranquilizers	Stimulants		Sedatives
		Pain Relievers	Tranquilizers	Any Stimulant	Metham- phetamine	Sedatives
*Low precision; no estimate reported. N/A: Not applicable. ¹ Nonmedical use of prescription-type pain relievers, tranquilizers, stimulants, or sedatives; does not include over-the-counter drugs. ² Nonmedical use of the prescription drug specified in the column, with or without other lifetime illicit or nonmedical use of other drugs. ³ Never used marijuana or hashish, cocaine, heroin, hallucinogens, or inhalants. Except for the "Any Prescription-Type Psychotherapeutic Drug" column, never used any prescription-type psychotherapeutic drug other than the drug category specified in a given column. ⁴ Nonmedical use of the prescription drug specified in the column and lifetime use of marijuana or hashish, cocaine, heroin, hallucinogens, or inhalants, or nonmedical use of any other prescription-type psychotherapeutic drug. ⁵ Lifetime use of both the prescription drug specified in the column and any of the following drugs: marijuana or hashish, cocaine, crack cocaine, heroin, hallucinogens, LSD, PCP, Ecstasy, or inhalants. ⁶ Lifetime use of prescription drug specified in column and any other prescription drug shown in the indented stub immediately below. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
TOTAL²	20.0	13.0	8.3	8.7	5.1	4.1
NO OTHER ILLICIT DRUG USE³	3.6	2.1	0.5	0.4	0.1	0.1
ANY OTHER ILLICIT DRUG USE⁴	16.3	10.9	7.8	8.3	5.0	4.0
ANY NONPSYCHOTHERAPEUTIC⁵	16.3	10.4	7.4	8.1	5.0	3.9
Marijuana or Hashish	15.8	10.0	7.3	8.0	4.9	3.8
Cocaine	9.1	5.8	5.0	5.6	4.0	3.1
Crack	2.5	1.9	1.6	1.7	1.4	0.9
Heroin	1.2	1.0	0.9	0.9	0.7	0.7
Hallucinogens	9.6	6.4	5.2	5.7	3.9	3.1
LSD	7.3	4.8	4.2	4.6	3.3	2.7
PCP	2.4	1.7	1.6	1.7	1.3	1.3
Ecstasy	3.2	2.6	2.0	1.8	1.2	0.7
Inhalants	6.2	4.4	3.5	3.6	2.4	2.0
ANY OTHER PSYCHOTHERAPEUTICS⁶	N/A	7.2	6.5	5.7	3.5	3.5
Pain Relievers	N/A	N/A	5.4	4.4	2.7	2.4
Tranquilizers	N/A	5.4	N/A	3.7	2.3	2.5
Any Stimulants	N/A	4.4	3.7	N/A	N/A	2.5
Methamphetamine	N/A	2.7	2.3	N/A	N/A	1.7
Sedatives	N/A	2.4	2.5	2.5	1.7	N/A
ALCOHOL	19.1	12.3	8.1	8.6	5.1	4.1
CIGARETTES	17.5	11.2	7.7	8.1	4.9	3.9

60315

**Table 5.2A Lifetime Use of Both Prescription-Type Psychotherapeutics and Other Substances among Persons Aged 12 to 17, by Drug Type: Numbers in Thousands, Annual Averages Based on 2002-2004**
Other Substance Use in Lifetime	Any Prescription- Type Psycho- therapeutic Drug¹	PRESCRIPTION DRUG TYPE
		Pain Relievers	Tranquilizers	Stimulants		Sedatives
		Pain Relievers	Tranquilizers	Any Stimulant	Metham- phetamine	Sedatives
*Low precision; no estimate reported. N/A: Not applicable. ¹ Nonmedical use of prescription-type pain relievers, tranquilizers, stimulants, or sedatives; does not include over-the-counter drugs. ² Nonmedical use of the prescription drug specified in the column, with or without other lifetime illicit or nonmedical use of other drugs. ³ Never used marijuana or hashish, cocaine, heroin, hallucinogens, or inhalants. Except for the "Any Prescription-Type Psychotherapeutic Drug" column, never used any prescription-type psychotherapeutic drug other than the drug category specified in a given column. ⁴ Nonmedical use of the prescription drug specified in the column and lifetime use of marijuana or hashish, cocaine, heroin, hallucinogens, or inhalants, or nonmedical use of any other prescription-type psychotherapeutic drug. ⁵ Lifetime use of both the prescription drug specified in the column and any of the following drugs: marijuana or hashish, cocaine, crack cocaine, heroin, hallucinogens, LSD, PCP, Ecstasy, or inhalants. ⁶ Lifetime use of prescription drug specified in column and any other prescription drug shown in the indented stub immediately below. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
TOTAL²	3,378	2,817	842	983	331	246
NO OTHER ILLICIT DRUG USE³	1,080	794	44	93	11	33
ANY OTHER ILLICIT DRUG USE⁴	2,298	2,023	797	889	320	213
ANY NONPSYCHOTHERAPEUTIC⁵	2,298	1,915	746	833	314	182
Marijuana or Hashish	1,873	1,576	681	712	290	137
Cocaine	475	415	270	271	168	58
Crack	123	104	77	83	65	20
Heroin	71	61	45	47	32	13
Hallucinogens	876	757	429	438	219	96
LSD	357	323	207	199	120	54
PCP	158	138	93	100	68	32
Ecstasy	474	411	267	244	137	54
Inhalants	1,114	936	377	454	176	129
ANY OTHER PSYCHOTHERAPEUTICS⁶	N/A	1,040	706	669	250	182
Pain Relievers	N/A	N/A	667	628	240	165
Tranquilizers	N/A	667	N/A	337	147	109
Any Stimulants	N/A	628	337	N/A	N/A	105
Methamphetamine	N/A	240	147	N/A	N/A	46
Sedatives	N/A	165	109	105	46	N/A
ALCOHOL	2,684	2,245	774	885	317	191
CIGARETTES	2,261	1,886	728	798	299	164

60315

**Table 5.2B Lifetime Use of Both Prescription-Type Psychotherapeutics and Other Substances among Persons Aged 12 to 17, by Drug Type: Percentages, Annual Averages Based on 2002-2004**
Other Substance Use in Lifetime	Any Prescription- Type Psycho- therapeutic Drug¹	PRESCRIPTION DRUG TYPE
		Pain Relievers	Tranquilizers	Stimulants		Sedatives
		Pain Relievers	Tranquilizers	Any Stimulant	Metham- phetamine	Sedatives
*Low precision; no estimate reported. N/A: Not applicable. ¹ Nonmedical use of prescription-type pain relievers, tranquilizers, stimulants, or sedatives; does not include over-the-counter drugs. ² Nonmedical use of the prescription drug specified in the column, with or without other lifetime illicit or nonmedical use of other drugs. ³ Never used marijuana or hashish, cocaine, heroin, hallucinogens, or inhalants. Except for the "Any Prescription-Type Psychotherapeutic Drug" column, never used any prescription-type psychotherapeutic drug other than the drug category specified in a given column. ⁴ Nonmedical use of the prescription drug specified in the column and lifetime use of marijuana or hashish, cocaine, heroin, hallucinogens, or inhalants, or nonmedical use of any other prescription-type psychotherapeutic drug. ⁵ Lifetime use of both the prescription drug specified in the column and any of the following drugs: marijuana or hashish, cocaine, crack cocaine, heroin, hallucinogens, LSD, PCP, Ecstasy, or inhalants. ⁶ Lifetime use of prescription drug specified in column and any other prescription drug shown in the indented stub immediately below. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
TOTAL²	13.5	11.3	3.4	3.9	1.3	1.0
NO OTHER ILLICIT DRUG USE³	4.3	3.2	0.2	0.4	0.0	0.1
ANY OTHER ILLICIT DRUG USE⁴	9.2	8.1	3.2	3.6	1.3	0.9
ANY NONPSYCHOTHERAPEUTIC⁵	9.2	7.7	3.0	3.3	1.3	0.7
Marijuana or Hashish	7.5	6.3	2.7	2.9	1.2	0.5
Cocaine	1.9	1.7	1.1	1.1	0.7	0.2
Crack	0.5	0.4	0.3	0.3	0.3	0.1
Heroin	0.3	0.2	0.2	0.2	0.1	0.1
Hallucinogens	3.5	3.0	1.7	1.8	0.9	0.4
LSD	1.4	1.3	0.8	0.8	0.5	0.2
PCP	0.6	0.6	0.4	0.4	0.3	0.1
Ecstasy	1.9	1.6	1.1	1.0	0.5	0.2
Inhalants	4.5	3.7	1.5	1.8	0.7	0.5
ANY OTHER PSYCHOTHERAPEUTICS⁶	N/A	4.2	2.8	2.7	1.0	0.7
Pain Relievers	N/A	N/A	2.7	2.5	1.0	0.7
Tranquilizers	N/A	2.7	N/A	1.3	0.6	0.4
Any Stimulants	N/A	2.5	1.3	N/A	N/A	0.4
Methamphetamine	N/A	1.0	0.6	N/A	N/A	0.2
Sedatives	N/A	0.7	0.4	0.4	0.2	N/A
ALCOHOL	10.7	9.0	3.1	3.5	1.3	0.8
CIGARETTES	9.0	7.5	2.9	3.2	1.2	0.7

60315

**Table 5.3A Lifetime Use of Both Prescription-Type Psychotherapeutics and Other Substances among Persons Aged 18 to 25, by Drug Type: Numbers in Thousands, Annual Averages Based on 2002-2004**
Other Substance Use in Lifetime	Any Prescription- Type Psycho- therapeutic Drug¹	PRESCRIPTION DRUG TYPE
		Pain Relievers	Tranquilizers	Stimulants		Sedatives
		Pain Relievers	Tranquilizers	Any Stimulant	Metham- phetamine	Sedatives
*Low precision; no estimate reported. N/A: Not applicable. ¹ Nonmedical use of prescription-type pain relievers, tranquilizers, stimulants, or sedatives; does not include over-the-counter drugs. ² Nonmedical use of the prescription drug specified in the column, with or without other lifetime illicit or nonmedical use of other drugs. ³ Never used marijuana or hashish, cocaine, heroin, hallucinogens, or inhalants. Except for the "Any Prescription-Type Psychotherapeutic Drug" column, never used any prescription-type psychotherapeutic drug other than the drug category specified in a given column. ⁴ Nonmedical use of the prescription drug specified in the column and lifetime use of marijuana or hashish, cocaine, heroin, hallucinogens, or inhalants, or nonmedical use of any other prescription-type psychotherapeutic drug. ⁵ Lifetime use of both the prescription drug specified in the column and any of the following drugs: marijuana or hashish, cocaine, crack cocaine, heroin, hallucinogens, LSD, PCP, Ecstasy, or inhalants. ⁶ Lifetime use of prescription drug specified in column and any other prescription drug shown in the indented stub immediately below. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
TOTAL²	9,063	7,393	3,763	3,395	1,698	613
NO OTHER ILLICIT DRUG USE³	1,260	871	100	108	11	16
ANY OTHER ILLICIT DRUG USE⁴	7,803	6,522	3,664	3,287	1,688	597
ANY NONPSYCHOTHERAPEUTIC⁵	7,803	6,371	3,554	3,222	1,675	566
Marijuana or Hashish	7,556	6,175	3,481	3,173	1,662	552
Cocaine	3,683	3,132	2,165	2,069	1,314	407
Crack	986	851	637	682	539	187
Heroin	455	414	345	316	226	118
Hallucinogens	4,967	4,182	2,738	2,456	1,412	475
LSD	3,342	2,851	2,018	1,818	1,126	379
PCP	698	623	471	454	307	149
Ecstasy	3,330	2,859	2,014	1,729	970	371
Inhalants	3,301	2,841	1,853	1,743	959	379
ANY OTHER PSYCHOTHERAPEUTICS⁶	N/A	3,959	3,189	2,520	1,316	562
Pain Relievers	N/A	N/A	3,033	2,369	1,237	523
Tranquilizers	N/A	3,033	N/A	1,642	919	453
Any Stimulants	N/A	2,369	1,642	N/A	N/A	385
Methamphetamine	N/A	1,237	919	N/A	N/A	251
Sedatives	N/A	523	453	385	251	N/A
ALCOHOL	8,764	7,149	3,716	3,358	1,688	605
CIGARETTES	8,091	6,592	3,559	3,227	1,652	577

60315

**Table 5.3B Lifetime Use of Both Prescription-Type Psychotherapeutics and Other Substances among Persons Aged 18 to 25, by Drug Type: Percentages, Annual Averages Based on 2002-2004**
Other Substance Use in Lifetime	Any Prescription- Type Psycho- therapeutic Drug¹	PRESCRIPTION DRUG TYPE
		Pain Relievers	Tranquilizers	Stimulants		Sedatives
		Pain Relievers	Tranquilizers	Any Stimulant	Metham- phetamine	Sedatives
*Low precision; no estimate reported. N/A: Not applicable. ¹ Nonmedical use of prescription-type pain relievers, tranquilizers, stimulants, or sedatives; does not include over-the-counter drugs. ² Nonmedical use of the prescription drug specified in the column, with or without other lifetime illicit or nonmedical use of other drugs. ³ Never used marijuana or hashish, cocaine, heroin, hallucinogens, or inhalants. Except for the "Any Prescription-Type Psychotherapeutic Drug" column, never used any prescription-type psychotherapeutic drug other than the drug category specified in a given column. ⁴ Nonmedical use of the prescription drug specified in the column and lifetime use of marijuana or hashish, cocaine, heroin, hallucinogens, or inhalants, or nonmedical use of any other prescription-type psychotherapeutic drug. ⁵ Lifetime use of both the prescription drug specified in the column and any of the following drugs: marijuana or hashish, cocaine, crack cocaine, heroin, hallucinogens, LSD, PCP, Ecstasy, or inhalants. ⁶ Lifetime use of prescription drug specified in column and any other prescription drug shown in the indented stub immediately below. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
TOTAL²	28.6	23.4	11.9	10.7	5.4	1.9
NO OTHER ILLICIT DRUG USE³	4.0	2.8	0.3	0.3	0.0	0.1
ANY OTHER ILLICIT DRUG USE⁴	24.7	20.6	11.6	10.4	5.3	1.9
ANY NONPSYCHOTHERAPEUTIC⁵	24.7	20.1	11.2	10.2	5.3	1.8
Marijuana or Hashish	23.9	19.5	11.0	10.0	5.3	1.7
Cocaine	11.6	9.9	6.8	6.5	4.2	1.3
Crack	3.1	2.7	2.0	2.2	1.7	0.6
Heroin	1.4	1.3	1.1	1.0	0.7	0.4
Hallucinogens	15.7	13.2	8.7	7.8	4.5	1.5
LSD	10.6	9.0	6.4	5.7	3.6	1.2
PCP	2.2	2.0	1.5	1.4	1.0	0.5
Ecstasy	10.5	9.0	6.4	5.5	3.1	1.2
Inhalants	10.4	9.0	5.9	5.5	3.0	1.2
ANY OTHER PSYCHOTHERAPEUTICS⁶	N/A	12.5	10.1	8.0	4.2	1.8
Pain Relievers	N/A	N/A	9.6	7.5	3.9	1.7
Tranquilizers	N/A	9.6	N/A	5.2	2.9	1.4
Any Stimulants	N/A	7.5	5.2	N/A	N/A	1.2
Methamphetamine	N/A	3.9	2.9	N/A	N/A	0.8
Sedatives	N/A	1.7	1.4	1.2	0.8	N/A
ALCOHOL	27.7	22.6	11.7	10.6	5.3	1.9
CIGARETTES	25.6	20.8	11.2	10.2	5.2	1.8

60315

**Table 5.4A Lifetime Use of Both Prescription-Type Psychotherapeutics and Other Substances among Persons Aged 26 or Older, by Drug Type: Numbers in Thousands, Annual Averages Based on 2002-2004**
Other Substance Use in Lifetime	Any Prescription- Type Psycho- therapeutic Drug¹	PRESCRIPTION DRUG TYPE
		Pain Relievers	Tranquilizers	Stimulants		Sedatives
		Pain Relievers	Tranquilizers	Any Stimulant	Metham- phetamine	Sedatives
*Low precision; no estimate reported. N/A: Not applicable. ¹ Nonmedical use of prescription-type pain relievers, tranquilizers, stimulants, or sedatives; does not include over-the-counter drugs. ² Nonmedical use of the prescription drug specified in the column, with or without other lifetime illicit or nonmedical use of other drugs. ³ Never used marijuana or hashish, cocaine, heroin, hallucinogens, or inhalants. Except for the "Any Prescription-Type Psychotherapeutic Drug" column, never used any prescription-type psychotherapeutic drug other than the drug category specified in a given column. ⁴ Nonmedical use of the prescription drug specified in the column and lifetime use of marijuana or hashish, cocaine, heroin, hallucinogens, or inhalants, or nonmedical use of any other prescription-type psychotherapeutic drug. ⁵ Lifetime use of both the prescription drug specified in the column and any of the following drugs: marijuana or hashish, cocaine, crack cocaine, heroin, hallucinogens, LSD, PCP, Ecstasy, or inhalants. ⁶ Lifetime use of prescription drug specified in column and any other prescription drug shown in the indented stub immediately below. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
TOTAL²	35,043	20,652	15,175	16,239	10,109	8,928
NO OTHER ILLICIT DRUG USE³	6,282	3,290	1,065	719	138	240
ANY OTHER ILLICIT DRUG USE⁴	28,761	17,362	14,110	15,521	9,971	8,687
ANY NONPSYCHOTHERAPEUTIC⁵	28,761	16,536	13,393	15,195	9,904	8,491
Marijuana or Hashish	28,028	16,012	13,121	15,024	9,812	8,392
Cocaine	17,578	10,180	9,397	10,962	7,984	6,807
Crack	4,884	3,490	3,187	3,233	2,657	1,997
Heroin	2,372	1,833	1,740	1,688	1,349	1,467
Hallucinogens	17,097	10,181	9,236	10,655	7,652	6,805
LSD	13,648	8,284	7,699	8,966	6,607	5,938
PCP	4,833	3,164	3,133	3,514	2,713	2,896
Ecstasy	3,919	2,819	2,550	2,216	1,690	1,224
Inhalants	10,414	6,661	6,032	6,463	4,558	4,360
ANY OTHER PSYCHOTHERAPEUTICS⁶	N/A	12,113	11,661	10,351	6,692	7,521
Pain Relievers	N/A	N/A	9,139	7,459	4,971	5,062
Tranquilizers	N/A	9,139	N/A	6,744	4,516	5,404
Any Stimulants	N/A	7,459	6,744	N/A	N/A	5,394
Methamphetamine	N/A	4,971	4,516	N/A	N/A	3,656
Sedatives	N/A	5,062	5,404	5,394	3,656	N/A
ALCOHOL	34,034	19,928	14,877	16,108	10,052	8,856
CIGARETTES	31,173	18,160	13,961	15,183	9,620	8,429

60315

**Table 5.4B Lifetime Use of Both Prescription-Type Psychotherapeutics and Other Substances among Persons Aged 26 or Older, by Drug Type: Percentages, Annual Averages Based on 2002-2004**
Other Substance Use in Lifetime	Any Prescription- Type Psycho- therapeutic Drug¹	PRESCRIPTION DRUG TYPE
		Pain Relievers	Tranquilizers	Stimulants		Sedatives
		Pain Relievers	Tranquilizers	Any Stimulant	Metham- phetamine	Sedatives
*Low precision; no estimate reported. N/A: Not applicable. ¹ Nonmedical use of prescription-type pain relievers, tranquilizers, stimulants, or sedatives; does not include over-the-counter drugs. ² Nonmedical use of the prescription drug specified in the column, with or without other lifetime illicit or nonmedical use of other drugs. ³ Never used marijuana or hashish, cocaine, heroin, hallucinogens, or inhalants. Except for the "Any Prescription-Type Psychotherapeutic Drug" column, never used any prescription-type psychotherapeutic drug other than the drug category specified in a given column. ⁴ Nonmedical use of the prescription drug specified in the column and lifetime use of marijuana or hashish, cocaine, heroin, hallucinogens, or inhalants, or nonmedical use of any other prescription-type psychotherapeutic drug. ⁵ Lifetime use of both the prescription drug specified in the column and any of the following drugs: marijuana or hashish, cocaine, crack cocaine, heroin, hallucinogens, LSD, PCP, Ecstasy, or inhalants. ⁶ Lifetime use of prescription drug specified in column and any other prescription drug shown in the indented stub immediately below. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
TOTAL²	19.3	11.4	8.4	9.0	5.6	4.9
NO OTHER ILLICIT DRUG USE³	3.5	1.8	0.6	0.4	0.1	0.1
ANY OTHER ILLICIT DRUG USE⁴	15.9	9.6	7.8	8.6	5.5	4.8
ANY NONPSYCHOTHERAPEUTIC⁵	15.9	9.1	7.4	8.4	5.5	4.7
Marijuana or Hashish	15.5	8.8	7.2	8.3	5.4	4.6
Cocaine	9.7	5.6	5.2	6.1	4.4	3.8
Crack	2.7	1.9	1.8	1.8	1.5	1.1
Heroin	1.3	1.0	1.0	0.9	0.7	0.8
Hallucinogens	9.4	5.6	5.1	5.9	4.2	3.8
LSD	7.5	4.6	4.3	4.9	3.6	3.3
PCP	2.7	1.7	1.7	1.9	1.5	1.6
Ecstasy	2.2	1.6	1.4	1.2	0.9	0.7
Inhalants	5.7	3.7	3.3	3.6	2.5	2.4
ANY OTHER PSYCHOTHERAPEUTICS⁶	N/A	6.7	6.4	5.7	3.7	4.2
Pain Relievers	N/A	N/A	5.0	4.1	2.7	2.8
Tranquilizers	N/A	5.0	N/A	3.7	2.5	3.0
Any Stimulants	N/A	4.1	3.7	N/A	N/A	3.0
Methamphetamine	N/A	2.7	2.5	N/A	N/A	2.0
Sedatives	N/A	2.8	3.0	3.0	2.0	N/A
ALCOHOL	18.8	11.0	8.2	8.9	5.5	4.9
CIGARETTES	17.2	10.0	7.7	8.4	5.3	4.7

60315

**Table 5.5A Past Year Use of Both Prescription-Type Psychotherapeutics and Other Substances among Persons Aged 12 or Older, by Drug Type: Numbers in Thousands, Annual Averages Based on 2002-2004**
Other Substance Use in Past Year	Any Prescription- Type Psycho- therapeutic Drug¹	PRESCRIPTION DRUG TYPE
		Pain Relievers	Tranquilizers	Stimulants		Sedatives
		Pain Relievers	Tranquilizers	Any Stimulant	Metham- phetamine	Sedatives
*Low precision; no estimate reported. N/A: Not applicable. ¹ Nonmedical use of prescription-type pain relievers, tranquilizers, stimulants, or sedatives; does not include over-the-counter drugs. ² Nonmedical use of the prescription drug specified in the column, with or without other past year illicit or nonmedical use of other drugs. ³ Never used marijuana or hashish, cocaine, heroin, hallucinogens, or inhalants. Except for the "Any Prescription-Type Psychotherapeutic Drug" column, never used any prescription-type psychotherapeutic drug other than the drug category specified in a given column. ⁴ Nonmedical use of the prescription drug specified in the column and past year use of marijuana or hashish, cocaine, heroin, hallucinogens, or inhalants, or nonmedical use of any other prescription-type psychotherapeutic drug. ⁵ Past year use of both the prescription drug specified in the column and any of the following drugs: marijuana or hashish, cocaine, crack cocaine, heroin, hallucinogens, LSD, PCP, Ecstasy, or inhalants. ⁶ Past year use of prescription drug specified in column and any other prescription drug shown in the indented stub immediately below. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
TOTAL²	14,769	11,306	4,989	2,950	1,432	850
NO OTHER ILLICIT DRUG USE³	6,816	4,216	960	490	139	211
ANY OTHER ILLICIT DRUG USE⁴	7,954	7,090	4,030	2,460	1,293	639
ANY NONPSYCHOTHERAPEUTIC⁵	7,954	6,199	3,277	2,274	1,240	475
Marijuana or Hashish	7,282	5,716	3,057	2,081	1,128	434
Cocaine	2,882	2,311	1,465	1,105	681	245
Crack	640	507	367	298	213	98
Heroin	239	203	140	89	62	46
Hallucinogens	2,309	1,906	1,194	873	476	168
LSD	505	450	298	229	133	62
PCP	147	130	81	74	45	25
Ecstasy	1,370	1,134	733	524	306	84
Inhalants	989	809	437	384	169	89
ANY OTHER PSYCHOTHERAPEUTICS⁶	N/A	3,889	3,290	1,664	799	585
Pain Relievers	N/A	N/A	3,095	1,512	733	496
Tranquilizers	N/A	3,095	N/A	952	496	433
Any Stimulants	N/A	1,512	952	N/A	N/A	250
Methamphetamine	N/A	733	496	N/A	N/A	126
Sedatives	N/A	496	433	250	126	N/A
ALCOHOL	12,780	9,783	4,534	2,734	1,343	735
CIGARETTES	9,081	7,018	3,514	2,222	1,197	545

60315

**Table 5.5B Past Year Use of Both Prescription-Type Psychotherapeutics and Other Substances among Persons Aged 12 or Older, by Drug Type: Percentages, Annual Averages Based on 2002-2004**
Other Substance Use in Past Year	Any Prescription- Type Psycho- therapeutic Drug¹	PRESCRIPTION DRUG TYPE
		Pain Relievers	Tranquilizers	Stimulants		Sedatives
		Pain Relievers	Tranquilizers	Any Stimulant	Metham- phetamine	Sedatives
*Low precision; no estimate reported. N/A: Not applicable. ¹ Nonmedical use of prescription-type pain relievers, tranquilizers, stimulants, or sedatives; does not include over-the-counter drugs. ² Nonmedical use of the prescription drug specified in the column, with or without other past year illicit or nonmedical use of other drugs. ³ Never used marijuana or hashish, cocaine, heroin, hallucinogens, or inhalants. Except for the "Any Prescription-Type Psychotherapeutic Drug" column, never used any prescription-type psychotherapeutic drug other than the drug category specified in a given column. ⁴ Nonmedical use of the prescription drug specified in the column and past year use of marijuana or hashish, cocaine, heroin, hallucinogens, or inhalants, or nonmedical use of any other prescription-type psychotherapeutic drug. ⁵ Past year use of both the prescription drug specified in the column and any of the following drugs: marijuana or hashish, cocaine, crack cocaine, heroin, hallucinogens, LSD, PCP, Ecstasy, or inhalants. ⁶ Past year use of prescription drug specified in column and any other prescription drug shown in the indented stub immediately below. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
TOTAL²	6.2	4.8	2.1	1.2	0.6	0.4
NO OTHER ILLICIT DRUG USE³	2.9	1.8	0.4	0.2	0.1	0.1
ANY OTHER ILLICIT DRUG USE⁴	3.3	3.0	1.7	1.0	0.5	0.3
ANY NONPSYCHOTHERAPEUTIC⁵	3.3	2.6	1.4	1.0	0.5	0.2
Marijuana or Hashish	3.1	2.4	1.3	0.9	0.5	0.2
Cocaine	1.2	1.0	0.6	0.5	0.3	0.1
Crack	0.3	0.2	0.2	0.1	0.1	0.0
Heroin	0.1	0.1	0.1	0.0	0.0	0.0
Hallucinogens	1.0	0.8	0.5	0.4	0.2	0.1
LSD	0.2	0.2	0.1	0.1	0.1	0.0
PCP	0.1	0.1	0.0	0.0	0.0	0.0
Ecstasy	0.6	0.5	0.3	0.2	0.1	0.0
Inhalants	0.4	0.3	0.2	0.2	0.1	0.0
ANY OTHER PSYCHOTHERAPEUTICS⁶	N/A	1.6	1.4	0.7	0.3	0.2
Pain Relievers	N/A	N/A	1.3	0.6	0.3	0.2
Tranquilizers	N/A	1.3	N/A	0.4	0.2	0.2
Any Stimulants	N/A	0.6	0.4	N/A	N/A	0.1
Methamphetamine	N/A	0.3	0.2	N/A	N/A	0.1
Sedatives	N/A	0.2	0.2	0.1	0.1	N/A
ALCOHOL	5.4	4.1	1.9	1.1	0.6	0.3
CIGARETTES	3.8	3.0	1.5	0.9	0.5	0.2

60315

Table 5.6A Lifetime Use of Other Substances among Lifetime Nonmedical Users and Lifetime Nonusers of Prescription-Type Psychotherapeutics Who Were Aged 12 Years or Older, by Drug Type: Numbers in Thousands, Annual Averages Based on 2002-2004
Other Substance Use in Lifetime	Any Prescription- Type Psycho- therapeutic Drug¹		PRESCRIPTION DRUG TYPE
			Pain Relievers		Tranquilizers		Stimulants				Sedatives
			Pain Relievers		Tranquilizers		Any Stimulant		Metham- phetamine		Sedatives
	Ever Used	Never Used	Ever Used	Never Used	Ever Used	Never Used	Ever Used	Never Used	Ever Used	Never Used	Ever Used	Never Used
*Low precision; no estimate reported. N/A: Not applicable. ¹ Nonmedical use of prescription-type pain relievers, tranquilizers, stimulants, or sedatives; does not include over-the-counter drugs. ² Nonmedical use of the prescription drug specified in the column and lifetime use of marijuana or hashish, cocaine, heroin, hallucinogens, or inhalants, or nonmedical use of any other prescription-type psychotherapeutic drug. ³ Lifetime use of both the prescription drug specified in the column and any of the following drugs: marijuana or hashish, cocaine, crack cocaine, heroin, hallucinogens, LSD, PCP, Ecstasy, or inhalants. ⁴ Lifetime use of prescription drug specified in column and any other prescription drug shown in the indented stub immediately below. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
ANY OTHER ILLICIT DRUG USE²	38,863	62,021	25,907	78,643	18,571	89,726	19,697	88,888	11,979	96,606	9,498	99,718
ANY NONPSYCHOTHERAPEUTIC³	38,863	62,021	24,821	76,063	17,693	83,191	19,250	81,634	11,893	88,991	9,240	91,645
Marijuana or Hashish	37,458	58,652	23,763	72,346	17,283	78,827	18,909	77,200	11,764	84,346	9,081	87,029
Cocaine	21,736	12,581	13,727	20,590	11,832	22,486	13,302	21,016	9,466	24,852	7,272	27,045
Crack	5,993	2,071	4,444	3,619	3,901	4,163	3,998	4,065	3,261	4,803	2,205	5,859
Heroin	2,898	621	2,308	1,211	2,130	1,389	2,051	1,468	1,607	1,912	1,599	1,920
Hallucinogens	22,940	11,397	15,119	19,218	12,403	21,934	13,549	20,788	9,283	25,054	7,377	26,959
LSD	17,347	6,765	11,458	12,655	9,924	14,189	10,983	13,130	7,853	16,260	6,371	17,742
PCP	5,688	1,407	3,924	3,171	3,698	3,398	4,069	3,027	3,089	4,007	3,077	4,019
Ecstasy	7,723	3,005	6,089	4,639	4,831	5,897	4,189	6,539	2,796	7,932	1,649	9,079
Inhalants	14,830	8,058	10,438	12,450	8,262	14,627	8,660	14,228	5,694	17,194	4,868	18,020
ANY OTHER PSYCHOTHERAPEUTICS⁴	N/A	N/A	17,111	16,622	15,556	27,704	13,539	26,867	8,259	32,148	8,265	37,697
Pain Relievers	N/A	N/A	N/A	N/A	12,839	18,023	10,456	20,406	6,447	24,415	5,750	25,112
Tranquilizers	N/A	N/A	12,839	6,941	N/A	N/A	8,723	11,057	5,581	14,198	5,967	13,813
Any Stimulants	N/A	N/A	10,456	10,161	8,723	11,894	N/A	N/A	N/A	N/A	5,883	14,734
Methamphetamine	N/A	N/A	6,447	5,690	5,581	6,556	N/A	N/A	N/A	N/A	3,953	8,184
Sedatives	N/A	N/A	5,750	4,037	5,967	3,821	5,883	3,905	3,953	5,834	N/A	N/A
ALCOHOL	45,482	151,586	29,322	167,746	19,367	177,701	20,351	176,717	12,057	185,012	9,652	187,416
CIGARETTES	41,525	121,020	26,638	135,907	18,249	144,296	19,208	143,337	11,571	150,974	9,170	153,375

60315

Table 5.6B Lifetime Use of Other Substances among Lifetime Nonmedical Users and Lifetime Nonusers of Prescription-Type Psychotherapeutics Who Were Aged 12 Years or Older, by Drug Type: Percentages, Annual Averages Based on 2002-2004
Other Substance Use in Lifetime	Any Prescription- Type Psycho- therapeutic Drug¹		PRESCRIPTION DRUG TYPE
			Pain Relievers		Tranquilizers		Stimulants				Sedatives
			Pain Relievers		Tranquilizers		Any Stimulant		Metham- phetamine		Sedatives
	Ever Used	Never Used	Ever Used	Never Used	Ever Used	Never Used	Ever Used	Never Used	Ever Used	Never Used	Ever Used	Never Used
*Low precision; no estimate reported. N/A: Not applicable. ¹ Nonmedical use of prescription-type pain relievers, tranquilizers, stimulants, or sedatives; does not include over-the-counter drugs. ² Nonmedical use of the prescription drug specified in the column and lifetime use of marijuana or hashish, cocaine, heroin, hallucinogens, or inhalants, or nonmedical use of any other prescription-type psychotherapeutic drug. ³ Lifetime use of both the prescription drug specified in the column and any of the following drugs: marijuana or hashish, cocaine, crack cocaine, heroin, hallucinogens, LSD, PCP, Ecstasy, or inhalants. ⁴ Lifetime use of prescription drug specified in column and any other prescription drug shown in the indented stub immediately below. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
ANY OTHER ILLICIT DRUG USE²	81.8	32.6	83.9	38.0	93.9	41.2	95.5	40.9	98.7	42.8	97.0	43.7
ANY NONPSYCHOTHERAPEUTIC³	81.8	32.6	80.4	36.8	89.4	38.2	93.4	37.6	98.0	39.4	94.4	40.2
Marijuana or Hashish	78.9	30.8	77.0	35.0	87.4	36.2	91.7	35.5	96.9	37.4	92.8	38.2
Cocaine	45.8	6.6	44.5	10.0	59.8	10.3	64.5	9.7	78.0	11.0	74.3	11.9
Crack	12.6	1.1	14.4	1.7	19.7	1.9	19.4	1.9	26.9	2.1	22.5	2.6
Heroin	6.1	0.3	7.5	0.6	10.8	0.6	9.9	0.7	13.2	0.8	16.3	0.8
Hallucinogens	48.3	6.0	49.0	9.3	62.7	10.1	65.7	9.6	76.5	11.1	75.4	11.8
LSD	36.5	3.6	37.1	6.1	50.2	6.5	53.3	6.0	64.7	7.2	65.1	7.8
PCP	12.0	0.7	12.7	1.5	18.7	1.6	19.7	1.4	25.5	1.8	31.4	1.8
Ecstasy	16.3	1.6	19.7	2.2	24.4	2.7	20.3	3.0	23.0	3.5	16.9	4.0
Inhalants	31.2	4.2	33.8	6.0	41.8	6.7	42.0	6.6	46.9	7.6	49.7	7.9
ANY OTHER PSYCHOTHERAPEUTICS⁴	N/A	N/A	55.4	8.0	78.6	12.7	65.7	12.4	68.0	14.2	84.4	16.5
Pain Relievers	N/A	N/A	N/A	N/A	64.9	8.3	50.7	9.4	53.1	10.8	58.7	11.0
Tranquilizers	N/A	N/A	41.6	3.4	N/A	N/A	42.3	5.1	46.0	6.3	61.0	6.1
Any Stimulants	N/A	N/A	33.9	4.9	44.1	5.5	N/A	N/A	N/A	N/A	60.1	6.5
Methamphetamine	N/A	N/A	20.9	2.8	28.2	3.0	N/A	N/A	N/A	N/A	40.4	3.6
Sedatives	N/A	N/A	18.6	2.0	30.2	1.8	28.5	1.8	32.6	2.6	N/A	N/A
ALCOHOL	95.8	79.7	95.0	81.1	97.9	81.5	98.7	81.4	99.3	82.0	98.6	82.2
CIGARETTES	87.4	63.6	86.3	65.7	92.3	66.2	93.2	66.0	95.3	66.9	93.7	67.3

60315

Table 5.7A Past Year Use of Other Substances among Past Year Nonmedical Users and Past Year Nonusers of Prescription-Type Psychotherapeutics Who Were Aged 12 Years or Older, by Drug Type: Numbers in Thousands, Annual Averages Based on 2002-2004
Other Substance Use in Past Year	Any Prescription- Type Psycho- therapeutic Drug,¹ Past Year		PRESCRIPTION DRUG TYPE
			Pain Relievers, Past Year		Tranquilizers, Past Year		Stimulants, Past Year				Sedatives, Past Year
			Pain Relievers, Past Year		Tranquilizers, Past Year		Any Stimulant		Metham- phetamine		Sedatives, Past Year
	Used	Did Not Use	Used	Did Not Use	Used	Did Not Use	Used	Did Not Use	Used	Did Not Use	Used	Did Not Use
*Low precision; no estimate reported. N/A: Not applicable. ¹ Nonmedical use of prescription-type pain relievers, tranquilizers, stimulants, or sedatives; does not include over-the-counter drugs. ² Nonmedical use of the prescription drug specified in the column and past year use of marijuana or hashish, cocaine, heroin, hallucinogens, or inhalants, or nonmedical use of any other prescription-type psychotherapeutic drug. ³ Past year use of both the prescription drug specified in the column and any of the following drugs: marijuana or hashish, cocaine, crack cocaine, heroin, hallucinogens, LSD, PCP, Ecstasy, or inhalants. ⁴ Past year use of prescription drug specified in column and any other prescription drug shown in the indented stub immediately below. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
ANY OTHER ILLICIT DRUG USE²	7,954	20,208	7,090	23,671	4,030	29,988	2,460	32,027	1,293	33,194	639	34,127
ANY NONPSYCHOTHERAPEUTIC³	7,954	20,208	6,199	21,963	3,277	24,884	2,274	25,888	1,240	26,921	475	27,686
Marijuana or Hashish	7,282	18,197	5,716	19,763	3,057	22,422	2,081	23,398	1,128	24,351	434	25,045
Cocaine	2,882	2,941	2,311	3,512	1,465	4,357	1,105	4,718	681	5,141	245	5,578
Crack	640	781	507	915	367	1,054	298	1,123	213	1,208	98	1,323
Heroin	239	133	203	169	140	232	89	283	62	310	46	326
Hallucinogens	2,309	1,879	1,906	2,282	1,194	2,994	873	3,315	476	3,712	168	4,020
LSD	505	212	450	267	298	418	229	487	133	583	62	654
PCP	147	75	130	92	81	141	74	147	45	176	25	197
Ecstasy	1,370	1,031	1,134	1,266	733	1,667	524	1,876	306	2,094	84	2,317
Inhalants	989	1,149	809	1,329	437	1,701	384	1,754	169	1,969	89	2,049
ANY OTHER PSYCHOTHERAPEUTICS⁴	N/A	N/A	3,889	3,464	3,290	9,780	1,664	11,819	799	12,684	585	13,920
Pain Relievers	N/A	N/A	N/A	N/A	3,095	8,211	1,512	9,794	733	10,572	496	10,810
Tranquilizers	N/A	N/A	3,095	1,895	N/A	N/A	952	4,037	496	4,494	433	4,557
Any Stimulants	N/A	N/A	1,512	1,438	952	1,998	N/A	N/A	N/A	N/A	250	2,700
Methamphetamine	N/A	N/A	733	698	496	936	N/A	N/A	N/A	N/A	126	1,305
Sedatives	N/A	N/A	496	354	433	417	250	599	126	723	N/A	N/A
ALCOHOL	12,780	142,788	9,783	145,784	4,534	151,034	2,734	152,834	1,343	154,225	735	154,833
CIGARETTES	9,081	61,277	7,018	63,339	3,514	66,843	2,222	68,136	1,197	69,160	545	69,813

60315

Table 5.7B Past Year Use of Other Substances among Past Year Nonmedical Users and Past Year Nonusers of Prescription-Type Psychotherapeutics Who Were Aged 12 Years or Older, by Drug Type: Percentages, Annual Averages Based on 2002-2004
Other Substance Use in Past Year	Any Prescription- Type Psycho- therapeutic Drug,¹ Past Year		PRESCRIPTION DRUG TYPE
			Pain Relievers, Past Year		Tranquilizers, Past Year		Stimulants, Past Year				Sedatives, Past Year
			Pain Relievers, Past Year		Tranquilizers, Past Year		Any Stimulant		Metham- phetamine		Sedatives, Past Year
	Used	Did Not Use	Used	Did Not Use	Used	Did Not Use	Used	Did Not Use	Used	Did Not Use	Used	Did Not Use
*Low precision; no estimate reported. N/A: Not applicable. ¹ Nonmedical use of prescription-type pain relievers, tranquilizers, stimulants, or sedatives; does not include over-the-counter drugs. ² Nonmedical use of the prescription drug specified in the column and past year use of marijuana or hashish, cocaine, heroin, hallucinogens, or inhalants, or nonmedical use of any other prescription-type psychotherapeutic drug. ³ Past year use of both the prescription drug specified in the column and any of the following drugs: marijuana or hashish, cocaine, crack cocaine, heroin, hallucinogens, LSD, PCP, Ecstasy, or inhalants. ⁴ Past year use of prescription drug specified in column and any other prescription drug shown in the indented stub immediately below. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
ANY OTHER ILLICIT DRUG USE²	53.9	9.1	62.7	10.5	80.8	12.9	83.4	13.6	90.3	14.0	75.2	14.4
ANY NONPSYCHOTHERAPEUTIC³	53.9	9.1	54.8	9.7	65.7	10.7	77.1	11.0	86.6	11.4	55.9	11.7
Marijuana or Hashish	49.3	8.2	50.6	8.7	61.3	9.6	70.6	10.0	78.8	10.3	51.0	10.6
Cocaine	19.5	1.3	20.4	1.6	29.4	1.9	37.4	2.0	47.6	2.2	28.8	2.4
Crack	4.3	0.4	4.5	0.4	7.4	0.5	10.1	0.5	14.9	0.5	11.6	0.6
Heroin	1.6	0.1	1.8	0.1	2.8	0.1	3.0	0.1	4.3	0.1	5.4	0.1
Hallucinogens	15.6	0.8	16.9	1.0	23.9	1.3	29.6	1.4	33.2	1.6	19.8	1.7
LSD	3.4	0.1	4.0	0.1	6.0	0.2	7.8	0.2	9.3	0.2	7.4	0.3
PCP	1.0	0.0	1.1	0.0	1.6	0.1	2.5	0.1	3.2	0.1	2.9	0.1
Ecstasy	9.3	0.5	10.0	0.6	14.7	0.7	17.8	0.8	21.4	0.9	9.8	1.0
Inhalants	6.7	0.5	7.2	0.6	8.8	0.7	13.0	0.7	11.8	0.8	10.5	0.9
ANY OTHER PSYCHOTHERAPEUTICS⁴	N/A	N/A	34.4	1.5	65.9	4.2	56.4	5.0	55.8	5.4	68.8	5.9
Pain Relievers	N/A	N/A	N/A	N/A	62.0	3.5	51.3	4.2	51.2	4.5	58.4	4.6
Tranquilizers	N/A	N/A	27.4	0.8	N/A	N/A	32.3	1.7	34.6	1.9	50.9	1.9
Any Stimulants	N/A	N/A	13.4	0.6	19.1	0.9	N/A	N/A	N/A	N/A	29.5	1.1
Methamphetamine	N/A	N/A	6.5	0.3	9.9	0.4	N/A	N/A	N/A	N/A	14.9	0.6
Sedatives	N/A	N/A	4.4	0.2	8.7	0.2	8.5	0.3	8.8	0.3	N/A	N/A
ALCOHOL	86.5	64.0	86.5	64.4	90.9	64.9	92.7	65.1	93.8	65.3	86.5	65.3
CIGARETTES	61.5	27.5	62.1	28.0	70.4	28.7	75.3	29.0	83.6	29.3	64.1	29.5

60315

Table 5.8A Lifetime Use of Both Prescription-Type Psychotherapeutics and Other Substances among Persons Aged 12 or Older, by Drug Type and Order in Which Drugs in Pairs Initially Were Used: Numbers in Thousands, Annual Averages Based on 2002-2004
Other Substance Use in Lifetime	Any Prescription- Type Psycho- therapeutic Drug¹		PRESCRIPTION DRUG TYPE
			Pain Relievers		Tranquilizers		Stimulants				Sedatives
			Pain Relievers		Tranquilizers		Any Stimulant		Metham- phetamine		Sedatives
	Drug in Column Used First	Drug in Row Used First	Drug in Column Used First	Drug in Row Used First	Drug in Column Used First	Drug in Row Used First	Drug in Column Used First	Drug in Row Used First	Drug in Column Used First	Drug in Row Used First	Drug in Column Used First	Drug in Row Used First
*Low precision; no estimate reported. N/A: Not applicable. ¹ Nonmedical use of prescription-type pain relievers, tranquilizers, stimulants, or sedatives; does not include over-the-counter drugs. ² Nonmedical use of the prescription drug specified in the column and lifetime use of marijuana or hashish, cocaine, heroin, hallucinogens, or inhalants, or nonmedical use of any other prescription-type psychotherapeutic drug. ³ Lifetime use of both the prescription drug specified in the column and any of the following drugs: marijuana or hashish, cocaine, crack cocaine, heroin, hallucinogens, LSD, PCP, Ecstasy, or inhalants. ⁴ Lifetime use of prescription drug specified in column and any other prescription drug shown in the indented stub immediately below. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
ANY OTHER ILLICIT DRUG USE²	4,455	29,041	2,313	20,825	750	15,942	1,535	15,332	477	10,024	304	7,813
ANY NON-PSYCHOTHERAPEUTIC³	4,455	29,041	2,314	20,183	968	15,314	1,613	14,878	512	9,862	476	7,583
Marijuana or Hashish	4,708	27,321	2,335	19,082	1,087	14,687	1,856	14,200	667	9,500	570	7,259
Cocaine	11,999	5,793	5,456	5,938	4,516	5,155	7,009	3,516	4,292	2,988	3,867	1,831
Crack	4,609	749	2,921	980	2,544	848	2,957	521	2,232	503	1,797	226
Heroin	2,118	385	1,444	511	1,235	558	1,455	302	1,047	316	1,062	267
Hallucinogens	7,600	9,015	3,483	8,396	2,301	7,506	3,987	5,571	2,103	4,478	1,732	3,413
LSD	6,107	6,484	2,677	6,361	1,970	5,875	3,517	4,238	1,961	3,564	1,727	2,730
PCP	2,920	1,356	1,468	1,608	1,293	1,541	1,890	1,081	1,186	1,028	1,420	840
Ecstasy	4,821	1,510	3,170	1,698	2,419	1,503	2,513	844	1,612	588	1,099	294
Inhalants	4,730	7,082	2,399	6,201	1,618	5,175	2,638	4,196	1,460	3,035	1,376	2,396
ANY OTHER PSYCHOTHERAPEUTICS⁴	N/A	N/A	4,112	6,999	2,067	7,749	4,765	4,281	2,590	3,287	1,488	3,234
Pain Relievers	N/A	N/A	N/A	N/A	2,701	4,488	4,789	2,857	2,679	2,239	2,166	1,599
Tranquilizers	N/A	N/A	4,488	2,701	N/A	N/A	4,177	1,902	2,391	1,739	2,192	1,329
Any Stimulants	N/A	N/A	2,857	4,789	1,902	4,177	N/A	N/A	N/A	N/A	1,263	1,945
Methamphetamine	N/A	N/A	2,239	2,679	1,739	2,391	N/A	N/A	N/A	N/A	1,241	1,041
Sedatives	N/A	N/A	1,599	2,166	1,329	2,192	1,945	1,263	1,041	1,241	N/A	N/A
ALCOHOL	3,926	37,620	2,482	24,887	714	17,598	1,054	17,536	386	10,722	474	8,409
CIGARETTES	3,170	35,474	1,833	23,339	673	16,762	1,111	16,868	520	10,433	473	8,119

60315

Table 5.8B Lifetime Use of Both Prescription-Type Psychotherapeutics and Other Substances among Persons Aged 12 or Older, by Drug Type and Order in Which Drugs in Pairs Initially Were Used: Percentages, Annual Averages Based on 2002-2004
Other Substance Use in Lifetime	Any Prescription- Type Psycho- therapeutic Drug¹		PRESCRIPTION DRUG TYPE
			Pain Relievers		Tranquilizers		Stimulants				Sedatives
			Pain Relievers		Tranquilizers		Any Stimulant		Metham- phetamine		Sedatives
	Drug in Column Used First	Drug in Row Used First	Drug in Column Used First	Drug in Row Used First	Drug in Column Used First	Drug in Row Used First	Drug in Column Used First	Drug in Row Used First	Drug in Column Used First	Drug in Row Used First	Drug in Column Used First	Drug in Row Used First
*Low precision; no estimate reported. N/A: Not applicable. NOTE: Cell entries are percentages of lifetime users of both row and column drugs classified according to the age at which the first used each of the two. Percentages do not sum to 100 because of persons who began using the two drugs at the same age. ¹ Nonmedical use of prescription-type pain relievers, tranquilizers, stimulants, or sedatives; does not include over-the-counter drugs. ² Nonmedical use of the prescription drug specified in the column and lifetime use of marijuana or hashish, cocaine, heroin, hallucinogens, or inhalants, or nonmedical use of any other prescription-type psychotherapeutic drug. ³ Lifetime use of both the prescription drug specified in the column and any of the following drugs: marijuana or hashish, cocaine, crack cocaine, heroin, hallucinogens, LSD, PCP, Ecstasy, or inhalants. ⁴ Lifetime use of prescription drug specified in column and any other prescription drug shown in the indented stub immediately below. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
ANY OTHER ILLICIT DRUG USE²	11.5	74.7	8.9	80.4	4.0	85.8	7.8	77.8	4.0	83.7	3.2	82.3
ANY NON-PSYCHOTHERAPEUTIC³	11.5	74.7	9.3	81.3	5.5	86.6	8.4	77.3	4.3	82.9	5.2	82.1
Marijuana or Hashish	12.6	72.9	9.8	80.3	6.3	85.0	9.8	75.1	5.7	80.8	6.3	79.9
Cocaine	55.2	26.7	39.7	43.3	38.2	43.6	52.7	26.4	45.3	31.6	53.2	25.2
Crack	76.9	12.5	65.7	22.1	65.2	21.8	74.0	13.0	68.4	15.4	81.5	10.3
Heroin	73.1	13.3	62.6	22.1	58.0	26.2	71.0	14.7	65.1	19.6	66.4	16.7
Hallucinogens	33.1	39.3	23.0	55.5	18.6	60.5	29.4	41.1	22.7	48.2	23.5	46.3
LSD	35.2	37.4	23.4	55.5	19.9	59.2	32.0	38.6	25.0	45.4	27.1	42.9
PCP	51.3	23.8	37.4	41.0	35.0	41.7	46.4	26.6	38.4	33.3	46.2	27.3
Ecstasy	62.4	19.5	52.1	27.9	50.1	31.1	60.0	20.1	57.6	21.0	66.7	17.8
Inhalants	31.9	47.8	23.0	59.4	19.6	62.6	30.5	48.5	25.6	53.3	28.3	49.2
ANY OTHER PSYCHOTHERAPEUTICS⁴	N/A	N/A	24.0	40.9	13.3	49.8	35.2	31.6	31.4	39.8	18.0	39.1
Pain Relievers	N/A	N/A	N/A	N/A	21.0	35.0	45.8	27.3	41.5	34.7	37.7	27.8
Tranquilizers	N/A	N/A	35.0	21.0	N/A	N/A	47.9	21.8	42.8	31.1	36.7	22.3
Any Stimulants	N/A	N/A	27.3	45.8	21.8	47.9	N/A	N/A	N/A	N/A	21.5	33.1
Methamphetamine	N/A	N/A	34.7	41.5	31.1	42.8	N/A	N/A	N/A	N/A	31.4	26.3
Sedatives	N/A	N/A	27.8	37.7	22.3	36.7	33.1	21.5	26.3	31.4	N/A	N/A
ALCOHOL	8.6	82.7	8.5	84.9	3.7	90.9	5.2	86.2	3.2	88.9	4.9	87.1
CIGARETTES	7.6	85.4	6.9	87.6	3.7	91.9	5.8	87.8	4.5	90.2	5.2	88.5

60124

**Table 6.1AB Substance Dependence or Abuse for Nonmedical Use of Prescription-Type Psychotherapeutics in Past Year, by Age Group: Numbers in Thousands and Percentages, 2002-2004**
Drug of Past Year Dependence or Abuse	Total			AGE GROUP
	Total			12-17			18-25			26 or Older
	2002	2003	2004	2002	2003	2004	2002	2003	2004	2002	2003	2004
	Numbers in Thousands
Low precision; no estimate reported. NOTE: Dependence or abuse is based on definitions found in the 4^th edition of the Diagnostic and Statistical Manual of Mental Disorders* (DSM-IV). ^a Difference between estimate and 2004 estimate is statistically significant at the .05 level. ^b Difference between estimate and 2004 estimate is statistically significant at the .01 level. ¹ Nonmedical use of prescription-type pain relievers, tranquilizers, stimulants, or sedatives; does not include over-the-counter drugs. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
Nonmedical Use of Psychotherapeutics¹	2,018	1,923	2,048	333	361	388	587	516^b	652	1,098	1,046	1,008
Pain Relievers	1,509	1,424	1,388	237^a	281	309	419	350^a	454	853	793	624
Tranquilizers	509	435	573	87	96	75	144	147	154	278	192	344
Stimulants	436	378	470	98	98	86	137	142	172	202	138	212
Sedatives	154	158	128	28	40	22	26	20	24	100	99	82
Drug of Past Year Dependence or Abuse	Percentages
Nonmedical Use of Psychotherapeutics¹	0.9	0.8	0.9	1.3	1.4	1.5	1.9	1.6^a	2.0	0.6	0.6	0.6
Pain Relievers	0.6	0.6	0.6	1.0^a	1.1	1.2	1.4	1.1^a	1.4	0.5	0.4	0.3
Tranquilizers	0.2	0.2	0.2	0.4	0.4	0.3	0.5	0.5	0.5	0.2	0.1	0.2
Stimulants	0.2	0.2	0.2	0.4	0.4	0.3	0.4	0.4	0.5	0.1	0.1	0.1
Sedatives	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0

60209

Table 6.2A Past Year Substance Dependence or Abuse for Nonmedical Use of Prescription-Type Psychotherapeutics among Persons Aged 12 or Older, by Drug Type, Age Group, Gender, and Race/Ethnicity: Numbers in Thousands, Annual Averages Based on 2002-2004
Demographic Characteristic	Any Prescription- Type Psycho- therapeutic Drug	PRESCRIPTION DRUG TYPE
Demographic Characteristic	Any Prescription- Type Psycho- therapeutic Drug	Pain Relievers	Tranquilizers	Stimulants	Sedatives
Low precision; no estimate reported. NOTE: Dependence or abuse is based on definitions found in the 4^th edition of the Diagnostic and Statistical Manual of Mental Disorders* (DSM-IV). NOTE: Nonmedical use of prescription-type pain relievers, tranquilizers, stimulants, or sedatives; does not include over-the-counter drugs. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
TOTAL	1,996	1,440	505	428	147
AGE
12-17	361	275	86	94	30
18-25	585	408	148	150	23
26 or Older	1,050	757	271	184	93
26-34	339	237	74	72	14
35-49	532	394	122	91	51
50 or Older	180	127	75	21	29
GENDER
Male	978	739	240	219	75
12-17	137	102	32	35	12
18-25	309	228	79	76	11
26 or Older	531	409	129	109	52
Female	1,018	701	265	209	72
12-17	223	174	54	59	18
18-25	276	180	69	75	12
26 or Older	519	348	143	75	42
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	1,745	1,248	442	402	135
White	1,496	1,071	379	360	115
Black or African American	139	110	20	17	13
American Indian or Alaska Native	27	16	12	8	2
Native Hawaiian or Other Pacific Islander	10	3	0	8	1
Asian	47	28	20	4	2
Two or More Races	27	21	10	6	2
Hispanic or Latino	251	192	63	26	11

60209

Table 6.2B Past Year Substance Dependence or Abuse for Nonmedical Use of Prescription-Type Psychotherapeutics among Persons Aged 12 or Older, by Drug Type, Age Group, Gender, and Race/Ethnicity: Percentages, Annual Averages Based on 2002-2004
Demographic Characteristic	Any Prescription- Type Psycho- therapeutic Drug	PRESCRIPTION DRUG TYPE
Demographic Characteristic	Any Prescription- Type Psycho- therapeutic Drug	Pain Relievers	Tranquilizers	Stimulants	Sedatives
Low precision; no estimate reported. NOTE: Dependence or abuse is based on definitions found in the 4^th edition of the Diagnostic and Statistical Manual of Mental Disorders* (DSM-IV). NOTE: Nonmedical use of prescription-type pain relievers, tranquilizers, stimulants, or sedatives; does not include over-the-counter drugs. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
TOTAL	0.8	0.6	0.2	0.2	0.1
AGE
12-17	1.4	1.1	0.3	0.4	0.1
18-25	1.8	1.3	0.5	0.5	0.1
26 or Older	0.6	0.4	0.1	0.1	0.1
26-34	1.0	0.7	0.2	0.2	0.0
35-49	0.8	0.6	0.2	0.1	0.1
50 or Older	0.2	0.2	0.1	0.0	0.0
GENDER
Male	0.9	0.6	0.2	0.2	0.1
12-17	1.1	0.8	0.3	0.3	0.1
18-25	1.9	1.4	0.5	0.5	0.1
26 or Older	0.6	0.5	0.1	0.1	0.1
Female	0.8	0.6	0.2	0.2	0.1
12-17	1.8	1.4	0.4	0.5	0.2
18-25	1.7	1.1	0.4	0.5	0.1
26 or Older	0.5	0.4	0.2	0.1	0.0
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.8	0.6	0.2	0.2	0.1
White	0.9	0.6	0.2	0.2	0.1
Black or African American	0.5	0.4	0.1	0.1	0.0
American Indian or Alaska Native	2.0	1.2	0.9	0.6	0.2
Native Hawaiian or Other Pacific Islander	1.6	0.4	0.0	1.2	0.2
Asian	0.5	0.3	0.2	0.0	0.0
Two or More Races	1.1	0.8	0.4	0.3	0.1
Hispanic or Latino	0.8	0.6	0.2	0.1	0.0

60206

Table 6.3A Past Year Substance Dependence or Abuse for Nonmedical Use of Prescription-Type Psychotherapeutics among Persons Aged 12 or Older, by Drug Type and Geographic Characteristics: Numbers in Thousands, Annual Averages Based on 2002-2004
Geographic Characteristic	Any Prescription- Type Psycho- therapeutic Drug	PRESCRIPTION DRUG TYPE
Geographic Characteristic	Any Prescription- Type Psycho- therapeutic Drug	Pain Relievers	Tranquilizers	Stimulants	Sedatives
Low precision; no estimate reported. NOTE: Dependence or abuse is based on definitions found in the 4^th edition of the Diagnostic and Statistical Manual of Mental Disorders* (DSM-IV). NOTE: Nonmedical use of prescription-type pain relievers, tranquilizers, stimulants, or sedatives; does not include over-the-counter drugs. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
TOTAL	1,996	1,440	505	428	147
GEOGRAPHIC DIVISION
Northeast	328	252	88	61	41
New England	127	104	36	35	23
Middle Atlantic	202	148	53	26	18
Midwest	358	252	83	89	32
East North Central	266	201	69	53	21
West North Central	93	51	14	36	11
South	794	588	238	145	54
South Atlantic	360	267	112	68	23
East South Central	177	142	52	26	12
West South Central	256	179	74	50	18
West	516	348	95	134	20
Mountain	143	96	30	37	7
Pacific	373	252	65	97	13
COUNTY TYPE
Large Metro	967	678	250	173	67
Small Metro	684	521	176	157	58
250K – 1 Mil. Pop.	401	294	85	87	15
< 250K Pop.	283	227	91	70	43
Nonmetro	345	241	80	98	22
Urbanized	155	112	32	38	7
Less Urbanized	165	115	41	52	14
Completely Rural	25	15	7	8	2

60206

Table 6.3B Past Year Substance Dependence or Abuse for Nonmedical Use of Prescription-Type Psychotherapeutics among Persons Aged 12 or Older, by Drug Type and Geographic Characteristics: Percentages, Annual Averages Based on 2002-2004
Geographic Characteristic	Any Prescription- Type Psycho- therapeutic Drug	PRESCRIPTION DRUG TYPE
Geographic Characteristic	Any Prescription- Type Psycho- therapeutic Drug	Pain Relievers	Tranquilizers	Stimulants	Sedatives
Low precision; no estimate reported. NOTE: Dependence or abuse is based on definitions found in the 4^th edition of the Diagnostic and Statistical Manual of Mental Disorders* (DSM-IV). NOTE: Nonmedical use of prescription-type pain relievers, tranquilizers, stimulants, or sedatives; does not include over-the-counter drugs. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
TOTAL	0.8	0.6	0.2	0.2	0.1
GEOGRAPHIC DIVISION
Northeast	0.7	0.6	0.2	0.1	0.1
New England	1.1	0.9	0.3	0.3	0.2
Middle Atlantic	0.6	0.4	0.2	0.1	0.1
Midwest	0.7	0.5	0.2	0.2	0.1
East North Central	0.7	0.5	0.2	0.1	0.1
West North Central	0.6	0.3	0.1	0.2	0.1
South	0.9	0.7	0.3	0.2	0.1
South Atlantic	0.8	0.6	0.3	0.2	0.1
East South Central	1.2	1.0	0.4	0.2	0.1
West South Central	1.0	0.7	0.3	0.2	0.1
West	1.0	0.6	0.2	0.2	0.0
Mountain	0.9	0.6	0.2	0.2	0.0
Pacific	1.0	0.7	0.2	0.3	0.0
COUNTY TYPE
Large Metro	0.8	0.5	0.2	0.1	0.1
Small Metro	1.0	0.7	0.2	0.2	0.1
250K – 1 Mil. Pop.	0.9	0.6	0.2	0.2	0.0
< 250K Pop.	1.2	0.9	0.4	0.3	0.2
Nonmetro	0.9	0.6	0.2	0.2	0.1
Urbanized	0.9	0.7	0.2	0.2	0.0
Less Urbanized	0.9	0.6	0.2	0.3	0.1
Completely Rural	0.6	0.4	0.2	0.2	0.1

60206

Table 6.4A Past Year Substance Dependence or Abuse for Nonmedical Use of Prescription-Type Psychotherapeutics among Past Year Nonmedical Users Aged 12 or Older, by Drug Type, Age Category, and Gender: Numbers in Thousands, Annual Averages Based on 2002-2004
Demographic Characteristic	Any Prescription- Type Psycho- therapeutic Drug	PRESCRIPTION DRUG TYPE
Demographic Characteristic	Any Prescription- Type Psycho- therapeutic Drug	Pain Relievers	Tranquilizers	Stimulants	Sedatives
Low precision; no estimate reported. NOTE: Dependence or abuse is based on definitions found in the 4^th edition of the Diagnostic and Statistical Manual of Mental Disorders* (DSM-IV). NOTE: Nonmedical use of prescription-type pain relievers, tranquilizers, stimulants, or sedatives; does not include over-the-counter drugs. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
TOTAL	1,995	1,440	505	424	147
AGE
12-17	361	275	86	94	30
18-25	584	408	148	146	23
26 or Older	1,050	757	271	184	93
GENDER
Male	977	739	240	216	75
Female	1,018	701	265	208	72

60206

Table 6.4B Past Year Substance Dependence or Abuse for Nonmedical Use of Prescription-Type Psychotherapeutics among Past Year Nonmedical Users Aged 12 or Older, by Drug Type, Age Category, and Gender: Percentages, Annual Averages Based on 2002-2004
Demographic Characteristic	Any Prescription- Type Psycho- therapeutic Drug	PRESCRIPTION DRUG TYPE
Demographic Characteristic	Any Prescription- Type Psycho- therapeutic Drug	Pain Relievers	Tranquilizers	Stimulants	Sedatives
Low precision; no estimate reported. NOTE: Dependence or abuse is based on definitions found in the 4^th edition of the Diagnostic and Statistical Manual of Mental Disorders* (DSM-IV). NOTE: Nonmedical use of prescription-type pain relievers, tranquilizers, stimulants, or sedatives; does not include over-the-counter drugs. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
TOTAL	13.5	12.7	10.1	14.4	17.3
AGE
12-17	15.9	14.6	15.3	16.4	22.3
18-25	12.7	10.9	9.2	12.8	14.5
26 or Older	13.3	13.3	9.7	14.9	16.8
GENDER
Male	13.0	12.4	9.9	14.0	19.8
Female	14.0	13.2	10.4	14.8	15.3

60209

Table 6.5A Past Year Substance Dependence or Abuse for Nonmedical Use of Prescription-Type Psychotherapeutics among Lifetime Users Aged 18 or Older, by Drug Type, Age at First Use, and Current Age: Numbers in Thousands, Annual Averages Based on 2002-2004
Age at First Use	Any Prescription- Type Psycho- therapeutic Drug	PRESCRIPTION DRUG TYPE
	Any Prescription- Type Psycho- therapeutic Drug	Pain Relievers	Tranquilizers	Stimulants	Sedatives
	Past Year Substance Dependence or Abuse among Lifetime Users Aged 18 or Older
Low precision; no estimate reported. NOTE: Dependence or abuse is based on definitions found in the 4^th edition of the Diagnostic and Statistical Manual of Mental Disorders* (DSM-IV). NOTE: Nonmedical use of prescription-type pain relievers, tranquilizers, stimulants, or sedatives; does not include over-the-counter drugs. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
TOTAL	1,635	1,165	420	334	117
Under 16 Years	500	269	99	117	33
16 Years or Older	1,135	896	321	217	83
16 to 20 Years	652	414	150	134	55
21 to 25 Years	254	234	53	31	9
26 Years or Older	230	248	118	52	20
Age at First Use	Past Year Substance Dependence or Abuse among Lifetime Users Aged 18 to 25
TOTAL	585	408	148	150	23
Under 16 Years	209	117	42	50	9
16 Years or Older	376	291	106	100	15
16 to 20 Years	340	244	90	93	11
21 to 25 Years	36	47	17	7	4
Age at First Use	Past Year Substance Dependence or Abuse among Lifetime Users Aged 26 or Older
TOTAL	1,050	757	271	184	93
Under 16 Years	291	151	57	67	25
16 Years or Older	759	605	214	117	69
16 to 20 Years	312	170	60	41	44
21 to 25 Years	218	187	36	24	5
26 Years or Older	230	248	118	52	20

60209

Table 6.5B Past Year Substance Dependence or Abuse for Nonmedical Use of Prescription-Type Psychotherapeutics among Lifetime Users Aged 18 or Older, by Drug Type, Age at First Use, and Current Age: Percentages, Annual Averages Based on 2002-2004
Age at First Use	Any Prescription- Type Psycho- therapeutic Drug	PRESCRIPTION DRUG TYPE
	Any Prescription- Type Psycho- therapeutic Drug	Pain Relievers	Tranquilizers	Stimulants	Sedatives
	Past Year Substance Dependence or Abuse among Lifetime Users Aged 18 or Older
Low precision; no estimate reported. NOTE: Dependence or abuse is based on definitions found in the 4^th edition of the Diagnostic and Statistical Manual of Mental Disorders* (DSM-IV). NOTE: Nonmedical use of prescription-type pain relievers, tranquilizers, stimulants, or sedatives; does not include over-the-counter drugs. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
TOTAL	3.7	4.2	2.2	1.7	1.2
Under 16 Years	7.5	7.4	5.1	3.9	2.3
16 Years or Older	3.0	3.7	1.9	1.3	1.0
16 to 20 Years	3.3	3.7	2.1	1.3	1.1
21 to 25 Years	2.8	3.8	1.2	0.8	0.5
26 Years or Older	2.6	3.5	2.2	2.1	1.4
Age at First Use	Past Year Substance Dependence or Abuse among Lifetime Users Aged 18 to 25
TOTAL	6.5	5.5	3.9	4.4	3.8
Under 16 Years	10.4	8.5	7.2	6.3	6.2
16 Years or Older	5.3	4.8	3.3	3.8	3.1
16 to 20 Years	5.7	4.8	3.5	4.1	2.8
21 to 25 Years	3.5	4.9	2.9	2.2	4.7
Age at First Use	Past Year Substance Dependence or Abuse among Lifetime Users Aged 26 or Older
TOTAL	3.0	3.7	1.8	1.1	1.0
Under 16 Years	6.2	6.6	4.2	3.0	1.9
16 Years or Older	2.5	3.3	1.6	0.8	0.9
16 to 20 Years	2.3	2.8	1.3	0.5	1.0
21 to 25 Years	2.7	3.6	0.9	0.7	0.3
26 Years or Older	2.6	3.5	2.2	2.1	1.4

60213

Table 6.6B Past Year Treatment for Illicit Drug Use at Any Facility and Met Criteria for Dependence on or Abuse of Prescription Drugs in the Past Year among Persons Aged 12 or Older, by Drug Type, Age Category, and Gender: Numbers in Thousands and Percentages, Annual Averages Based on 2002-2004
Demographic Characteristic	Any Prescription- Type Psycho- therapeutic Drug¹	Past Year Drug Dependence or Abuse and Receiving Treatment for Any Illicit Drug in Past Year
		Prescription Drug Type
		Pain Relievers	Tranquilizers	Stimulants	Sedatives
	Numbers in Thousands
Low precision; no estimate reported. NOTE: Received treatment for use of illicit drug at any facility refers to treatment received in order to reduce or stop use of any illicit drug, or for medical problems associated with illicit drug use. It includes treatment received at any location, such as hospital, a rehabilitation facility (impatient or outpatient), mental health center, emergency room, private doctor's office, self-help group, or prison/jail. NOTE: Dependence or abuse is based on definitions found in the 4^th edition of the Diagnostic and Statistical Manual of Mental Disorders* (DSM-IV). ¹ Nonmedical use of prescription-type pain relievers, tranquilizers, stimulants, or sedatives; does not include over-the-counter drugs. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
TOTAL	290	210	106	104	39
AGE GROUP
12 to 17	41	31	15	18	6
18 to 25	90	59	23	38	4
26 or Older	159	120	69	48	29
GENDER
Male	145	108	56	52	31
Female	145	102	51	51	8
Demographic Characteristic	Percentage among Persons Aged 12 or Older
TOTAL	0.1	0.1	0.0	0.0	0.0
AGE GROUP
12 to 17	0.2	0.1	0.1	0.1	0.0
18 to 25	0.3	0.2	0.1	0.1	0.0
26 or Older	0.1	0.1	0.0	0.0	0.0
GENDER
Male	0.1	0.1	0.0	0.0	0.0
Female	0.1	0.1	0.0	0.0	0.0
Demographic Characteristic	Percentage among Persons Aged 12 or Older Dependent on or Abusing Relevant Drug in the Past Year
TOTAL	14.5	14.6	21.1	24.2	*
AGE GROUP
12 to 17	11.3	11.2	17.0	19.3	*
18 to 25	15.4	14.5	15.6	25.1	*
26 or Older	15.1	15.9	*	*	*
GENDER
Male	14.8	14.6	*	*	*
Female	14.3	14.6	19.1	24.6	*

60209

Table 6.7B Past Year Treatment for Illicit Drug Use at Specialty Facility and Met Criteria for Dependence on or Abuse of Prescription Drugs in the Past Year among Persons Aged 12 or Older, by Drug Type, Age Category, and Gender: Numbers in Thousands and Percentages, Annual Averages Based on 2002-2004
Demographic Characteristic	Any Prescription- Type Psycho- therapeutic Drug¹	Past Year Drug Dependence or Abuse and Receiving Treatment for Any Illicit Drug in Past Year
		Prescription Drug Type
		Pain Relievers	Tranquilizers	Stimulants	Sedatives
	Numbers in Thousands
Low precision; no estimate reported. NOTE: Received treatment for use of any illicit drug at a specialty facility refers to treatment received at a hospital (inpatient), a rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop illicit drug use, or for medical problems associated with illicit drug use. NOTE: Dependence or abuse is based on definitions found in the 4^th edition of the Diagnostic and Statistical Manual of Mental Disorders* (DSM-IV). ¹ Nonmedical use of prescription-type pain relievers, tranquilizers, stimulants, or sedatives; does not include over-the-counter drugs. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
TOTAL	249	186	98	87	38
AGE GROUP
12 to 17	29	22	13	13	5
18 to 25	74	49	21	31	4
26 or Older	146	114	64	43	29
GENDER
Male	130	98	55	46	30
Female	119	88	43	42	8
Demographic Characteristic	Percentage among Persons Aged 12 or Older
TOTAL	0.1	0.1	0.0	0.0	0.0
AGE GROUP
12 to 17	0.1	0.1	0.1	0.1	0.0
18 to 25	0.2	0.2	0.1	0.1	0.0
26 or Older	0.1	0.1	0.0	0.0	0.0
GENDER
Male	0.1	0.1	0.0	0.0	0.0
Female	0.1	0.1	0.0	0.0	0.0
Demographic Characteristic	Percentage among Persons Aged 12 or Older Dependent on or Abusing Relevant Drug in the Past Year
TOTAL	12.5	12.9	19.3	20.4	*
AGE GROUP
12 to 17	7.9	8.1	15.0	13.7	*
18 to 25	12.7	12.1	14.0	20.8	*
26 or Older	13.9	15.1	*	*	*
GENDER
Male	13.3	13.3	*	*	*
Female	11.7	12.5	16.0	19.9	*

60213

Table 6.8B Last or Current Treatment in the Past Year at Any Facility for Problems Related to Prescription Drugs and Met Criteria for Dependence on or Abuse of Those Drugs in the Past Year among Persons Aged 12 or Older, by Drug Type, Age Category, and Gender: Numbers in Thousands and Percentages, Annual Averages Based on 2002-2004
Demographic Characteristic	Any Prescription- Type Psycho- therapeutic Drug¹	Drug for which Last or Current Treatment in the Past Year Was Received and That Individual was Dependent on or Abusing in the Past Year
		Prescription Drug Type
		Pain Relievers	Tranquilizers	Stimulants	Sedatives
	Numbers in Thousands
Low precision; no estimate reported. NOTE: If respondents reported that they were currently receiving treatment, they were asked questions regarding specific substances for their current treatment; otherwise, questions pertained to the last treatment they received. Only persons who received treatment in the past year are included. NOTE: Received treatment for use of illicit drug at any facility refers to treatment received in order to reduce or stop use of any illicit drug, or for medical problems associated with illicit drug use. It includes treatment received at any location, such as hospital, a rehabilitation facility (impatient or outpatient), mental health center, emergency room, private doctor's office, self-help group, or prison/jail. NOTE: Dependence or abuse is based on definitions found in the 4^th edition of the Diagnostic and Statistical Manual of Mental Disorders* (DSM-IV). ¹ Nonmedical use of prescription-type pain relievers, tranquilizers, stimulants, or sedatives; does not include over-the-counter drugs. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
TOTAL	209	135	50	64	34
AGE GROUP
12 to 17	24	20	8	9	4
18 to 25	68	42	15	29	3
26 or Older	117	74	27	26	27
GENDER
Male	101	59	20	25	27
Female	108	76	30	39	7
Demographic Characteristic	Percentage among Persons Aged 12 or Older
TOTAL	0.1	0.1	0.0	0.0	0.0
AGE GROUP
12 to 17	0.1	0.1	0.0	0.0	0.0
18 to 25	0.2	0.1	0.0	0.1	0.0
26 or Older	0.1	0.0	0.0	0.0	0.0
GENDER
Male	0.1	0.1	0.0	0.0	0.0
Female	0.1	0.1	0.0	0.0	0.0
Demographic Characteristic	Percentage among Persons Aged 12 or Older Dependent on or Abusing Relevant Drug in the Past Year
TOTAL	10.5	9.4	9.8	15.0	*
AGE GROUP
12 to 17	6.5	7.1	9.4	10.0	*
18 to 25	11.6	10.4	10.0	19.0	*
26 or Older	11.2	9.7	9.8	*	*
GENDER
Male	10.3	8.0	8.3	11.3	*
Female	10.6	10.8	11.2	18.8	*

60406

**Table 7.1A Nonmedical Use of Any Prescription Psychotherapeutic Drugs in Past Year, by Age Group and State: Numbers in Thousands, Annual Averages Based on 2002-2004**
State	Total		AGE GROUP (Years)
	Total		12-17		18-25		26 or Older
	Total	95% Confidence Interval	Total	95% Confidence Interval	Total	95% Confidence Interval	Total	95% Confidence Interval
*Low precision; no estimate reported. NOTE: Nonmedical use of prescription-type pain relievers, tranquilizers, stimulants, or sedatives; does not include over-the-counter drugs. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
Total	14,769	(14,303 - 15,250)	2,266	(2,190 - 2,344)	4,587	(4,455 - 4,721)	7,917	(7,504 - 8,352)
Alabama	242	(190 - 307)	36	(28 - 46)	83	(71 - 98)	123	(82 - 183)
Alaska	32	(26 - 40)	6	(5 - 7)	10	(9 - 12)	16	(10 - 25)
Arizona	339	(279 - 411)	52	(37 - 72)	94	(74 - 120)	193	(149 - 249)
Arkansas	159	(130 - 194)	26	(21 - 32)	58	(49 - 68)	76	(57 - 100)
California	2,038	(1,821 - 2,278)	289	(264 - 317)	491	(439 - 548)	1,258	(1,058 - 1,492)
Colorado	289	(222 - 374)	39	(31 - 49)	87	(75 - 101)	163	(110 - 239)
Connecticut	165	(134 - 203)	20	(15 - 27)	51	(41 - 64)	94	(62 - 140)
Delaware	41	(35 - 49)	6	(5 - 8)	16	(13 - 19)	20	(15 - 26)
District of Columbia	24	(18 - 31)	2	(1 - 3)	7	(5 - 9)	15	(10 - 22)
Florida	910	(826 - 1,001)	123	(108 - 140)	252	(231 - 274)	535	(463 - 617)
Georgia	484	(367 - 634)	72	(54 - 94)	115	(90 - 144)	297	(200 - 438)
Hawaii	49	(41 - 59)	10	(8 - 12)	14	(12 - 17)	25	(19 - 34)
Idaho	84	(70 - 100)	13	(10 - 16)	26	(22 - 31)	45	(33 - 61)
Illinois	502	(441 - 572)	83	(72 - 95)	171	(156 - 187)	249	(196 - 316)
Indiana	383	(313 - 468)	52	(39 - 67)	126	(107 - 147)	206	(151 - 278)
Iowa	109	(89 - 133)	18	(12 - 27)	38	(28 - 50)	54	(40 - 72)
Kansas	130	(101 - 166)	17	(14 - 22)	40	(29 - 55)	72	(51 - 103)
Kentucky	290	(256 - 328)	42	(35 - 50)	89	(77 - 101)	160	(127 - 200)
Louisiana	250	(210 - 298)	35	(27 - 44)	105	(88 - 124)	110	(81 - 149)
Maine	63	(48 - 81)	9	(6 - 12)	23	(20 - 26)	31	(19 - 50)
Maryland	226	(161 - 314)	32	(22 - 45)	60	(49 - 74)	134	(78 - 226)
Massachusetts	396	(304 - 512)	56	(48 - 66)	121	(91 - 158)	219	(142 - 333)
Michigan	534	(486 - 587)	104	(93 - 115)	162	(151 - 175)	268	(227 - 315)
Minnesota	211	(169 - 263)	35	(23 - 51)	71	(59 - 85)	105	(74 - 148)
Mississippi	117	(102 - 135)	27	(20 - 35)	40	(32 - 50)	50	(36 - 71)
Missouri	322	(265 - 389)	50	(40 - 62)	97	(77 - 121)	175	(127 - 239)
Montana	47	(38 - 59)	9	(7 - 12)	15	(13 - 17)	23	(16 - 34)
Nebraska	64	(48 - 83)	13	(10 - 16)	24	(18 - 32)	27	(19 - 39)
Nevada	148	(123 - 178)	17	(14 - 21)	36	(29 - 45)	95	(75 - 120)
New Hampshire	62	(50 - 78)	9	(6 - 14)	25	(21 - 30)	28	(20 - 38)
New Jersey	295	(224 - 387)	56	(39 - 80)	91	(76 - 109)	147	(96 - 226)
New Mexico	117	(96 - 141)	18	(14 - 22)	34	(27 - 41)	66	(47 - 91)
New York	778	(671 - 901)	108	(95 - 122)	262	(231 - 297)	408	(319 - 521)
North Carolina	398	(326 - 485)	77	(58 - 101)	125	(98 - 157)	196	(127 - 299)
North Dakota	25	(21 - 30)	4	(3 - 5)	9	(7 - 12)	12	(8 - 18)
Ohio	569	(523 - 619)	82	(72 - 93)	192	(175 - 210)	295	(255 - 342)
Oklahoma	202	(162 - 250)	34	(26 - 44)	82	(70 - 96)	85	(55 - 130)
Oregon	228	(172 - 299)	34	(28 - 43)	64	(53 - 78)	129	(85 - 194)
Pennsylvania	505	(453 - 563)	78	(69 - 87)	184	(167 - 203)	243	(198 - 298)
Rhode Island	69	(57 - 84)	8	(6 - 11)	30	(25 - 35)	32	(23 - 44)
South Carolina	233	(193 - 279)	31	(25 - 38)	75	(58 - 96)	127	(91 - 176)
South Dakota	25	(21 - 30)	7	(5 - 9)	9	(7 - 11)	9	(6 - 14)
Tennessee	318	(266 - 379)	50	(39 - 64)	102	(83 - 124)	166	(127 - 215)
Texas	1,081	(965 - 1,211)	176	(157 - 198)	352	(313 - 396)	553	(458 - 667)
Utah	142	(124 - 162)	19	(15 - 23)	55	(46 - 66)	68	(52 - 89)
Vermont	33	(27 - 41)	6	(4 - 8)	12	(10 - 15)	15	(11 - 22)
Virginia	286	(251 - 325)	53	(43 - 65)	105	(85 - 128)	128	(90 - 182)
Washington	376	(294 - 480)	64	(54 - 76)	111	(92 - 133)	201	(136 - 295)
West Virginia	102	(81 - 128)	13	(10 - 17)	38	(29 - 49)	52	(38 - 69)
Wisconsin	250	(205 - 303)	44	(35 - 56)	96	(75 - 122)	109	(75 - 160)
Wyoming	27	(23 - 30)	4	(3 - 5)	10	(8 - 11)	13	(10 - 16)

60406

**Table 7.1B Nonmedical Use of Any Prescription Psychotherapeutic Drugs in Past Year, by Age Group and State: Percentages, Annual Averages Based on 2002-2004**
State	Total		AGE GROUP (Years)
	Total		12-17		18-25		26 or Older
	Total	95% Confidence Interval	Total	95% Confidence Interval	Total	95% Confidence Interval	Total	95% Confidence Interval
*Low precision; no estimate reported. NOTE: Nonmedical use of prescription-type pain relievers, tranquilizers, stimulants, or sedatives; does not include over-the-counter drugs. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
Total	6.2	(6.0 - 6.4)	9.1	(8.8 - 9.4)	14.5	(14.1 - 14.9)	4.4	(4.1 - 4.6)
Alabama	6.5	(5.1 - 8.3)	9.4	(7.3 - 12.2)	16.6	(14.1 - 19.4)	4.4	(2.9 - 6.5)
Alaska	6.4	(5.1 - 7.9)	8.6	(6.7 - 10.9)	15.9	(13.3 - 18.8)	4.3	(2.7 - 6.7)
Arizona	7.6	(6.2 - 9.2)	10.6	(7.5 - 14.7)	15.4	(12.0 - 19.5)	5.7	(4.4 - 7.4)
Arkansas	7.1	(5.8 - 8.7)	11.2	(8.9 - 13.9)	19.0	(16.1 - 22.3)	4.4	(3.4 - 5.9)
California	7.1	(6.4 - 8.0)	9.1	(8.3 - 10.0)	12.5	(11.1 - 13.9)	5.8	(4.9 - 6.9)
Colorado	7.8	(6.0 - 10.1)	10.0	(8.0 - 12.5)	17.6	(15.1 - 20.4)	5.8	(3.9 - 8.5)
Connecticut	5.8	(4.7 - 7.1)	6.7	(4.9 - 9.2)	15.6	(12.3 - 19.5)	4.2	(2.8 - 6.3)
Delaware	6.1	(5.1 - 7.3)	9.3	(7.3 - 11.8)	17.4	(14.6 - 20.8)	3.8	(2.8 - 5.0)
District of Columbia	5.0	(3.8 - 6.5)	5.5	(4.0 - 7.5)	9.5	(6.8 - 13.1)	4.1	(2.8 - 5.8)
Florida	6.4	(5.8 - 7.1)	9.1	(8.0 - 10.3)	15.6	(14.3 - 17.0)	4.8	(4.1 - 5.5)
Georgia	7.0	(5.3 - 9.1)	9.5	(7.2 - 12.4)	12.0	(9.5 - 15.1)	5.7	(3.8 - 8.4)
Hawaii	4.9	(4.1 - 5.9)	9.5	(7.5 - 11.8)	11.6	(9.6 - 14.0)	3.3	(2.4 - 4.4)
Idaho	7.6	(6.4 - 9.1)	10.1	(7.9 - 12.8)	15.6	(13.2 - 18.4)	5.6	(4.1 - 7.5)
Illinois	4.9	(4.3 - 5.5)	7.6	(6.6 - 8.7)	12.3	(11.2 - 13.5)	3.2	(2.5 - 4.0)
Indiana	7.6	(6.2 - 9.2)	9.5	(7.2 - 12.4)	17.8	(15.2 - 20.7)	5.4	(4.0 - 7.3)
Iowa	4.4	(3.6 - 5.4)	7.3	(4.8 - 11.0)	10.7	(8.0 - 14.1)	2.9	(2.2 - 3.9)
Kansas	5.9	(4.6 - 7.5)	7.2	(5.7 - 9.2)	12.6	(9.1 - 17.2)	4.4	(3.1 - 6.2)
Kentucky	8.5	(7.5 - 9.7)	12.7	(10.6 - 15.3)	19.5	(17.0 - 22.3)	6.1	(4.8 - 7.7)
Louisiana	6.9	(5.8 - 8.2)	8.6	(6.8 - 10.9)	19.5	(16.4 - 23.0)	4.1	(3.0 - 5.6)
Maine	5.6	(4.3 - 7.3)	8.2	(5.9 - 11.3)	17.3	(14.9 - 19.9)	3.5	(2.2 - 5.8)
Maryland	5.0	(3.6 - 7.0)	6.6	(4.6 - 9.4)	11.1	(9.0 - 13.5)	3.8	(2.2 - 6.5)
Massachusetts	7.4	(5.7 - 9.5)	11.0	(9.3 - 13.0)	17.9	(13.5 - 23.5)	5.2	(3.4 - 7.9)
Michigan	6.4	(5.8 - 7.1)	11.5	(10.4 - 12.8)	14.8	(13.7 - 15.9)	4.2	(3.6 - 5.0)
Minnesota	5.0	(4.0 - 6.3)	7.8	(5.2 - 11.5)	12.3	(10.2 - 14.6)	3.3	(2.3 - 4.7)
Mississippi	5.1	(4.4 - 5.8)	10.4	(7.9 - 13.5)	11.5	(9.2 - 14.4)	2.9	(2.1 - 4.1)
Missouri	6.8	(5.6 - 8.3)	10.2	(8.2 - 12.6)	15.2	(12.0 - 19.0)	4.9	(3.6 - 6.7)
Montana	6.2	(4.9 - 7.7)	11.3	(8.8 - 14.5)	14.3	(12.5 - 16.3)	4.0	(2.7 - 5.9)
Nebraska	4.5	(3.4 - 5.9)	8.4	(6.5 - 10.7)	11.6	(8.6 - 15.4)	2.5	(1.8 - 3.6)
Nevada	8.1	(6.7 - 9.8)	9.1	(7.5 - 11.1)	16.2	(12.9 - 20.2)	6.7	(5.3 - 8.5)
New Hampshire	5.8	(4.6 - 7.2)	8.3	(5.6 - 12.0)	19.3	(16.3 - 22.7)	3.3	(2.4 - 4.5)
New Jersey	4.1	(3.1 - 5.4)	7.7	(5.4 - 11.0)	11.4	(9.5 - 13.6)	2.6	(1.7 - 4.0)
New Mexico	7.7	(6.3 - 9.3)	10.1	(8.0 - 12.7)	15.6	(12.6 - 19.2)	5.8	(4.2 - 8.0)
New York	4.9	(4.2 - 5.7)	6.9	(6.0 - 7.8)	12.9	(11.3 - 14.6)	3.3	(2.6 - 4.2)
North Carolina	5.8	(4.8 - 7.1)	11.1	(8.4 - 14.6)	14.2	(11.1 - 17.8)	3.7	(2.4 - 5.7)
North Dakota	4.8	(4.0 - 5.7)	8.0	(6.5 - 9.8)	10.6	(8.0 - 14.0)	3.1	(2.1 - 4.5)
Ohio	6.0	(5.5 - 6.6)	8.3	(7.3 - 9.4)	15.4	(14.1 - 16.9)	4.1	(3.5 - 4.8)
Oklahoma	7.1	(5.7 - 8.8)	11.4	(8.7 - 14.7)	19.9	(16.9 - 23.2)	4.0	(2.6 - 6.1)
Oregon	7.7	(5.8 - 10.1)	11.5	(9.3 - 14.3)	16.6	(13.6 - 20.1)	5.7	(3.7 - 8.5)
Pennsylvania	4.9	(4.4 - 5.4)	7.5	(6.7 - 8.5)	14.2	(12.9 - 15.6)	3.0	(2.5 - 3.7)
Rhode Island	7.7	(6.4 - 9.3)	9.1	(6.6 - 12.4)	23.4	(19.8 - 27.5)	4.6	(3.4 - 6.3)
South Carolina	6.8	(5.7 - 8.2)	8.7	(7.0 - 10.8)	16.3	(12.5 - 20.9)	4.9	(3.5 - 6.8)
South Dakota	4.0	(3.4 - 4.8)	9.9	(7.3 - 13.4)	10.0	(8.1 - 12.3)	2.0	(1.3 - 3.1)
Tennessee	6.6	(5.5 - 7.9)	10.5	(8.1 - 13.5)	16.2	(13.3 - 19.7)	4.5	(3.4 - 5.8)
Texas	6.2	(5.5 - 6.9)	8.7	(7.7 - 9.7)	13.8	(12.3 - 15.6)	4.3	(3.5 - 5.2)
Utah	7.8	(6.8 - 8.9)	8.1	(6.6 - 9.9)	15.4	(12.9 - 18.4)	5.5	(4.2 - 7.2)
Vermont	6.2	(5.1 - 7.7)	10.8	(7.6 - 15.0)	17.5	(14.1 - 21.4)	3.7	(2.6 - 5.3)
Virginia	4.8	(4.2 - 5.5)	8.7	(7.0 - 10.7)	14.0	(11.4 - 17.1)	2.8	(2.0 - 4.0)
Washington	7.5	(5.8 - 9.5)	12.2	(10.2 - 14.5)	16.8	(13.9 - 20.0)	5.2	(3.5 - 7.6)
West Virginia	6.7	(5.3 - 8.3)	9.3	(7.1 - 12.1)	19.5	(14.9 - 25.1)	4.3	(3.2 - 5.7)
Wisconsin	5.5	(4.5 - 6.7)	9.2	(7.2 - 11.6)	15.3	(11.9 - 19.5)	3.2	(2.2 - 4.6)
Wyoming	6.3	(5.5 - 7.3)	9.4	(7.3 - 12.0)	15.9	(13.1 - 19.1)	4.1	(3.2 - 5.2)

60406

**Table 7.2A Nonmedical Use of Pain Relievers in Past Year, by Age Group and State: Numbers in Thousands, Annual Averages Based on 2002-2004**
State	Total		AGE GROUP (Years)
	Total		12-17		18-25		26 or Older
	Total	95% Confidence Interval	Total	95% Confidence Interval	Total	95% Confidence Interval	Total	95% Confidence Interval
*Low precision; no estimate reported. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
Total	11,306	(10,918 - 11,707)	1,884	(1,814 - 1,956)	3,726	(3,612 - 3,842)	5,696	(5,352 - 6,062)
Alabama	184	(146 - 231)	32	(24 - 42)	71	(63 - 80)	81	(52 - 125)
Alaska	28	(24 - 32)	5	(4 - 7)	9	(8 - 11)	13	(9 - 19)
Arizona	264	(212 - 327)	43	(29 - 62)	75	(55 - 100)	146	(106 - 200)
Arkansas	114	(92 - 141)	21	(15 - 29)	43	(36 - 53)	50	(37 - 66)
California	1,483	(1,308 - 1,678)	249	(224 - 276)	390	(346 - 439)	843	(685 - 1,036)
Colorado	246	(187 - 323)	34	(27 - 43)	72	(60 - 86)	141	(92 - 213)
Connecticut	112	(87 - 144)	17	(12 - 23)	40	(31 - 53)	55	(34 - 90)
Delaware	33	(27 - 41)	5	(4 - 6)	13	(10 - 16)	15	(11 - 22)
District of Columbia	12	(10 - 16)	1	(1 - 2)	4	(3 - 5)	7	(4 - 12)
Florida	691	(612 - 780)	94	(82 - 107)	205	(185 - 226)	392	(324 - 474)
Georgia	394	(285 - 541)	59	(43 - 80)	97	(77 - 121)	239	(147 - 383)
Hawaii	38	(29 - 50)	8	(6 - 11)	10	(8 - 13)	20	(13 - 31)
Idaho	64	(50 - 81)	11	(8 - 14)	22	(18 - 27)	31	(21 - 45)
Illinois	387	(343 - 436)	69	(60 - 80)	144	(130 - 160)	173	(135 - 222)
Indiana	306	(245 - 380)	45	(33 - 63)	111	(93 - 131)	150	(105 - 213)
Iowa	64	(46 - 90)	13	(8 - 19)	28	(20 - 38)	24	(15 - 40)
Kansas	93	(65 - 133)	13	(10 - 17)	32	(23 - 44)	48	(28 - 82)
Kentucky	238	(214 - 264)	34	(27 - 41)	79	(68 - 91)	126	(105 - 150)
Louisiana	179	(148 - 215)	28	(22 - 36)	79	(65 - 94)	72	(49 - 105)
Maine	49	(38 - 63)	7	(5 - 11)	20	(17 - 23)	22	(13 - 36)
Maryland	161	(120 - 216)	21	(15 - 30)	56	(45 - 68)	84	(48 - 147)
Massachusetts	261	(198 - 345)	46	(36 - 57)	100	(79 - 124)	116	(63 - 212)
Michigan	450	(410 - 495)	89	(79 - 99)	136	(125 - 148)	225	(190 - 267)
Minnesota	152	(123 - 186)	25	(16 - 39)	49	(41 - 58)	77	(58 - 103)
Mississippi	84	(71 - 101)	21	(15 - 30)	33	(26 - 42)	30	(19 - 48)
Missouri	239	(194 - 295)	39	(28 - 53)	76	(58 - 98)	125	(90 - 171)
Montana	31	(24 - 40)	7	(6 - 9)	11	(9 - 13)	13	(7 - 22)
Nebraska	40	(31 - 52)	10	(8 - 13)	18	(13 - 25)	12	(7 - 20)
Nevada	110	(88 - 137)	15	(11 - 19)	29	(22 - 37)	67	(50 - 88)
New Hampshire	52	(40 - 68)	8	(6 - 12)	21	(18 - 25)	23	(16 - 34)
New Jersey	226	(173 - 295)	45	(29 - 70)	80	(65 - 98)	101	(68 - 148)
New Mexico	81	(63 - 103)	15	(12 - 19)	26	(20 - 33)	40	(24 - 66)
New York	626	(532 - 736)	96	(83 - 110)	209	(183 - 239)	321	(240 - 429)
North Carolina	313	(259 - 378)	66	(51 - 85)	106	(83 - 134)	141	(90 - 221)
North Dakota	19	(16 - 22)	3	(2 - 5)	6	(4 - 8)	9	(7 - 14)
Ohio	448	(405 - 496)	70	(61 - 81)	162	(145 - 180)	216	(181 - 258)
Oklahoma	153	(128 - 183)	30	(23 - 37)	63	(51 - 78)	60	(38 - 94)
Oregon	177	(124 - 249)	30	(24 - 37)	55	(44 - 69)	92	(51 - 161)
Pennsylvania	414	(369 - 464)	64	(55 - 73)	152	(138 - 167)	198	(161 - 245)
Rhode Island	55	(47 - 64)	7	(5 - 10)	23	(18 - 29)	25	(19 - 33)
South Carolina	168	(134 - 210)	26	(21 - 32)	58	(47 - 70)	84	(56 - 126)
South Dakota	17	(14 - 20)	5	(3 - 7)	6	(5 - 7)	6	(3 - 10)
Tennessee	231	(185 - 288)	42	(33 - 53)	72	(59 - 86)	117	(80 - 170)
Texas	818	(716 - 934)	143	(125 - 162)	275	(241 - 314)	400	(315 - 507)
Utah	111	(91 - 134)	15	(11 - 19)	46	(39 - 54)	50	(32 - 75)
Vermont	27	(22 - 33)	5	(3 - 7)	10	(8 - 12)	13	(9 - 18)
Virginia	243	(209 - 281)	48	(37 - 61)	85	(69 - 104)	110	(75 - 162)
Washington	315	(252 - 392)	57	(47 - 68)	99	(82 - 118)	160	(108 - 235)
West Virginia	83	(66 - 104)	11	(9 - 14)	31	(24 - 41)	40	(30 - 53)
Wisconsin	200	(164 - 243)	36	(26 - 48)	83	(63 - 109)	81	(58 - 115)
Wyoming	21	(17 - 24)	4	(3 - 5)	7	(6 - 9)	10	(8 - 13)

60406

**Table 7.2B Nonmedical Use of Pain Relievers in Past Year, by Age Group and State: Percentages, Annual Averages Based on 2002-2004**
State	Total		AGE GROUP (Years)
	Total		12-17		18-25		26 or Older
	Total	95% Confidence Interval	Total	95% Confidence Interval	Total	95% Confidence Interval	Total	95% Confidence Interval
*Low precision; no estimate reported. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
Total	4.8	(4.6 - 4.9)	7.5	(7.3 - 7.8)	11.8	(11.4 - 12.1)	3.1	(3.0 - 3.3)
Alabama	5.0	(3.9 - 6.2)	8.4	(6.4 - 11.1)	14.1	(12.6 - 15.8)	2.9	(1.8 - 4.4)
Alaska	5.5	(4.7 - 6.4)	7.6	(5.6 - 10.1)	13.9	(11.5 - 16.6)	3.6	(2.5 - 5.1)
Arizona	5.9	(4.7 - 7.3)	8.7	(6.0 - 12.5)	12.2	(9.1 - 16.3)	4.3	(3.1 - 5.9)
Arkansas	5.1	(4.1 - 6.3)	9.0	(6.6 - 12.3)	14.3	(11.7 - 17.3)	2.9	(2.2 - 3.9)
California	5.2	(4.6 - 5.9)	7.8	(7.1 - 8.7)	9.9	(8.8 - 11.2)	3.9	(3.2 - 4.8)
Colorado	6.7	(5.0 - 8.7)	8.7	(6.8 - 11.0)	14.4	(12.0 - 17.2)	5.0	(3.3 - 7.6)
Connecticut	3.9	(3.0 - 5.0)	5.6	(4.0 - 7.8)	12.3	(9.3 - 16.0)	2.5	(1.5 - 4.0)
Delaware	4.9	(4.0 - 6.0)	7.3	(5.7 - 9.2)	14.2	(11.6 - 17.4)	3.0	(2.1 - 4.2)
District of Columbia	2.6	(2.0 - 3.4)	4.3	(2.9 - 6.3)	5.3	(3.8 - 7.4)	1.9	(1.1 - 3.3)
Florida	4.9	(4.3 - 5.5)	6.9	(6.1 - 7.9)	12.7	(11.5 - 14.0)	3.5	(2.9 - 4.2)
Georgia	5.7	(4.1 - 7.8)	7.8	(5.7 - 10.5)	10.1	(8.0 - 12.7)	4.6	(2.8 - 7.3)
Hawaii	3.8	(3.0 - 5.0)	7.7	(5.5 - 10.9)	8.3	(6.5 - 10.4)	2.6	(1.7 - 4.0)
Idaho	5.8	(4.5 - 7.3)	8.4	(6.3 - 11.0)	13.3	(10.6 - 16.5)	3.8	(2.6 - 5.6)
Illinois	3.7	(3.3 - 4.2)	6.4	(5.5 - 7.4)	10.4	(9.3 - 11.6)	2.2	(1.7 - 2.8)
Indiana	6.1	(4.9 - 7.5)	8.4	(6.0 - 11.5)	15.6	(13.1 - 18.5)	3.9	(2.8 - 5.6)
Iowa	2.6	(1.9 - 3.7)	5.1	(3.4 - 7.6)	7.8	(5.6 - 10.8)	1.3	(0.8 - 2.1)
Kansas	4.2	(3.0 - 6.0)	5.4	(4.2 - 7.0)	10.0	(7.2 - 13.8)	2.9	(1.7 - 5.0)
Kentucky	7.0	(6.3 - 7.8)	10.2	(8.2 - 12.5)	17.3	(14.9 - 20.0)	4.8	(4.0 - 5.8)
Louisiana	4.9	(4.1 - 5.9)	7.0	(5.5 - 8.8)	14.6	(12.1 - 17.4)	2.7	(1.8 - 3.9)
Maine	4.4	(3.4 - 5.6)	6.7	(4.6 - 9.8)	14.8	(12.6 - 17.3)	2.5	(1.5 - 4.2)
Maryland	3.6	(2.7 - 4.8)	4.4	(3.1 - 6.1)	10.2	(8.2 - 12.5)	2.4	(1.4 - 4.2)
Massachusetts	4.9	(3.7 - 6.4)	9.0	(7.1 - 11.2)	14.8	(11.7 - 18.4)	2.8	(1.5 - 5.1)
Michigan	5.4	(4.9 - 6.0)	9.9	(8.8 - 11.1)	12.4	(11.4 - 13.5)	3.6	(3.0 - 4.2)
Minnesota	3.6	(2.9 - 4.4)	5.7	(3.7 - 8.7)	8.4	(7.1 - 10.1)	2.4	(1.8 - 3.2)
Mississippi	3.6	(3.0 - 4.4)	8.1	(5.7 - 11.6)	9.6	(7.5 - 12.1)	1.8	(1.1 - 2.8)
Missouri	5.1	(4.1 - 6.3)	7.9	(5.7 - 10.8)	12.0	(9.2 - 15.4)	3.5	(2.5 - 4.8)
Montana	4.0	(3.1 - 5.3)	9.0	(6.9 - 11.8)	10.5	(8.7 - 12.7)	2.2	(1.3 - 3.7)
Nebraska	2.8	(2.2 - 3.6)	6.5	(5.0 - 8.4)	8.7	(6.1 - 12.3)	1.1	(0.7 - 1.9)
Nevada	6.1	(4.8 - 7.5)	7.8	(6.0 - 9.9)	13.0	(10.1 - 16.6)	4.7	(3.6 - 6.2)
New Hampshire	4.8	(3.7 - 6.3)	7.2	(5.0 - 10.3)	15.8	(13.3 - 18.6)	2.8	(1.9 - 4.1)
New Jersey	3.2	(2.4 - 4.1)	6.2	(4.0 - 9.7)	9.9	(8.1 - 12.2)	1.8	(1.2 - 2.7)
New Mexico	5.3	(4.1 - 6.8)	8.6	(6.7 - 11.0)	12.0	(9.4 - 15.2)	3.5	(2.1 - 5.8)
New York	3.9	(3.3 - 4.6)	6.1	(5.3 - 7.0)	10.3	(9.0 - 11.7)	2.6	(1.9 - 3.5)
North Carolina	4.6	(3.8 - 5.5)	9.6	(7.4 - 12.3)	12.0	(9.4 - 15.2)	2.7	(1.7 - 4.2)
North Dakota	3.6	(3.0 - 4.3)	6.2	(4.5 - 8.5)	7.4	(5.3 - 10.1)	2.4	(1.7 - 3.5)
Ohio	4.8	(4.3 - 5.3)	7.1	(6.1 - 8.2)	13.0	(11.7 - 14.5)	3.0	(2.5 - 3.6)
Oklahoma	5.4	(4.5 - 6.4)	9.9	(7.8 - 12.5)	15.3	(12.4 - 18.8)	2.8	(1.8 - 4.4)
Oregon	6.0	(4.2 - 8.4)	10.0	(8.0 - 12.3)	14.3	(11.4 - 17.8)	4.0	(2.3 - 7.1)
Pennsylvania	4.0	(3.6 - 4.5)	6.2	(5.4 - 7.1)	11.7	(10.6 - 12.9)	2.5	(2.0 - 3.0)
Rhode Island	6.1	(5.2 - 7.1)	7.8	(5.4 - 11.1)	18.3	(14.5 - 22.8)	3.6	(2.7 - 4.8)
South Carolina	4.9	(3.9 - 6.2)	7.5	(6.0 - 9.2)	12.5	(10.2 - 15.3)	3.3	(2.2 - 4.8)
South Dakota	2.7	(2.2 - 3.2)	7.1	(5.0 - 10.0)	6.7	(5.6 - 7.9)	1.2	(0.7 - 2.2)
Tennessee	4.8	(3.8 - 6.0)	8.9	(7.0 - 11.3)	11.4	(9.4 - 13.7)	3.1	(2.2 - 4.6)
Texas	4.7	(4.1 - 5.3)	7.0	(6.2 - 8.0)	10.8	(9.5 - 12.4)	3.1	(2.4 - 3.9)
Utah	6.1	(5.0 - 7.3)	6.5	(5.0 - 8.5)	12.9	(11.0 - 15.2)	4.0	(2.6 - 6.1)
Vermont	5.2	(4.2 - 6.3)	8.8	(6.0 - 12.9)	14.4	(11.6 - 17.7)	3.1	(2.1 - 4.5)
Virginia	4.1	(3.5 - 4.7)	7.8	(6.0 - 10.0)	11.3	(9.2 - 13.9)	2.4	(1.6 - 3.5)
Washington	6.2	(5.0 - 7.8)	10.7	(8.9 - 12.9)	14.9	(12.3 - 17.8)	4.1	(2.8 - 6.1)
West Virginia	5.4	(4.3 - 6.7)	8.0	(6.2 - 10.2)	16.2	(12.3 - 21.0)	3.3	(2.5 - 4.4)
Wisconsin	4.4	(3.6 - 5.3)	7.4	(5.4 - 10.1)	13.2	(10.0 - 17.4)	2.4	(1.7 - 3.3)
Wyoming	4.9	(4.2 - 5.8)	8.1	(6.2 - 10.5)	11.6	(9.3 - 14.4)	3.2	(2.5 - 4.1)

60406

**Table 7.3A Nonmedical Use of Tranquilizers in Past Year, by Age Group and State: Numbers in Thousands, Annual Averages Based on 2002-2004**
State	Total		AGE GROUP (Years)
	Total		12-17		18-25		26 or Older
	Total	95% Confidence Interval	Total	95% Confidence Interval	Total	95% Confidence Interval	Total	95% Confidence Interval
*Low precision; no estimate reported. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
Total	4,989	(4,727 - 5,266)	562	(525 - 601)	1,616	(1,538 - 1,698)	2,811	(2,578 - 3,064)
Alabama	105	(79 - 139)	11	(6 - 18)	40	(31 - 51)	54	(32 - 91)
Alaska	9	(7 - 13)	1	(0 - 3)	2	(1 - 4)	6	(3 - 11)
Arizona	94	(54 - 165)	14	(9 - 22)	36	(21 - 62)	44	(19 - 103)
Arkansas	69	(56 - 84)	9	(6 - 13)	29	(21 - 38)	31	(20 - 47)
California	513	(415 - 633)	66	(54 - 79)	122	(97 - 151)	326	(243 - 436)
Colorado	85	(60 - 120)	8	(6 - 12)	27	(16 - 45)	50	(28 - 89)
Connecticut	46	(30 - 69)	2	(1 - 5)	13	(9 - 19)	30	(17 - 53)
Delaware	14	(11 - 19)	2	(1 - 3)	5	(4 - 7)	7	(4 - 12)
District of Columbia	9	(6 - 14)	0	(0 - 0)	2	(1 - 4)	7	(4 - 12)
Florida	431	(363 - 510)	48	(38 - 60)	124	(109 - 141)	259	(201 - 332)
Georgia	156	(100 - 242)	17	(11 - 26)	40	(24 - 65)	100	(52 - 191)
Hawaii	10	(7 - 15)	1	(1 - 3)	3	(2 - 5)	6	(3 - 11)
Idaho	20	(14 - 29)	3	(2 - 5)	5	(3 - 7)	12	(8 - 20)
Illinois	160	(122 - 209)	15	(11 - 20)	38	(31 - 47)	107	(74 - 155)
Indiana	142	(103 - 195)	15	(10 - 22)	48	(36 - 66)	78	(48 - 127)
Iowa	27	(16 - 45)	3	(1 - 9)	7	(6 - 10)	17	(8 - 34)
Kansas	42	(29 - 60)	4	(2 - 7)	13	(8 - 21)	25	(15 - 41)
Kentucky	158	(137 - 182)	16	(13 - 19)	50	(44 - 57)	91	(68 - 123)
Louisiana	125	(98 - 159)	15	(11 - 19)	53	(45 - 62)	58	(37 - 90)
Maine	21	(16 - 26)	2	(2 - 2)	11	(8 - 15)	8	(4 - 15)
Maryland	84	(48 - 145)	6	(3 - 13)	21	(14 - 31)	57	(24 - 131)
Massachusetts	158	(97 - 257)	16	(13 - 20)	38	(27 - 53)	105	(54 - 201)
Michigan	132	(108 - 161)	17	(13 - 22)	45	(39 - 52)	71	(51 - 98)
Minnesota	34	(23 - 50)	5	(2 - 13)	14	(10 - 19)	15	(7 - 32)
Mississippi	56	(42 - 74)	8	(4 - 16)	20	(14 - 27)	28	(19 - 42)
Missouri	120	(87 - 164)	14	(9 - 23)	43	(33 - 56)	62	(32 - 119)
Montana	11	(7 - 18)	2	(1 - 3)	4	(2 - 5)	6	(2 - 14)
Nebraska	14	(9 - 20)	2	(1 - 4)	6	(4 - 9)	5	(2 - 11)
Nevada	47	(33 - 67)	4	(2 - 8)	12	(9 - 17)	31	(17 - 54)
New Hampshire	20	(14 - 26)	2	(1 - 4)	8	(6 - 10)	10	(5 - 18)
New Jersey	128	(88 - 187)	11	(5 - 25)	36	(26 - 48)	81	(45 - 146)
New Mexico	37	(25 - 53)	1	(1 - 3)	9	(6 - 13)	26	(15 - 46)
New York	245	(188 - 317)	18	(14 - 25)	70	(57 - 85)	156	(105 - 232)
North Carolina	152	(104 - 219)	27	(16 - 44)	53	(37 - 77)	71	(39 - 129)
North Dakota	4	(3 - 6)	1	(1 - 1)	1	(1 - 2)	2	(1 - 4)
Ohio	196	(165 - 232)	17	(14 - 22)	79	(69 - 91)	99	(72 - 137)
Oklahoma	80	(61 - 106)	9	(6 - 15)	37	(30 - 47)	34	(21 - 53)
Oregon	59	(35 - 96)	5	(3 - 9)	17	(11 - 26)	37	(19 - 72)
Pennsylvania	183	(151 - 222)	19	(15 - 24)	67	(56 - 78)	98	(69 - 138)
Rhode Island	22	(17 - 28)	2	(1 - 4)	9	(6 - 14)	11	(7 - 17)
South Carolina	122	(97 - 154)	12	(8 - 19)	30	(21 - 42)	80	(56 - 114)
South Dakota	4	(2 - 6)	1	(1 - 2)	1	(0 - 2)	2	(1 - 4)
Tennessee	146	(112 - 190)	18	(11 - 28)	59	(43 - 80)	69	(41 - 114)
Texas	329	(277 - 389)	57	(47 - 69)	136	(114 - 163)	136	(100 - 184)
Utah	41	(30 - 55)	3	(2 - 6)	18	(14 - 24)	19	(10 - 36)
Vermont	9	(6 - 14)	1	(1 - 3)	4	(2 - 6)	4	(2 - 8)
Virginia	101	(72 - 143)	13	(9 - 18)	29	(20 - 41)	60	(33 - 110)
Washington	91	(66 - 124)	7	(3 - 17)	32	(20 - 50)	52	(32 - 83)
West Virginia	41	(31 - 55)	5	(3 - 7)	20	(15 - 27)	17	(10 - 27)
Wisconsin	83	(47 - 144)	7	(3 - 16)	27	(14 - 50)	48	(20 - 115)
Wyoming	8	(6 - 11)	1	(0 - 1)	2	(1 - 3)	5	(3 - 8)

60406

**Table 7.3B Nonmedical Use of Tranquilizers in Past Year, by Age Group and State: Percentages, Annual Averages Based on 2002-2004**
State	Total		AGE GROUP (Years)
	Total		12-17		18-25		26 or Older
	Total	95% Confidence Interval	Total	95% Confidence Interval	Total	95% Confidence Interval	Total	95% Confidence Interval
*Low precision; no estimate reported. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
Total	2.1	(2.0 - 2.2)	2.2	(2.1 - 2.4)	5.1	(4.9 - 5.4)	1.6	(1.4 - 1.7)
Alabama	2.8	(2.1 - 3.7)	2.8	(1.6 - 4.7)	8.0	(6.2 - 10.2)	1.9	(1.1 - 3.2)
Alaska	1.8	(1.3 - 2.6)	1.6	(0.7 - 3.9)	3.7	(2.3 - 5.9)	1.6	(0.8 - 3.1)
Arizona	2.1	(1.2 - 3.7)	2.8	(1.8 - 4.4)	6.0	(3.4 - 10.2)	1.3	(0.6 - 3.0)
Arkansas	3.1	(2.5 - 3.8)	3.9	(2.6 - 5.7)	9.4	(7.0 - 12.5)	1.8	(1.2 - 2.7)
California	1.8	(1.4 - 2.2)	2.1	(1.7 - 2.5)	3.1	(2.5 - 3.8)	1.5	(1.1 - 2.0)
Colorado	2.3	(1.6 - 3.2)	2.1	(1.4 - 3.0)	5.4	(3.2 - 9.1)	1.8	(1.0 - 3.2)
Connecticut	1.6	(1.0 - 2.4)	0.8	(0.4 - 1.6)	4.0	(2.8 - 5.7)	1.3	(0.8 - 2.4)
Delaware	2.1	(1.6 - 2.7)	2.7	(1.4 - 5.1)	5.8	(4.5 - 7.3)	1.4	(0.8 - 2.3)
District of Columbia	2.0	(1.3 - 2.9)	0.1	(0.0 - 0.8)	2.8	(1.5 - 5.1)	2.0	(1.2 - 3.2)
Florida	3.0	(2.6 - 3.6)	3.5	(2.8 - 4.4)	7.7	(6.8 - 8.7)	2.3	(1.8 - 3.0)
Georgia	2.2	(1.4 - 3.5)	2.2	(1.4 - 3.4)	4.1	(2.5 - 6.8)	1.9	(1.0 - 3.6)
Hawaii	1.0	(0.7 - 1.5)	1.4	(0.8 - 2.5)	2.6	(1.7 - 3.9)	0.7	(0.4 - 1.4)
Idaho	1.8	(1.3 - 2.6)	2.4	(1.4 - 4.1)	2.8	(1.8 - 4.4)	1.5	(1.0 - 2.4)
Illinois	1.5	(1.2 - 2.0)	1.3	(1.0 - 1.9)	2.7	(2.2 - 3.4)	1.4	(0.9 - 2.0)
Indiana	2.8	(2.0 - 3.9)	2.7	(1.8 - 4.1)	6.9	(5.0 - 9.3)	2.1	(1.3 - 3.3)
Iowa	1.1	(0.7 - 1.9)	1.3	(0.4 - 3.5)	2.1	(1.6 - 2.8)	0.9	(0.4 - 1.8)
Kansas	1.9	(1.3 - 2.7)	1.6	(0.9 - 3.0)	4.1	(2.5 - 6.6)	1.5	(0.9 - 2.5)
Kentucky	4.6	(4.0 - 5.3)	4.9	(4.1 - 5.8)	11.1	(9.7 - 12.6)	3.5	(2.6 - 4.7)
Louisiana	3.5	(2.7 - 4.4)	3.6	(2.7 - 4.7)	9.8	(8.3 - 11.6)	2.2	(1.4 - 3.4)
Maine	1.9	(1.4 - 2.4)	1.8	(1.5 - 2.2)	8.2	(6.0 - 11.2)	0.9	(0.5 - 1.7)
Maryland	1.9	(1.1 - 3.2)	1.2	(0.6 - 2.8)	3.8	(2.6 - 5.6)	1.6	(0.7 - 3.8)
Massachusetts	2.9	(1.8 - 4.8)	3.1	(2.5 - 3.9)	5.6	(4.0 - 7.9)	2.5	(1.3 - 4.8)
Michigan	1.6	(1.3 - 1.9)	1.9	(1.4 - 2.4)	4.1	(3.5 - 4.7)	1.1	(0.8 - 1.5)
Minnesota	0.8	(0.5 - 1.2)	1.0	(0.4 - 2.9)	2.4	(1.7 - 3.4)	0.5	(0.2 - 1.0)
Mississippi	2.4	(1.8 - 3.2)	3.1	(1.5 - 6.3)	5.6	(4.1 - 7.7)	1.7	(1.1 - 2.5)
Missouri	2.5	(1.8 - 3.5)	3.0	(1.9 - 4.6)	6.8	(5.3 - 8.8)	1.7	(0.9 - 3.3)
Montana	1.4	(0.9 - 2.3)	2.1	(1.2 - 3.7)	3.4	(2.4 - 5.0)	1.0	(0.4 - 2.5)
Nebraska	1.0	(0.7 - 1.4)	1.4	(0.8 - 2.6)	3.0	(2.1 - 4.4)	0.5	(0.2 - 1.1)
Nevada	2.6	(1.8 - 3.7)	1.9	(0.9 - 4.2)	5.5	(4.0 - 7.6)	2.2	(1.2 - 3.8)
New Hampshire	1.8	(1.3 - 2.4)	1.7	(0.9 - 3.1)	6.0	(4.6 - 7.8)	1.2	(0.6 - 2.1)
New Jersey	1.8	(1.2 - 2.6)	1.5	(0.7 - 3.5)	4.5	(3.3 - 6.0)	1.5	(0.8 - 2.6)
New Mexico	2.4	(1.7 - 3.5)	0.8	(0.4 - 1.6)	4.2	(2.9 - 6.1)	2.3	(1.3 - 4.0)
New York	1.5	(1.2 - 2.0)	1.2	(0.9 - 1.6)	3.4	(2.8 - 4.2)	1.3	(0.9 - 1.9)
North Carolina	2.2	(1.5 - 3.2)	3.9	(2.4 - 6.3)	6.1	(4.2 - 8.7)	1.4	(0.7 - 2.5)
North Dakota	0.8	(0.5 - 1.1)	1.5	(1.1 - 2.1)	1.3	(0.7 - 2.5)	0.5	(0.3 - 1.0)
Ohio	2.1	(1.8 - 2.5)	1.8	(1.4 - 2.3)	6.4	(5.6 - 7.4)	1.4	(1.0 - 1.9)
Oklahoma	2.8	(2.1 - 3.7)	3.0	(1.9 - 4.9)	9.0	(7.2 - 11.3)	1.6	(1.0 - 2.5)
Oregon	2.0	(1.2 - 3.2)	1.6	(0.9 - 2.9)	4.3	(2.7 - 6.6)	1.6	(0.8 - 3.2)
Pennsylvania	1.8	(1.5 - 2.1)	1.8	(1.5 - 2.3)	5.1	(4.3 - 6.0)	1.2	(0.9 - 1.7)
Rhode Island	2.4	(1.9 - 3.1)	2.2	(1.2 - 4.2)	7.4	(5.0 - 10.8)	1.5	(1.0 - 2.4)
South Carolina	3.6	(2.9 - 4.5)	3.5	(2.3 - 5.4)	6.5	(4.6 - 9.1)	3.1	(2.2 - 4.4)
South Dakota	0.6	(0.4 - 1.0)	1.7	(0.8 - 3.5)	0.9	(0.5 - 1.7)	0.4	(0.2 - 0.9)
Tennessee	3.0	(2.3 - 3.9)	3.8	(2.4 - 6.0)	9.5	(6.9 - 12.8)	1.8	(1.1 - 3.1)
Texas	1.9	(1.6 - 2.2)	2.8	(2.3 - 3.4)	5.4	(4.5 - 6.4)	1.1	(0.8 - 1.4)
Utah	2.2	(1.7 - 3.0)	1.5	(0.8 - 2.7)	5.0	(3.8 - 6.6)	1.5	(0.8 - 2.9)
Vermont	1.7	(1.1 - 2.7)	2.5	(1.2 - 4.9)	5.5	(3.5 - 8.6)	0.9	(0.4 - 2.0)
Virginia	1.7	(1.2 - 2.4)	2.1	(1.5 - 3.0)	3.8	(2.7 - 5.5)	1.3	(0.7 - 2.4)
Washington	1.8	(1.3 - 2.5)	1.4	(0.6 - 3.3)	4.8	(3.0 - 7.5)	1.3	(0.8 - 2.1)
West Virginia	2.7	(2.0 - 3.6)	3.3	(2.1 - 5.1)	10.3	(7.5 - 13.9)	1.4	(0.8 - 2.2)
Wisconsin	1.8	(1.0 - 3.2)	1.5	(0.7 - 3.4)	4.3	(2.3 - 8.0)	1.4	(0.6 - 3.3)
Wyoming	1.9	(1.3 - 2.7)	1.8	(1.1 - 3.0)	3.5	(2.4 - 5.1)	1.6	(1.0 - 2.6)

60406

**Table 7.4A Nonmedical Use of Stimulants in Past Year, by Age Group and State: Numbers in Thousands, Annual Averages Based on 2002-2004**
State	Total		AGE GROUP (Years)
	Total		12-17		18-25		26 or Older
	Total	95% Confidence Interval	Total	95% Confidence Interval	Total	95% Confidence Interval	Total	95% Confidence Interval
*Low precision; no estimate reported. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
Total	2,950	(2,774 - 3,137)	571	(532 - 613)	1,147	(1,072 - 1,226)	1,232	(1,091 - 1,391)
Alabama	55	(41 - 75)	10	(7 - 14)	23	(15 - 35)	22	(13 - 37)
Alaska	6	(4 - 8)	1	(1 - 2)	3	(2 - 4)	2	(1 - 4)
Arizona	74	(53 - 105)	14	(9 - 22)	22	(12 - 40)	38	(23 - 62)
Arkansas	41	(30 - 55)	8	(4 - 13)	20	(14 - 28)	14	(8 - 24)
California	457	(370 - 563)	61	(46 - 80)	133	(106 - 165)	264	(189 - 366)
Colorado	51	(29 - 88)	12	(8 - 17)	21	(14 - 30)	18	(4 - 73)
Connecticut	20	(15 - 26)	5	(3 - 8)	13	(9 - 19)	2	(0 - 13)
Delaware	9	(7 - 13)	2	(1 - 2)	5	(3 - 7)	3	(1 - 6)
District of Columbia	7	(4 - 12)	0	(0 - 1)	3	(2 - 6)	3	(1 - 7)
Florida	101	(77 - 133)	26	(19 - 36)	40	(34 - 49)	35	(19 - 64)
Georgia	79	(50 - 122)	18	(12 - 27)	23	(12 - 45)	38	(20 - 69)
Hawaii	15	(11 - 21)	3	(2 - 4)	5	(3 - 8)	8	(5 - 13)
Idaho	20	(15 - 26)	4	(2 - 7)	6	(5 - 8)	9	(5 - 17)
Illinois	80	(64 - 102)	20	(15 - 27)	33	(25 - 44)	27	(16 - 47)
Indiana	84	(58 - 122)	13	(9 - 20)	27	(17 - 43)	44	(26 - 75)
Iowa	42	(28 - 60)	7	(4 - 12)	15	(11 - 22)	19	(10 - 38)
Kansas	37	(28 - 48)	5	(3 - 8)	12	(6 - 20)	20	(12 - 33)
Kentucky	69	(47 - 101)	10	(7 - 14)	16	(10 - 25)	43	(26 - 73)
Louisiana	50	(34 - 74)	9	(6 - 13)	26	(17 - 41)	14	(7 - 29)
Maine	16	(8 - 31)	2	(1 - 4)	5	(4 - 7)	8	(2 - 28)
Maryland	44	(26 - 74)	10	(4 - 22)	14	(10 - 20)	20	(7 - 60)
Massachusetts	101	(63 - 163)	17	(11 - 26)	48	(29 - 80)	36	(11 - 113)
Michigan	103	(85 - 125)	29	(24 - 34)	40	(32 - 49)	35	(22 - 56)
Minnesota	65	(49 - 85)	15	(9 - 25)	29	(20 - 40)	21	(10 - 45)
Mississippi	28	(17 - 48)	7	(3 - 13)	10	(6 - 17)	11	(3 - 36)
Missouri	85	(60 - 121)	12	(8 - 17)	31	(20 - 47)	42	(25 - 71)
Montana	18	(15 - 23)	4	(3 - 5)	6	(4 - 7)	9	(6 - 13)
Nebraska	24	(16 - 37)	4	(3 - 7)	9	(7 - 11)	11	(6 - 23)
Nevada	48	(34 - 68)	5	(3 - 8)	11	(7 - 18)	33	(20 - 53)
New Hampshire	11	(8 - 15)	3	(2 - 5)	7	(5 - 11)	0	(0 - 1)
New Jersey	36	(22 - 57)	15	(8 - 27)	18	(11 - 29)	3	(0 - 27)
New Mexico	25	(14 - 44)	3	(2 - 5)	9	(6 - 13)	13	(5 - 34)
New York	111	(80 - 152)	21	(16 - 27)	62	(47 - 81)	28	(12 - 65)
North Carolina	30	(17 - 53)	12	(5 - 28)	12	(6 - 24)	5	(1 - 47)
North Dakota	8	(5 - 13)	2	(1 - 3)	3	(2 - 5)	3	(1 - 7)
Ohio	93	(76 - 114)	21	(16 - 27)	42	(33 - 54)	30	(18 - 52)
Oklahoma	51	(34 - 75)	10	(5 - 18)	22	(16 - 31)	19	(10 - 33)
Oregon	55	(38 - 80)	5	(2 - 11)	18	(13 - 25)	32	(17 - 59)
Pennsylvania	91	(73 - 114)	21	(16 - 28)	45	(35 - 57)	26	(14 - 48)
Rhode Island	16	(10 - 25)	3	(2 - 4)	10	(7 - 15)	3	(1 - 11)
South Carolina	53	(37 - 76)	8	(5 - 13)	26	(16 - 42)	19	(8 - 41)
South Dakota	11	(9 - 14)	3	(2 - 4)	4	(3 - 6)	4	(3 - 7)
Tennessee	40	(30 - 53)	8	(4 - 15)	20	(12 - 31)	12	(4 - 33)
Texas	240	(199 - 288)	48	(37 - 61)	91	(69 - 120)	101	(71 - 143)
Utah	28	(21 - 38)	4	(2 - 7)	11	(6 - 18)	14	(7 - 26)
Vermont	8	(6 - 11)	1	(1 - 2)	5	(4 - 7)	1	(1 - 4)
Virginia	46	(31 - 68)	13	(7 - 23)	28	(16 - 49)	5	(1 - 23)
Washington	96	(59 - 155)	16	(9 - 26)	30	(19 - 48)	50	(24 - 103)
West Virginia	19	(10 - 35)	3	(2 - 5)	10	(6 - 15)	6	(2 - 21)
Wisconsin	43	(31 - 58)	16	(11 - 24)	20	(13 - 29)	7	(1 - 34)
Wyoming	9	(7 - 11)	1	(1 - 2)	4	(4 - 5)	3	(2 - 6)

60406

**Table 7.4B Nonmedical Use of Stimulants in Past Year, by Age Group and State: Percentages, Annual Averages Based on 2002-2004**
State	Total		AGE GROUP (Years)
	Total		12-17		18-25		26 or Older
	Total	95% Confidence Interval	Total	95% Confidence Interval	Total	95% Confidence Interval	Total	95% Confidence Interval
*Low precision; no estimate reported. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
Total	1.2	(1.2 - 1.3)	2.3	(2.1 - 2.5)	3.6	(3.4 - 3.9)	0.7	(0.6 - 0.8)
Alabama	1.5	(1.1 - 2.0)	2.7	(1.9 - 3.7)	4.6	(3.1 - 6.9)	0.8	(0.5 - 1.3)
Alaska	1.2	(0.8 - 1.7)	2.0	(1.2 - 3.3)	3.9	(2.4 - 6.2)	0.5	(0.2 - 1.2)
Arizona	1.7	(1.2 - 2.3)	2.9	(1.9 - 4.4)	3.6	(2.0 - 6.6)	1.1	(0.7 - 1.8)
Arkansas	1.8	(1.3 - 2.5)	3.2	(1.9 - 5.5)	6.5	(4.5 - 9.2)	0.8	(0.4 - 1.4)
California	1.6	(1.3 - 2.0)	1.9	(1.4 - 2.5)	3.4	(2.7 - 4.2)	1.2	(0.9 - 1.7)
Colorado	1.4	(0.8 - 2.4)	3.1	(2.1 - 4.3)	4.2	(2.9 - 6.0)	0.6	(0.2 - 2.6)
Connecticut	0.7	(0.5 - 0.9)	1.8	(1.2 - 2.9)	3.9	(2.6 - 5.8)	0.1	(0.0 - 0.6)
Delaware	1.4	(1.0 - 1.9)	2.4	(1.6 - 3.6)	5.4	(3.6 - 8.2)	0.5	(0.2 - 1.2)
District of Columbia	1.5	(0.9 - 2.5)	1.2	(0.7 - 2.2)	4.9	(3.0 - 7.8)	0.9	(0.4 - 2.0)
Florida	0.7	(0.5 - 0.9)	1.9	(1.4 - 2.6)	2.5	(2.1 - 3.0)	0.3	(0.2 - 0.6)
Georgia	1.1	(0.7 - 1.8)	2.4	(1.6 - 3.6)	2.4	(1.2 - 4.7)	0.7	(0.4 - 1.3)
Hawaii	1.5	(1.1 - 2.1)	2.5	(1.7 - 3.5)	3.8	(2.1 - 6.6)	1.1	(0.7 - 1.7)
Idaho	1.8	(1.3 - 2.4)	3.2	(1.9 - 5.3)	3.9	(3.0 - 4.9)	1.1	(0.6 - 2.2)
Illinois	0.8	(0.6 - 1.0)	1.9	(1.4 - 2.5)	2.4	(1.8 - 3.1)	0.3	(0.2 - 0.6)
Indiana	1.7	(1.1 - 2.4)	2.4	(1.6 - 3.6)	3.8	(2.3 - 6.1)	1.2	(0.7 - 2.0)
Iowa	1.7	(1.2 - 2.5)	2.9	(1.7 - 5.1)	4.3	(3.0 - 6.2)	1.0	(0.5 - 2.0)
Kansas	1.7	(1.3 - 2.1)	2.2	(1.4 - 3.4)	3.6	(2.0 - 6.4)	1.2	(0.7 - 2.0)
Kentucky	2.0	(1.4 - 3.0)	2.9	(2.0 - 4.2)	3.5	(2.2 - 5.4)	1.7	(1.0 - 2.8)
Louisiana	1.4	(0.9 - 2.0)	2.2	(1.5 - 3.3)	4.9	(3.1 - 7.6)	0.5	(0.3 - 1.1)
Maine	1.4	(0.7 - 2.7)	2.2	(1.4 - 3.5)	4.0	(3.0 - 5.3)	0.9	(0.3 - 3.3)
Maryland	1.0	(0.6 - 1.6)	2.1	(0.9 - 4.6)	2.5	(1.8 - 3.6)	0.6	(0.2 - 1.7)
Massachusetts	1.9	(1.2 - 3.0)	3.4	(2.2 - 5.0)	7.2	(4.2 - 11.8)	0.9	(0.3 - 2.7)
Michigan	1.2	(1.0 - 1.5)	3.2	(2.6 - 3.8)	3.6	(2.9 - 4.4)	0.6	(0.3 - 0.9)
Minnesota	1.5	(1.2 - 2.0)	3.4	(2.0 - 5.7)	4.9	(3.5 - 7.0)	0.7	(0.3 - 1.4)
Mississippi	1.2	(0.7 - 2.1)	2.6	(1.3 - 5.2)	3.0	(1.8 - 4.9)	0.7	(0.2 - 2.1)
Missouri	1.8	(1.3 - 2.6)	2.4	(1.7 - 3.4)	4.9	(3.2 - 7.5)	1.2	(0.7 - 2.0)
Montana	2.4	(1.9 - 3.0)	4.8	(3.7 - 6.2)	5.5	(4.2 - 7.1)	1.5	(1.1 - 2.2)
Nebraska	1.7	(1.1 - 2.6)	2.9	(1.8 - 4.6)	4.3	(3.3 - 5.5)	1.1	(0.5 - 2.1)
Nevada	2.7	(1.9 - 3.8)	2.6	(1.6 - 4.1)	4.9	(2.9 - 8.1)	2.3	(1.4 - 3.8)
New Hampshire	1.0	(0.7 - 1.4)	2.7	(1.6 - 4.6)	5.7	(3.8 - 8.3)	0.0	(0.0 - 0.2)
New Jersey	0.5	(0.3 - 0.8)	2.0	(1.1 - 3.7)	2.2	(1.3 - 3.6)	0.1	(0.0 - 0.5)
New Mexico	1.6	(0.9 - 2.9)	1.7	(1.0 - 3.0)	4.2	(2.9 - 6.0)	1.1	(0.4 - 3.0)
New York	0.7	(0.5 - 1.0)	1.3	(1.0 - 1.7)	3.0	(2.3 - 4.0)	0.2	(0.1 - 0.5)
North Carolina	0.4	(0.2 - 0.8)	1.8	(0.8 - 4.0)	1.4	(0.7 - 2.7)	0.1	(0.0 - 0.9)
North Dakota	1.6	(1.0 - 2.4)	3.5	(2.3 - 5.4)	3.8	(2.3 - 6.3)	0.8	(0.4 - 1.8)
Ohio	1.0	(0.8 - 1.2)	2.1	(1.6 - 2.7)	3.4	(2.7 - 4.3)	0.4	(0.2 - 0.7)
Oklahoma	1.8	(1.2 - 2.6)	3.3	(1.8 - 5.9)	5.4	(3.9 - 7.5)	0.9	(0.5 - 1.6)
Oregon	1.9	(1.3 - 2.7)	1.8	(0.8 - 3.8)	4.6	(3.3 - 6.4)	1.4	(0.8 - 2.6)
Pennsylvania	0.9	(0.7 - 1.1)	2.0	(1.5 - 2.7)	3.4	(2.7 - 4.4)	0.3	(0.2 - 0.6)
Rhode Island	1.8	(1.1 - 2.8)	3.1	(2.0 - 4.9)	8.1	(5.6 - 11.6)	0.5	(0.1 - 1.5)
South Carolina	1.6	(1.1 - 2.2)	2.4	(1.5 - 3.8)	5.7	(3.5 - 9.2)	0.7	(0.3 - 1.6)
South Dakota	1.8	(1.4 - 2.3)	4.0	(3.0 - 5.4)	4.5	(3.0 - 6.7)	0.9	(0.6 - 1.5)
Tennessee	0.8	(0.6 - 1.1)	1.8	(0.9 - 3.2)	3.1	(2.0 - 4.9)	0.3	(0.1 - 0.9)
Texas	1.4	(1.1 - 1.6)	2.4	(1.8 - 3.0)	3.6	(2.7 - 4.7)	0.8	(0.5 - 1.1)
Utah	1.5	(1.1 - 2.1)	1.6	(0.8 - 3.0)	3.0	(1.8 - 5.0)	1.1	(0.6 - 2.1)
Vermont	1.5	(1.1 - 2.1)	2.8	(1.9 - 4.0)	7.4	(5.8 - 9.3)	0.4	(0.1 - 1.0)
Virginia	0.8	(0.5 - 1.1)	2.2	(1.2 - 3.8)	3.8	(2.2 - 6.5)	0.1	(0.0 - 0.5)
Washington	1.9	(1.2 - 3.1)	3.0	(1.8 - 4.9)	4.6	(2.9 - 7.2)	1.3	(0.6 - 2.7)
West Virginia	1.2	(0.7 - 2.3)	2.4	(1.5 - 3.7)	4.9	(3.0 - 7.9)	0.5	(0.2 - 1.8)
Wisconsin	0.9	(0.7 - 1.3)	3.4	(2.3 - 4.9)	3.1	(2.1 - 4.6)	0.2	(0.0 - 1.0)
Wyoming	2.1	(1.6 - 2.7)	2.4	(1.5 - 3.7)	7.1	(5.9 - 8.6)	1.1	(0.6 - 1.9)

60406

**Table 7.5A Nonmedical Use of Methamphetamine in Past Year, by Age Group and State: Numbers in Thousands, Annual Averages Based on 2002-2004**
State	Total		AGE GROUP (Years)
	Total		12-17		18-25		26 or Older
	Total	95% Confidence Interval	Total	95% Confidence Interval	Total	95% Confidence Interval	Total	95% Confidence Interval
*Low precision; no estimate reported. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
Total	1,432	(1,310 - 1,564)	187	(165 - 212)	516	(469 - 566)	729	(624 - 851)
Alabama	28	(16 - 50)	3	(1 - 5)	14	(8 - 23)	12	(4 - 36)
Alaska	3	(2 - 5)	1	(0 - 2)	2	(1 - 3)	1	(0 - 3)
Arizona	58	(38 - 86)	6	(3 - 14)	14	(7 - 26)	38	(23 - 62)
Arkansas	28	(20 - 38)	3	(2 - 7)	14	(10 - 20)	10	(5 - 21)
California	338	(270 - 422)	30	(22 - 41)	104	(80 - 134)	204	(143 - 289)
Colorado	41	(19 - 84)	5	(3 - 11)	17	(10 - 28)	18	(4 - 73)
Connecticut	1	(0 - 6)	0	(0 - 2)	1	(0 - 7)	*	(* - *)
Delaware	2	(1 - 4)	1	(0 - 1)	1	(0 - 2)	0	(0 - 3)
District of Columbia	2	(1 - 7)	0	(0 - 0)	1	(0 - 2)	1	(0 - 6)
Florida	52	(32 - 83)	7	(4 - 13)	12	(8 - 17)	33	(17 - 61)
Georgia	33	(16 - 67)	7	(2 - 19)	9	(3 - 24)	17	(7 - 41)
Hawaii	11	(8 - 16)	1	(1 - 2)	3	(1 - 6)	7	(4 - 12)
Idaho	13	(10 - 18)	2	(1 - 3)	4	(3 - 7)	7	(4 - 12)
Illinois	23	(14 - 37)	5	(3 - 8)	9	(6 - 12)	10	(3 - 28)
Indiana	40	(27 - 60)	5	(3 - 10)	13	(7 - 22)	22	(12 - 39)
Iowa	28	(18 - 43)	3	(1 - 5)	8	(5 - 15)	17	(8 - 35)
Kansas	19	(12 - 32)	3	(2 - 6)	5	(3 - 11)	10	(5 - 23)
Kentucky	32	(19 - 55)	2	(1 - 7)	7	(4 - 12)	23	(11 - 48)
Louisiana	17	(11 - 26)	4	(1 - 12)	9	(4 - 18)	4	(1 - 18)
Maine	2	(1 - 2)	0	(0 - 1)	1	(1 - 2)	*	(* - *)
Maryland	7	(4 - 14)	1	(0 - 5)	4	(2 - 9)	2	(0 - 17)
Massachusetts	9	(4 - 17)	3	(1 - 7)	6	(2 - 16)	*	(* - *)
Michigan	33	(22 - 51)	5	(3 - 8)	12	(9 - 17)	16	(7 - 35)
Minnesota	41	(28 - 60)	5	(3 - 9)	22	(14 - 36)	14	(4 - 45)
Mississippi	21	(11 - 39)	3	(2 - 7)	8	(5 - 15)	9	(3 - 35)
Missouri	44	(28 - 68)	2	(1 - 4)	17	(10 - 29)	25	(12 - 52)
Montana	11	(7 - 17)	2	(1 - 3)	4	(2 - 6)	6	(3 - 11)
Nebraska	18	(11 - 30)	2	(1 - 5)	6	(4 - 9)	10	(5 - 22)
Nevada	40	(27 - 61)	3	(2 - 6)	10	(6 - 16)	28	(15 - 50)
New Hampshire	2	(1 - 2)	1	(0 - 1)	1	(0 - 2)	0	(0 - 1)
New Jersey	9	(4 - 20)	3	(1 - 6)	7	(3 - 16)	*	(* - *)
New Mexico	20	(10 - 40)	1	(1 - 3)	7	(5 - 9)	12	(4 - 36)
New York	18	(9 - 39)	3	(1 - 6)	5	(3 - 10)	10	(3 - 35)
North Carolina	8	(4 - 18)	4	(1 - 13)	4	(1 - 10)	*	(* - *)
North Dakota	6	(4 - 10)	1	(1 - 2)	2	(1 - 4)	3	(1 - 7)
Ohio	25	(17 - 35)	6	(3 - 10)	14	(10 - 20)	5	(2 - 17)
Oklahoma	27	(17 - 42)	3	(1 - 8)	15	(9 - 25)	9	(3 - 27)
Oregon	31	(22 - 45)	3	(1 - 7)	10	(5 - 17)	19	(11 - 34)
Pennsylvania	14	(8 - 23)	3	(1 - 6)	7	(4 - 12)	4	(1 - 16)
Rhode Island	2	(1 - 6)	1	(0 - 2)	1	(0 - 3)	1	(0 - 7)
South Carolina	20	(10 - 38)	3	(1 - 7)	9	(6 - 12)	8	(2 - 32)
South Dakota	8	(6 - 10)	2	(1 - 3)	3	(2 - 4)	4	(2 - 7)
Tennessee	12	(7 - 23)	2	(1 - 6)	5	(2 - 10)	5	(1 - 30)
Texas	115	(89 - 150)	16	(10 - 25)	44	(32 - 61)	55	(34 - 92)
Utah	18	(11 - 29)	1	(0 - 3)	7	(4 - 13)	9	(4 - 24)
Vermont	1	(0 - 3)	0	(0 - 1)	0	(0 - 1)	1	(0 - 5)
Virginia	15	(9 - 27)	8	(4 - 18)	7	(3 - 15)	*	(* - *)
Washington	58	(32 - 104)	8	(4 - 16)	20	(11 - 37)	30	(12 - 70)
West Virginia	7	(4 - 11)	1	(1 - 3)	4	(2 - 8)	1	(0 - 7)
Wisconsin	14	(6 - 33)	2	(1 - 4)	6	(2 - 14)	7	(1 - 34)
Wyoming	6	(4 - 9)	1	(0 - 1)	3	(2 - 4)	2	(1 - 5)

60406

**Table 7.5B Nonmedical Use of Methamphetamine in Past Year, by Age Group and State: Percentages, Annual Averages Based on 2002-2004**
State	Total		AGE GROUP (Years)
	Total		12-17		18-25		26 or Older
	Total	95% Confidence Interval	Total	95% Confidence Interval	Total	95% Confidence Interval	Total	95% Confidence Interval
*Low precision; no estimate reported. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
Total	0.6	(0.6 - 0.7)	0.7	(0.7 - 0.8)	1.6	(1.5 - 1.8)	0.4	(0.3 - 0.5)
Alabama	0.8	(0.4 - 1.4)	0.7	(0.3 - 1.4)	2.8	(1.7 - 4.6)	0.4	(0.1 - 1.3)
Alaska	0.6	(0.4 - 1.0)	1.0	(0.4 - 2.2)	2.5	(1.4 - 4.5)	0.2	(0.1 - 0.9)
Arizona	1.3	(0.9 - 1.9)	1.3	(0.6 - 2.8)	2.2	(1.2 - 4.2)	1.1	(0.7 - 1.8)
Arkansas	1.2	(0.9 - 1.7)	1.4	(0.7 - 2.8)	4.6	(3.2 - 6.5)	0.6	(0.3 - 1.2)
California	1.2	(0.9 - 1.5)	1.0	(0.7 - 1.3)	2.6	(2.0 - 3.4)	0.9	(0.7 - 1.3)
Colorado	1.1	(0.5 - 2.3)	1.4	(0.7 - 2.7)	3.4	(2.0 - 5.7)	0.6	(0.2 - 2.6)
Connecticut	0.0	(0.0 - 0.2)	0.1	(0.0 - 0.7)	0.3	(0.0 - 2.2)	*	(* - *)
Delaware	0.3	(0.1 - 0.5)	0.8	(0.5 - 1.5)	1.0	(0.4 - 2.4)	0.1	(0.0 - 0.5)
District of Columbia	0.4	(0.1 - 1.4)	0.1	(0.0 - 0.9)	0.8	(0.3 - 2.2)	0.4	(0.1 - 1.7)
Florida	0.4	(0.2 - 0.6)	0.5	(0.3 - 1.0)	0.7	(0.5 - 1.1)	0.3	(0.2 - 0.5)
Georgia	0.5	(0.2 - 1.0)	0.9	(0.3 - 2.5)	0.9	(0.3 - 2.5)	0.3	(0.1 - 0.8)
Hawaii	1.1	(0.8 - 1.6)	1.2	(0.7 - 2.0)	2.3	(1.1 - 5.0)	0.9	(0.5 - 1.5)
Idaho	1.2	(0.9 - 1.6)	1.4	(0.8 - 2.6)	2.7	(1.7 - 4.0)	0.8	(0.5 - 1.5)
Illinois	0.2	(0.1 - 0.4)	0.4	(0.3 - 0.7)	0.6	(0.4 - 0.9)	0.1	(0.0 - 0.4)
Indiana	0.8	(0.5 - 1.2)	1.0	(0.5 - 1.9)	1.8	(1.0 - 3.1)	0.6	(0.3 - 1.0)
Iowa	1.1	(0.7 - 1.8)	1.0	(0.5 - 2.2)	2.4	(1.3 - 4.3)	0.9	(0.4 - 1.9)
Kansas	0.9	(0.5 - 1.5)	1.4	(0.7 - 2.7)	1.7	(0.8 - 3.4)	0.6	(0.3 - 1.4)
Kentucky	0.9	(0.5 - 1.6)	0.7	(0.3 - 2.0)	1.5	(0.8 - 2.6)	0.9	(0.4 - 1.8)
Louisiana	0.5	(0.3 - 0.7)	1.0	(0.3 - 3.1)	1.7	(0.8 - 3.3)	0.1	(0.0 - 0.7)
Maine	0.1	(0.1 - 0.2)	0.4	(0.1 - 1.3)	0.8	(0.4 - 1.7)	*	(* - *)
Maryland	0.2	(0.1 - 0.3)	0.3	(0.1 - 1.1)	0.8	(0.4 - 1.6)	0.1	(0.0 - 0.5)
Massachusetts	0.2	(0.1 - 0.3)	0.6	(0.3 - 1.4)	0.8	(0.3 - 2.4)	*	(* - *)
Michigan	0.4	(0.3 - 0.6)	0.6	(0.3 - 0.9)	1.1	(0.8 - 1.6)	0.3	(0.1 - 0.6)
Minnesota	1.0	(0.7 - 1.4)	1.1	(0.6 - 2.1)	3.9	(2.4 - 6.2)	0.4	(0.1 - 1.4)
Mississippi	0.9	(0.5 - 1.7)	1.3	(0.6 - 2.7)	2.4	(1.4 - 4.2)	0.6	(0.1 - 2.1)
Missouri	0.9	(0.6 - 1.4)	0.4	(0.2 - 0.9)	2.7	(1.6 - 4.6)	0.7	(0.3 - 1.5)
Montana	1.5	(1.0 - 2.2)	2.3	(1.4 - 3.6)	3.4	(2.2 - 5.2)	1.0	(0.5 - 1.9)
Nebraska	1.3	(0.8 - 2.1)	1.3	(0.5 - 3.3)	2.9	(2.0 - 4.2)	1.0	(0.5 - 2.0)
Nevada	2.2	(1.5 - 3.3)	1.6	(0.8 - 3.2)	4.3	(2.5 - 7.3)	2.0	(1.1 - 3.6)
New Hampshire	0.2	(0.1 - 0.2)	0.6	(0.3 - 1.1)	0.6	(0.2 - 1.6)	0.0	(0.0 - 0.2)
New Jersey	0.1	(0.1 - 0.3)	0.4	(0.2 - 0.8)	0.8	(0.3 - 2.0)	*	(* - *)
New Mexico	1.3	(0.7 - 2.6)	0.8	(0.4 - 1.6)	3.1	(2.1 - 4.4)	1.1	(0.4 - 3.1)
New York	0.1	(0.1 - 0.2)	0.2	(0.1 - 0.4)	0.3	(0.1 - 0.5)	0.1	(0.0 - 0.3)
North Carolina	0.1	(0.1 - 0.3)	0.6	(0.2 - 1.9)	0.4	(0.2 - 1.2)	*	(* - *)
North Dakota	1.2	(0.7 - 2.0)	1.7	(1.0 - 2.9)	3.0	(1.7 - 5.2)	0.8	(0.3 - 1.8)
Ohio	0.3	(0.2 - 0.4)	0.6	(0.3 - 1.0)	1.1	(0.8 - 1.6)	0.1	(0.0 - 0.2)
Oklahoma	0.9	(0.6 - 1.5)	1.0	(0.3 - 2.8)	3.6	(2.1 - 6.0)	0.4	(0.1 - 1.3)
Oregon	1.1	(0.7 - 1.5)	0.9	(0.3 - 2.4)	2.5	(1.4 - 4.5)	0.8	(0.5 - 1.5)
Pennsylvania	0.1	(0.1 - 0.2)	0.3	(0.1 - 0.6)	0.5	(0.3 - 0.9)	0.0	(0.0 - 0.2)
Rhode Island	0.3	(0.1 - 0.7)	0.6	(0.2 - 2.3)	0.8	(0.3 - 2.1)	0.1	(0.0 - 1.1)
South Carolina	0.6	(0.3 - 1.1)	0.8	(0.3 - 2.0)	1.9	(1.4 - 2.5)	0.3	(0.1 - 1.2)
South Dakota	1.3	(1.0 - 1.7)	2.4	(1.4 - 4.1)	3.0	(2.0 - 4.6)	0.8	(0.4 - 1.5)
Tennessee	0.3	(0.1 - 0.5)	0.5	(0.2 - 1.3)	0.8	(0.4 - 1.6)	0.1	(0.0 - 0.8)
Texas	0.7	(0.5 - 0.9)	0.8	(0.5 - 1.2)	1.7	(1.3 - 2.4)	0.4	(0.3 - 0.7)
Utah	1.0	(0.6 - 1.6)	0.4	(0.1 - 1.2)	2.1	(1.2 - 3.5)	0.8	(0.3 - 1.9)
Vermont	0.2	(0.1 - 0.6)	0.4	(0.1 - 1.3)	0.4	(0.1 - 1.4)	0.1	(0.0 - 1.2)
Virginia	0.3	(0.1 - 0.5)	1.3	(0.6 - 3.0)	1.0	(0.4 - 2.0)	*	(* - *)
Washington	1.1	(0.6 - 2.1)	1.6	(0.8 - 3.0)	3.0	(1.7 - 5.5)	0.8	(0.3 - 1.8)
West Virginia	0.4	(0.2 - 0.7)	0.9	(0.4 - 2.0)	2.3	(1.2 - 4.2)	0.1	(0.0 - 0.6)
Wisconsin	0.3	(0.1 - 0.7)	0.4	(0.2 - 0.8)	0.9	(0.4 - 2.3)	0.2	(0.0 - 1.0)
Wyoming	1.5	(1.0 - 2.2)	1.6	(0.8 - 2.9)	5.3	(4.0 - 7.0)	0.8	(0.4 - 1.5)

60406

**Table 7.6A Nonmedical Use of Sedatives in Past Year, by Age Group and State: Numbers in Thousands, Annual Averages Based on 2002-2004**
State	Total		AGE GROUP (Years)
	Total		12-17		18-25		26 or Older
	Total	95% Confidence Interval	Total	95% Confidence Interval	Total	95% Confidence Interval	Total	95% Confidence Interval
*Low precision; no estimate reported. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
Total	850	(741 - 975)	134	(115 - 157)	160	(140 - 184)	555	(453 - 681)
Alabama	17	(8 - 39)	1	(0 - 5)	4	(2 - 10)	12	(3 - 39)
Alaska	2	(1 - 2)	1	(0 - 2)	0	(0 - 1)	1	(0 - 1)
Arizona	10	(5 - 22)	2	(1 - 9)	3	(2 - 8)	5	(1 - 22)
Arkansas	11	(5 - 25)	2	(1 - 4)	5	(3 - 9)	4	(0 - 32)
California	90	(59 - 138)	17	(9 - 32)	12	(6 - 24)	61	(34 - 109)
Colorado	12	(4 - 35)	1	(0 - 5)	4	(1 - 10)	7	(1 - 40)
Connecticut	19	(6 - 59)	2	(0 - 5)	3	(1 - 7)	14	(3 - 66)
Delaware	1	(1 - 2)	0	(0 - 1)	1	(0 - 1)	*	(* - *)
District of Columbia	3	(2 - 7)	0	(0 - 1)	1	(0 - 2)	3	(1 - 6)
Florida	58	(41 - 82)	9	(5 - 16)	10	(7 - 16)	39	(23 - 66)
Georgia	21	(8 - 60)	6	(2 - 15)	2	(0 - 10)	14	(4 - 49)
Hawaii	1	(0 - 4)	0	(0 - 1)	0	(0 - 1)	1	(0 - 4)
Idaho	8	(5 - 12)	1	(0 - 2)	1	(1 - 3)	6	(3 - 10)
Illinois	18	(11 - 32)	7	(4 - 12)	3	(2 - 6)	9	(3 - 25)
Indiana	20	(8 - 50)	1	(0 - 5)	4	(2 - 9)	16	(5 - 51)
Iowa	14	(6 - 32)	1	(0 - 3)	0	(0 - 3)	12	(5 - 30)
Kansas	7	(2 - 24)	1	(0 - 4)	2	(1 - 7)	4	(0 - 34)
Kentucky	20	(10 - 39)	3	(2 - 5)	1	(0 - 6)	16	(7 - 34)
Louisiana	16	(8 - 31)	2	(0 - 6)	3	(1 - 5)	11	(4 - 30)
Maine	6	(1 - 28)	0	(0 - 1)	1	(0 - 2)	5	(1 - 33)
Maryland	24	(6 - 92)	3	(1 - 7)	3	(1 - 9)	18	(3 - 108)
Massachusetts	52	(17 - 154)	5	(1 - 15)	1	(0 - 5)	46	(13 - 155)
Michigan	25	(16 - 40)	7	(4 - 11)	7	(4 - 10)	12	(5 - 28)
Minnesota	15	(5 - 44)	2	(0 - 11)	1	(0 - 9)	12	(4 - 37)
Mississippi	10	(7 - 14)	1	(0 - 4)	2	(1 - 4)	7	(5 - 11)
Missouri	29	(13 - 65)	3	(1 - 7)	5	(2 - 12)	21	(7 - 62)
Montana	2	(1 - 3)	0	(0 - 1)	1	(0 - 2)	0	(0 - 4)
Nebraska	1	(0 - 4)	1	(0 - 2)	1	(0 - 4)	*	(* - *)
Nevada	6	(3 - 11)	2	(1 - 4)	2	(1 - 4)	2	(0 - 8)
New Hampshire	5	(2 - 14)	0	(0 - 1)	1	(1 - 3)	4	(1 - 15)
New Jersey	21	(11 - 42)	3	(1 - 9)	3	(1 - 10)	15	(7 - 35)
New Mexico	7	(3 - 17)	1	(0 - 2)	2	(1 - 4)	5	(2 - 14)
New York	51	(34 - 78)	7	(4 - 12)	10	(6 - 16)	34	(18 - 65)
North Carolina	24	(9 - 60)	4	(1 - 10)	3	(1 - 13)	17	(5 - 65)
North Dakota	0	(0 - 2)	0	(0 - 1)	*	(* - *)	*	(* - *)
Ohio	32	(20 - 49)	4	(2 - 7)	6	(3 - 10)	22	(12 - 41)
Oklahoma	10	(4 - 28)	3	(1 - 8)	2	(1 - 7)	5	(1 - 25)
Oregon	12	(4 - 31)	1	(0 - 4)	2	(1 - 4)	8	(2 - 33)
Pennsylvania	23	(16 - 34)	5	(3 - 8)	9	(6 - 14)	9	(4 - 25)
Rhode Island	6	(2 - 18)	0	(0 - 1)	1	(1 - 2)	5	(1 - 20)
South Carolina	16	(7 - 35)	0	(0 - 2)	3	(1 - 7)	12	(4 - 34)
South Dakota	1	(0 - 1)	0	(0 - 1)	0	(0 - 1)	0	(0 - 1)
Tennessee	11	(6 - 20)	5	(3 - 9)	3	(2 - 4)	3	(0 - 24)
Texas	41	(26 - 64)	12	(8 - 17)	12	(7 - 20)	18	(7 - 42)
Utah	9	(4 - 18)	1	(0 - 4)	3	(1 - 6)	5	(1 - 16)
Vermont	1	(0 - 3)	0	(0 - 1)	0	(0 - 1)	0	(0 - 3)
Virginia	10	(6 - 17)	4	(2 - 10)	6	(2 - 15)	*	(* - *)
Washington	36	(16 - 82)	1	(0 - 6)	3	(1 - 6)	32	(13 - 82)
West Virginia	7	(3 - 16)	0	(0 - 1)	2	(1 - 5)	4	(1 - 16)
Wisconsin	6	(2 - 18)	2	(0 - 6)	4	(1 - 15)	*	(* - *)
Wyoming	2	(1 - 3)	0	(0 - 1)	1	(0 - 2)	1	(1 - 2)

60406

**Table 7.6B Nonmedical Use of Sedatives in Past Year, by Age Group and State: Percentages, Annual Averages Based on 2002-2004**
State	Total		AGE GROUP (Years)
	Total		12-17		18-25		26 or Older
	Total	95% Confidence Interval	Total	95% Confidence Interval	Total	95% Confidence Interval	Total	95% Confidence Interval
*Low precision; no estimate reported. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
Total	0.4	(0.3 - 0.4)	0.5	(0.5 - 0.6)	0.5	(0.4 - 0.6)	0.3	(0.2 - 0.4)
Alabama	0.5	(0.2 - 1.1)	0.4	(0.1 - 1.3)	0.8	(0.3 - 2.0)	0.4	(0.1 - 1.4)
Alaska	0.3	(0.2 - 0.5)	0.9	(0.3 - 3.4)	0.7	(0.3 - 1.8)	0.1	(0.1 - 0.4)
Arizona	0.2	(0.1 - 0.5)	0.5	(0.1 - 1.8)	0.6	(0.2 - 1.2)	0.1	(0.0 - 0.6)
Arkansas	0.5	(0.2 - 1.1)	1.0	(0.5 - 1.7)	1.8	(1.0 - 3.0)	0.2	(0.0 - 1.9)
California	0.3	(0.2 - 0.5)	0.5	(0.3 - 1.0)	0.3	(0.2 - 0.6)	0.3	(0.2 - 0.5)
Colorado	0.3	(0.1 - 0.9)	0.4	(0.1 - 1.2)	0.8	(0.3 - 2.0)	0.3	(0.0 - 1.4)
Connecticut	0.6	(0.2 - 2.1)	0.5	(0.2 - 1.6)	0.9	(0.4 - 2.2)	0.6	(0.1 - 2.9)
Delaware	0.1	(0.1 - 0.3)	0.5	(0.2 - 1.7)	0.7	(0.3 - 1.6)	*	(* - *)
District of Columbia	0.7	(0.3 - 1.4)	0.3	(0.1 - 1.8)	0.8	(0.2 - 2.6)	0.7	(0.3 - 1.7)
Florida	0.4	(0.3 - 0.6)	0.6	(0.3 - 1.2)	0.6	(0.4 - 1.0)	0.4	(0.2 - 0.6)
Georgia	0.3	(0.1 - 0.9)	0.7	(0.3 - 2.0)	0.2	(0.1 - 1.0)	0.3	(0.1 - 0.9)
Hawaii	0.1	(0.0 - 0.4)	0.2	(0.0 - 0.8)	0.0	(0.0 - 0.4)	0.1	(0.0 - 0.6)
Idaho	0.7	(0.5 - 1.1)	0.6	(0.2 - 1.7)	0.8	(0.4 - 1.7)	0.7	(0.4 - 1.3)
Illinois	0.2	(0.1 - 0.3)	0.6	(0.4 - 1.1)	0.2	(0.1 - 0.4)	0.1	(0.0 - 0.3)
Indiana	0.4	(0.2 - 1.0)	0.1	(0.0 - 0.9)	0.6	(0.3 - 1.3)	0.4	(0.1 - 1.3)
Iowa	0.6	(0.2 - 1.3)	0.5	(0.2 - 1.2)	0.1	(0.0 - 1.0)	0.7	(0.3 - 1.6)
Kansas	0.3	(0.1 - 1.1)	0.4	(0.1 - 1.8)	0.6	(0.2 - 2.1)	0.2	(0.0 - 2.1)
Kentucky	0.6	(0.3 - 1.1)	0.9	(0.5 - 1.5)	0.3	(0.1 - 1.3)	0.6	(0.3 - 1.3)
Louisiana	0.4	(0.2 - 0.9)	0.4	(0.1 - 1.4)	0.5	(0.3 - 1.0)	0.4	(0.2 - 1.1)
Maine	0.5	(0.1 - 2.5)	0.4	(0.1 - 1.1)	0.5	(0.1 - 1.6)	0.6	(0.1 - 3.7)
Maryland	0.5	(0.1 - 2.0)	0.6	(0.2 - 1.5)	0.6	(0.2 - 1.6)	0.5	(0.1 - 3.1)
Massachusetts	1.0	(0.3 - 2.9)	0.9	(0.3 - 2.9)	0.2	(0.0 - 0.8)	1.1	(0.3 - 3.7)
Michigan	0.3	(0.2 - 0.5)	0.8	(0.4 - 1.3)	0.6	(0.4 - 1.0)	0.2	(0.1 - 0.4)
Minnesota	0.4	(0.1 - 1.1)	0.4	(0.1 - 2.4)	0.2	(0.0 - 1.5)	0.4	(0.1 - 1.2)
Mississippi	0.4	(0.3 - 0.6)	0.3	(0.1 - 1.6)	0.6	(0.3 - 1.0)	0.4	(0.3 - 0.7)
Missouri	0.6	(0.3 - 1.4)	0.7	(0.3 - 1.4)	0.8	(0.3 - 1.9)	0.6	(0.2 - 1.7)
Montana	0.2	(0.1 - 0.5)	0.2	(0.1 - 0.9)	0.9	(0.4 - 1.8)	0.1	(0.0 - 0.7)
Nebraska	0.1	(0.0 - 0.3)	0.5	(0.2 - 1.3)	0.3	(0.1 - 1.8)	*	(* - *)
Nevada	0.3	(0.2 - 0.6)	0.8	(0.3 - 2.3)	0.9	(0.4 - 2.0)	0.1	(0.0 - 0.6)
New Hampshire	0.5	(0.2 - 1.3)	0.3	(0.1 - 1.0)	1.0	(0.5 - 1.9)	0.4	(0.1 - 1.8)
New Jersey	0.3	(0.2 - 0.6)	0.4	(0.1 - 1.3)	0.4	(0.1 - 1.2)	0.3	(0.1 - 0.6)
New Mexico	0.5	(0.2 - 1.1)	0.4	(0.1 - 1.4)	0.8	(0.3 - 1.8)	0.4	(0.1 - 1.3)
New York	0.3	(0.2 - 0.5)	0.5	(0.3 - 0.8)	0.5	(0.3 - 0.8)	0.3	(0.1 - 0.5)
North Carolina	0.3	(0.1 - 0.9)	0.5	(0.2 - 1.4)	0.3	(0.1 - 1.4)	0.3	(0.1 - 1.2)
North Dakota	0.1	(0.0 - 0.4)	0.5	(0.2 - 1.3)	*	(* - *)	*	(* - *)
Ohio	0.3	(0.2 - 0.5)	0.4	(0.2 - 0.7)	0.5	(0.3 - 0.8)	0.3	(0.2 - 0.6)
Oklahoma	0.4	(0.1 - 1.0)	0.9	(0.3 - 2.8)	0.5	(0.1 - 1.7)	0.3	(0.1 - 1.2)
Oregon	0.4	(0.1 - 1.1)	0.5	(0.2 - 1.4)	0.5	(0.3 - 0.9)	0.4	(0.1 - 1.4)
Pennsylvania	0.2	(0.2 - 0.3)	0.5	(0.3 - 0.8)	0.7	(0.4 - 1.0)	0.1	(0.0 - 0.3)
Rhode Island	0.7	(0.2 - 2.0)	0.2	(0.0 - 1.1)	1.1	(0.7 - 1.7)	0.7	(0.1 - 2.9)
South Carolina	0.5	(0.2 - 1.0)	0.1	(0.0 - 0.6)	0.7	(0.3 - 1.6)	0.5	(0.2 - 1.3)
South Dakota	0.1	(0.1 - 0.2)	0.6	(0.2 - 1.8)	0.3	(0.1 - 1.1)	0.0	(0.0 - 0.1)
Tennessee	0.2	(0.1 - 0.4)	1.0	(0.6 - 1.9)	0.5	(0.3 - 0.7)	0.1	(0.0 - 0.6)
Texas	0.2	(0.1 - 0.4)	0.6	(0.4 - 0.8)	0.5	(0.3 - 0.8)	0.1	(0.1 - 0.3)
Utah	0.5	(0.2 - 1.0)	0.5	(0.1 - 1.6)	0.8	(0.4 - 1.7)	0.4	(0.1 - 1.3)
Vermont	0.2	(0.1 - 0.5)	0.9	(0.4 - 1.8)	0.4	(0.1 - 1.2)	0.1	(0.0 - 0.8)
Virginia	0.2	(0.1 - 0.3)	0.7	(0.3 - 1.6)	0.8	(0.3 - 2.0)	*	(* - *)
Washington	0.7	(0.3 - 1.6)	0.2	(0.0 - 1.1)	0.4	(0.2 - 1.0)	0.8	(0.3 - 2.1)
West Virginia	0.4	(0.2 - 1.0)	0.3	(0.1 - 0.8)	1.0	(0.5 - 2.4)	0.3	(0.1 - 1.3)
Wisconsin	0.1	(0.0 - 0.4)	0.3	(0.1 - 1.2)	0.6	(0.2 - 2.4)	*	(* - *)
Wyoming	0.5	(0.3 - 0.8)	0.8	(0.3 - 2.2)	1.2	(0.5 - 2.9)	0.3	(0.2 - 0.7)

Appendix D: Selected Data Tables